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Abstract 
It has been well known that the extracellular matrix (ECM) is important to the aortic 
valve function and that mechanical forces and cell-cell communication can regulate 
ECM remodeling. However, it has not been determined which cells regulate ECM 
production by valve interstitial cells (VICs). Thus, this study aimed to investigate if 
the valve endothelial cells (VECs) can influence ECM production and whether there 
is a differential role of VECs from either surface of the valve. In addition, the study 
aimed to assess the suitability of adipose derived stem cells (ADSCs) to differentiate 
into VECs with side-specific characteristics, so that could be used to populate tissue 
engineered heart valves.  
Firstly, a reliable method of side-specific isolation and culture of VECs was 
developed. Consequently, the phenotypic characteristics of aortic VECs (aVECs) and 
ventricular VECs (vVECs) were investigated in vitro by immunostaining, western 
blots and protein array. Endothelial markers vWF, CD-31, VE-cadherin and eNOS 
and the release of cytokines IL-1β, IL-8, and TGF-β were assessed in cultured VECs 
from either side of the valve. However the distinct phenotypes between aVECs and 
vVECs in culture were not established.  
The differential ability of side-specific VECs to regulate the production of ECM 
components by VICs was observed when VICs were cultured with media containing 
molecules released from side-specific VECs, in static culture, and when aVECs or 
vVECs were co-cultured with VICs. The media collected from vVECs increased 
amount of collagen by VICs while the media from aVECs showed no significant 
changes in the content of ECM. Interestingly, in the co-culture system, vVECs-VIC co-
culturing enhanced the amount of both collagen and glycosaminoglycans (GAGs) 
whereas aVECs did not affect the ECM proteins.  
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Moreover side-specific VECs were exposed to the oscillatory and laminar shear 
stresses (flow patterns experienced by aortic and ventricular surface of the valve, 
respectively). Their distinct responses on the production of ECM by VICs were 
investigated. Aortic VECs exposed to oscillatory flow had higher content of collagen 
and GAGs while vVECs did not share this effect. The laminar shear stress on both 
sides of the valve maintained elastin content (as compared to fresh tissue).   
ADSCs were also exposed to side-specific patterns of flow to assess their ability to 
differentiate into side-specific VECs. With respect to these factors, the exposure of 
ADSCs to the oscillatory shear stress induced the differential expression of NOS III 
and SMαA, similar to reported differences found between porcine aVECs and vVECs. 
Both flow patterns also increased the endothelial function of ADSCs by up-taking 
low-density lipoprotein. 
In conclusion, this study reveals the unique functional phenotypes between the 
aortic and ventricular VECs, and the unique communication between VECs and VICs 
that is mediated by shear stress to regulate the specific production of ECM 
components. ADSCs appear to have the capacity to express endothelial markers, but 
a full functional assessment of their communication with VICs remains to be 
investigated. This information is important to the development of a living tissue 
engineered heart valve.  
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1 CHAPTER 1 Introduction 
 
1.1  The Aortic Valve  
The aortic valve is a tricuspid structure that ensures the uni-directional flow of 
blood out of the left ventricle into the ascending aorta and optimises coronary 
perfusion.  It is calculated to open and close, approximately 3 billion times in an 
average lifetime.  
The valve was previously believed to be a passive structure that functioned in 
response to differences in transvalvular pressures between left ventricle and aorta.  
The mechanism for valve function was thought to rely only on the changes in 
pressure that occur during the cardiac cycle, whereby, during systole, the left 
ventricle contracts to produce a rise in pressure in the chamber higher than that in 
the aorta, thus causing the aortic valve to open.  When systole finishes, the left 
ventricle relaxes (turning to diastole) causing the pressure in it to drop.  At this 
moment the pressure in the aorta is higher than left ventricle letting the aortic valve 
close thereby preventing flow of blood back into the left ventricle.   
However, it is now widely accepted that the aortic valve is a highly complex 
structure that relies on its cellular components for the coordinated movements of its 
constituent parts (Yacoub et al., 1999).  This is illustrated by the fact that the valve 
actually starts to open before there is outflow of blood from the left ventricle 
(Higashidate et al., 1995).  Furthermore viable cells in the valve are needed to 
maintain the durability and functionality of the valve (Schneider and Deck, 1981). 
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Understanding the function of the cellular components of the valve during 
development, in the post-natal period and into adulthood, is to be able to fully 
comprehend how the valve maintains its function over the course of a lifetime as 
well as how and why the valves may become diseased in certain individuals.  
   
1.2  Development of Aortic Valve 
During embryonic development, the aortic valvulogenesis starts from the creation of 
endocardial cushions in the atrioventricular (AV) canal.  It involves a series of 
delamination, migration and transdifferentiation of particular cells as well as 
remodeling of extracellular matrix (ECM). The endocardial cushion formation is 
induced by the myocardium that produces a hyaluronan-rich matrix.  The 
hyaluronic matrix has hydrophilic properties; thus, it is termed “cardiac jelly”.  It is 
secreted and accumulated between the myocardium and the endocardium at the AV 
canal creating swelling regions, known as the endocardial cushions (Figure 1.1).  
Moreover the hydrophilic cardiac jelly serves as a physical scaffold for the 
endocardial cells to migrate into, populate, synthesise matrix proteins and 
subsequently lay down the ECM of the valve.  Although the endocardial cushions are 
formed at the early stage of embryonic development, they function as a physical 
barrier to prevent the regurgitation of blood through the primitive heart tube prior 
to the individual cushions becoming the heart valve cusps.  
Following endocardial cushion development, overlying endothelial cells are 
subsequently delaminated from the single layer, allowing them to migrate into the 
cardiac jelly.  The cushion-resident cells laterally develop into mesenchymal cells or 
valve interstitial cells. The process of endothelial cells differentiating into 
mesenchymal cells, known as Endothelial-Mesenchymal-Transition (EndoMT), 
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requires complicated signaling pathways that transduce signals from myocardium 
and endocardium (Figure 1.1).  
The key mediators involved in the EndoMT process are transforming growth factor 
(TGF), Notch, vascular endothelial growth factor (VEGF), wnt/β-catenin and the 
NFAT family of proteins.  The TGF superfamily, including TGFβ and bone 
morphogenetic proteins (BMPs), is also important for inducing endocardial cushion 
formation.  Although Notch signaling is not essential for initial endocardial cushion 
formation, it is indispensible for EndoMT. VEGF plays an important role in 
regulating the proliferation of endothelial cells which are profoundly associated 
with the initiation of the endocardial cushion, the deposition of cardiac jelly and 
EndoMT.  In addition, the wnt/β-catenin and the NFAT family of proteins have 
important roles for the migration and EndoMT of endocardial cells (Combs and 
Yutzey, 2009; Armstrong and Bischoff, 2004).  
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Figure 1.1 Model of heart valve development.  Heart valve development occurs in the developing 
heart tubes containing the outer layer of myocardium and the inner layer of endocardium.  BMP 
expression in myocardium results in the production and deposition of hyaluronic matrix, cardiac 
jelly, between myocardium and the endocardium.  It generates the protruding area known as 
endocardial cushion.  Endocardial VEGF expression increases the proliferation of endocardial cells 
during the cushion formation, a), and endothelial-to-mesenchymal transition (EndoMT), b).  During 
EndoMT, the endocardium express VEGF, TGF-β and NFAT to increase the proliferation, 
delamination and migration of themselves into the cardiac jelly to become mesenchymal cells 
(represented in star-shaped green model).   The expressions of Wnt/β-catenin by endocardium and 
BMPs by myocardium are important to EndoMT. 
 
Once in the cardiac jelly, endocardium undergoing EndoMT digests the previously 
deposited ECM and produces new ECM components such as collagen type I, II and 
III, versican and other proteoglycans to create more rigid cusps (Liu et al., 2007).  
After birth, the aortic valve adapts its strength by modulating the ECM in response 
to the increased systemic pressures.  There is also adaptive change in cell-loss of 
myofibroblasts and a gain of quiescent valve interstitial cells (VICs) over the period 
of a lifetime (Rabkin-Aikawa et al., 2004b).  In fetal valves, myofibroblasts are 
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prominently found at about 62% of total amount of VICs as their function is 
required to remodel the ECM components during development.  However, they are 
less abundant (presenting at 2.5% of total VICs) in adult healthy valves (Rabkin-
Aikawa et al., 2004b). The fully developed elongated thin valve cusp that has 
stratified layers of ECM and specific cellular components are further remodeled 
after birth and are important for the structure-function relationship of the valve.  
 
1.3  Structure of the Aortic Valve  
The aortic valve is a complex structure consisting of many functional units, for 
example, annulus, (three) cusps, sinotubular junction and (three) sinuses.  The 
whole valve machinery is termed the ‘aortic root’ and it sits between the left 
ventricle and the ascending aorta. 
The valve cusps are attached to a crown-shaped annulus in a semilunar pattern.  The 
highest point of the attachment, where adjacent cusps are closest together (known 
as commissures), marks the boundary of the valve and the ascending aorta, which is 
identified as small ridge, termed the sinotubular junction. 
At the basal point of attachment of each cusp, the annulus is bulged creating three 
“pockets”-called the sinuses of Valsalva.  Two of the sinuses of Valsalva have ostia 
that give rise to left and right coronary arteries.   Thus, the sinuses and cusps are 
named according to the coronary arteries arising from; namely the left, right or non-
coronary sinus or cusp (Figure 1.2). 
The competent seal of the aortic valve prevents the regurgitation of blood flow back 
into the left ventricle and involves the coapting areas on individual cusps.  In the 
middle of the free edge of each cusp, nodules of Arantius are created from bundles 
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of fibrous tissue.  The co-aptation of 3 nodules at the centre of the aorta ensures a 
tight seal during valve closure.  Two crescentic areas of each cusp known as lunulae 
are located along the free edge between the commissures and the nodule of 
Arantius.  The lunulae affect the competent seal during diastole by contact with the 
corresponding region of the contiguous cusps.  The remaining area of the cusp, apart 
from coapting area, is termed the “belly” region. The microstructure and cellular 
compositions of each of the structures within the valve dictate the durability and 
function of the valve.  
 
 
Figure 1.2 Anatomy of the aortic valve.  Aortic root consists of 3 semilunar cusps sitting between 
the aorta and left ventricle.  The bulged pockets in the aortic root are called Sinus of Valsava in 
which two of them have the ostria known as left and right coronary artery.  The edge of fibrous ring 
on top of the aortic root is Sinotubular junction.  The coronary cusps are attached on the aorta wall 
in a crown shape and join to each other at the commissures.  Free edge of each cusps consists of 
Nodule of Arantius and Lunalae.  During dystole, the free edges are tightly in contact to the adjacent 
leaflet and asssure the closing of the valve. Adapted from 
http://www.cicmd.com/images/cicmd/anatomy%20images/aortic-valve.gif 
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1.3.1 Histological profile of the aortic valve  
Histological examination of aortic valve leaflets reveals 3 distinct layers, which are 
different in terms of extracellular matrix (ECM) components and cellular 
components.  
The fibrosa layer, which is mainly composed of collagen, is on the aorta side of the 
valve.  The middle layer, termed the spongiosa contains glycosaminoglycans (GAGs) 
as a major component.  Finally the ventricularis layer is on the ventricular side of 
the valve and is composed of abundant amounts of elastin (Figure 1.3). The 
microstructure architecture of the aortic valve is preserved among different species.  
Sus Scrofa (pig) and Ovis Aries (sheep) have cellular and extracellular composition 
similar to human; thus, they are commonly employed as animal models for studying 
valve biology and disease.  
 
Figure 1.3 Histological structure of an aortic valve cusp.  ECM component in a human aortic valve 
leaflet was stained with sirius red, alcian blue and Millaer’s elastin.  Collagen, GAGs and elastin are 
represented in pink, blue and purple, respectively.  Provided by Dr. Padmini Sarathchandra. 
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1.3.2 Cellular components  
The durability and functionality of the valve is maintained by its cellular population.  
Rabkin-Aikawa and colleagues showed that a pulmonary autograft (where the 
pulmonary valve is placed in the aortic position) could adapt its functionality to 
cope with the new heamodynamic environment on the left side of the heart (Rabkin-
Aikawa et al., 2004a).  The ability of the pulmonary valve to adapt in this way and 
the importance of living cells to the valve was recently illustrated by El-Hamamsy et 
al. who showed that the survival of patients following the implantation of a living 
valve substitute (such as a pulmonary autograft) was indistinguishable to the 
survival rate of an aged matched population and superior to the recipients who 
received a homograft valve (that contains no living cells) (El-Hamamsy et al., 2010).   
There are 2 principal types of cells found in the aortic valve.  Valve endothelial cells 
(VECs) are on the surface and VICs that are distributed throughout the tri-layered 
structure of the leaflet.  
 
1.3.2.1 Valve Interstitial Cells 
VICs is the collective name for cells that populate the ECM of the valve cusps.  They 
have been observed to have distinct characteristics different to other fibroblast-like 
cells from pericardium and skin (Taylor et al., 2000).  Moreover the unique 
phenotypes among subpopulations of VICs from different valves are also evident.  In 
mature valves, VICs are comprised principally of 3 distinct phenotypes; fibroblasts, 
myofibroblasts and smooth muscle cells.  
(i)   Fibroblasts express fibroblast surface antigen (FSA) and vimentin, an 
intermediate filament of mesenchymal cells.  The unique characteristic, which 
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differentiates fibroblastic VIC phenotype from other two phenotypes, is the 
absence of smooth muscle alpha-actin (SMαA).  About 80% of cultured human 
VICs from all 4 heart valves are positive for FSA (Rabkin-Aikawa et al., 2004b; 
Taylor et al., 2000).  Moreover, fibroblastic VICs possess ECM sectretory and 
remodeling properties.  All cultures of VICs express prolyl 4-hydroxylase (the 
collagen triple helix cross-linking enzyme) (Taylor et al., 2000).  The electron 
microscope pictures of VICs also show the secretory organelles associating 
with prolyl 4-hydroxylase expression (Messier, Jr. et al., 1994).    
VICs are believed to remain quiescence in normal healthy valves but become 
activated under pathological circumstances.  Chemokines and growth factors 
are produced by VECs and macrophages following injury or abnormal 
hemodynamic mechanical stress.  They are considered as precursors of the 
trans-differentiation pathway that normal VICs enter in becoming the 
osteoblast-like cells and associating with calcification of the valve (Osman et 
al., 2006; Rajamannan et al., 2003).   
 
(ii)  VICs identified as myofibroblasts express intermediate filaments 
(vimentin and desmin), cytoskeletal filaments (SMαA) and non-muscle 
myosin (SMemb) which are markers for activated mesenchymal cells.  
Additionally, they are negative for myosin, which is expressed by smooth 
muscle cells (Rabkin et al., 2001).  Myofibroblasts are considered as activated 
VICs. After become activated, they increase the production of one autocrine, 
TGF-β (Liu et al., 2007), which plays important role in the trans-
differentiation of VICs into osteoblast-liked VICs (Osman et al., 2006).  
Primary VICs, which were isolated from normal human valves and treated 
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with osteogenic media, bone morphogenic proteins and TGF-β, increased 
expression and activity of alkaline phosphatase (Osman et al., 2006).  
Activated VICs actively remodel ECM components during development, 
adaptation and pathology (Rabkin-Aikawa et al., 2004b).  During fetal 
development, SMαA and SMemb possitive cells were found abundantly in 
about 62% of VICs.  Interestingly, in normal adult valves, the amount of 
myofibroblasts are significantly decreased to 2.5% (while the majority 
phenotype of VICs are fibroblasts).  Similarly, the amount of myofibroblasts 
was decreased in long-term pulmonary-autografted aortic valves, compared 
to newly transplanted valves which have not adapted to their new 
heamodynamic environment.  Lastly, myofibroblastic phenotypes were found 
abundantly in myxomatous degenerative valves (Rabkin-Aikawa et al., 
2004b). The myofibroblasts in all valves (fetal, newly autografted and 
diseased valves) also expressed ECM remodeling enzymes (Rabkin et al., 
2001; Rabkin-Aikawa et al., 2004b).  Matrix metalloprotease (MMPs), which 
are a family of collagen and elastin degrading enzymes, and their inhibitors, 
tissue inhibitors of matrix metalloproteases (TIMPs), were also observed in 
normal human valves around VICs positive for SMαA.  These results 
demostrate that myofibroblastic phenotype and, thus, function are required 
for heart valves to modulate ECM components in reposnse to the 
microenvironment.  
 
(iii) Smooth muscle cells (SMCs) are found less frequently in the valve than 
the other two cell types.  They express vimentin, SMαA and smooth muscle 
myosin (SMM) heavy chain, but not desmin nor SMemb (Rabkin et al., 2001).  
SMCs also exhibit contractile properties; thus, they are believed to mediate 
the observed contractile properties in the valve (Chester et al., 2000).  
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Moreover, the comparison between porcine aortic VICs (PAVICs) and porcine 
aortic smooth muscle cells (PASMCs), from the same animal, substantiated 
the unique abilities of VICs to contract and synthesise matrix component 
(Butcher and Nerem, 2004).  When PAVICs and PASMCs are encapsulated in 
collagen type I, they both showed the ability to compact the gel at similar 
extent. Additionally they express SMαA to a similar level.  However PAVICs 
expressed different amounts of desmin which is a muscle cell marker and 
produced more protein and glycosaminosglycans (GAGs) (Butcher and 
Nerem, 2004).  
 
Valve interstitial cells actively communicate with each other and the ECM as well as 
dynamically respond to the mechanical changes through particular (membrane) 
proteins. The presence of N-cadherens, desmogleins, connexins (Cx) 26 and 43 
suggests that VICs have cell to cell communication through junctional proteins (Latif 
et al., 2006); although tight junctions were not found.  They are thought to use cell-
matrix communication to respond to the ever changing mechanical environment.  
Integrins, are abundant membrane bound proteins expressed by VICs, and play an 
importance role in the transmission of mechanical force experienced by the ECM 
into cells (Latif et al., 2005).  The extracellular part of the integrin binds to collagen 
and senses the mechanical stress in ECM, while the intracellular components are 
linked to the cell’s cyotoskeleton.  
 
1.3.2.2 Valve Endothelial Cells (VECs) 
VECs inhabit the surface of the valve on both the aortic and ventricular aspects of 
the valve and are named, aortic valve endothelial cells (aVECs) and ventricular valve 
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endothelial cells (vVECs). They populate the surfaces of the cusps and are, 
continuous with the endothelium of aorta and endocardium of the left ventricle. 
During the cardiac cycle, VECs on the opposite sides of the valve are exposed to 
different flow patterns.  While VECs that lie on the aortic side encounter low 
oscillatory shear stress, VECs on the ventricular side experience high laminar shear 
stress.  The different magnitude of the shear stress is therefore speculated to effect 
VEC morphology – with cubodial shape of aVECs and a more elongated and flat 
shape of vVECs (Hurle and Colvee, 1983; Maron and Hutchins, 1974).  
VECs are considered to have a function similar to vascular endothelial cells (ECs) 
elsewhere in the cardiovascular system.  For example, they regulate inflammatory 
reactions between blood and tissue (Muller et al., 2000), deliver nutrients to the 
underlying cells (Tompkins et al., 1989) and regulate the phenotype of cells within 
the valve (Butcher and Nerem, 2006). 
Cell adhesion molecules (CAMs) expressed by activated vascular ECs play an 
important role in the interaction between vascular ECs and circulating blood cells.  
Likewise, adhesion molecules in VECs have been identified (Muller et al., 2000).  
Muller reported the expression of a range of CAMs including ICAM-1, CD34, PECAM-
1 (CD31) and VCAM-1, all of which were constitutively expressed by VECs in 
calcified and inflamed valves.   
Circulating macromolecules can be delivered to VICs within the valve through the 
function of VECs (Tompkins et al., 1989).  In vivo autoradiographic studies by 
Tompkins and colleagues demonstrated that the radiolabeled low-density 
lipoproteins (LDL) and albumin were able to immediately permeate into the aortic 
valve through VECs.  There was no difference in permeability between VECs on the 
aortic and ventricular sides in spite of the different magnitudes of shear stress 
between each side of the valve.  However, the average LDL permeability of VECs was 
 38 
 
found to be significantly higher than those of ECs on the aorta (Tompkins et al., 
1989).  
VECs have been shown to regulate VIC proliferation and trans-differentiation 
(Butcher and Nerem, 2006).  In the presence of VECs in a 3-dimensional co-culture 
model with laminar flow, VICs remain quiescent by showing less proliferation and 
expressing less SMαA.  When cultured with osteogenic differentiation media 
without the effect of shear stress, VECs prevent VICs differentiation into 
myofibroblasts.  
Paracrine mediators produced by vascular ECs are well characterised and they 
function to regulate the contraction of the vessel wall (Vanhoutte and Tang, 2008).  
Likewise, valvular ECs have the potential capability to control the contraction of the 
aortic valve by releasing vasodilators such as prostacyclin and nitric oxide (NO) (Ku 
et al., 1990; Pompilio et al., 1998) and vasoconstrictor agents such as endothelin-1 
(ET-1) (Peltonen et al., 2009).  
Evidence of the regulation of valve stiffness by VECs was revealed in porcine aortic 
and pulmonary valves. The contraction of valves cusps was increased with 
increasing concentration of the exogenous ET-1 in both intact and VEC-denuded 
valves (Pompilio et al., 1998).  However, the contraction of the denuded valves was 
higher than the intact valves at the same concentration of exogenous ET-1.  
Moreover, the contraction of the valves was profoundly increased when an NO 
synthase inhibitor was used to block the release of NO.  It was noted that the NO 
syhthase inhibitor did not affect the contraction of the valves from which ECs had 
been intentionally removed (Pompilio et al., 1998).  Recently El-Hamamsy et al. 
have shown that VECs regulate the valve mechanical properties through an 
endothelium-dependent mechanism that involves NO.  They revealed the effect of 
serotonin (5-HT), which releases NO, decreases the stiffness of the valve.  However, 
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the effect of 5-HT was reversed when VECs are intentionally removed from the valve 
or in the presence of a NO synthase inhibitor (El-Hamamsy et al., 2009).  
The valve endothelial cells do not only maintain valve homeostasis at the tissue 
level, they also regulate the cellularity of the valve.  VECs are thought to have the 
property of valve progenitor cells that act to replenish VICs through activation of 
EndoMT.  Evidence of this process can be seen by the co-expression of endothelial 
and mesenchymal markers by endothelial cells in both on the mature valves and in 
culture.  Co-expression of CD31 (an endothelial specific marker) and SMαA by VECs 
have been reported in mature ovine aortic valves (Paranya et al., 2001), mitral 
valves (Wylie-Sears et al., 2011) and human pulmonary valves (Paruchuri et al., 
2006).  The ability to express SMαA by VECs is enhanced  by the exogenous 
treatment of TGF-β (Paranya et al., 2001; Paruchuri et al., 2006).  Although the 
mechanisms were not pursued by these studies, it is now well known that TGF-β 
increases the expression of SMαA through Snail1 (Piera-Velazquez et al., 2011; Li 
and Jimenez, 2011).  Moreover, the cultures of mitral VECs are able to be 
differentiated into osteogenic and chondrogenic lineage in a comparable way to 
VICs and bone marrow-derived mesenchymal stem cells (Wylie-Sears et al., 2011).  
Although VECs exhibit functions similar to ECs elsewhere in the circulation, there is 
increasing evidence showing that VECs have distinct properties compared to the 
vascular ECs.  Studies in the canine aortic valves revealed that VECs on both side of 
the valves lie circumferentially to the free edge (Deck, 1986) which is, in fact, 
parallel to the collagen fiber alignment but perpendicular to the flow experienced on 
the ventricular surface.  Moreover the unique alignment of VECs is conserved in 
cultured cells that were maintained in a culture dish without an aligned substrate 
(Butcher et al., 2004).  Porcine VECs and ECs from the aorta from the same animals 
were expanded in vitro and exposed to steady laminar shear stress for 48 hours.  
Aorta ECs responded to the flow by aligning parallel to the direction of flow, while 
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VECs maintained perpendicular alignment to the flow similar to the observation 
made in vivo (Butcher et al., 2004; Deck, 1986).  The signaling pathway in response 
to the shear stress revealed differences between VECs and aorta ECs.  While the 
shear stress induced only Rho-kinase signaling in VECs, both Rho-kinase and 
phosphatidylinositol 3-kinase pathways were involved in alignment of EC from the 
aorta (Butcher et al., 2004).  
In addition, VECs from aortic valves also appear to have a different transcriptional 
profile and a higher proliferation rate than ECs from the aorta. Under static 
conditions, VECs are most proliferative when cultured on gelatin and collagen 
substrate, whereas ECs from the aorta grow most rapidly on lysine and laminin 
(Farivar et al., 2003).  The differential proliferation rate could be due to an effect of 
different cell-matrix interactions between VECs and vascular ECs. Different 
materials coated on the culture plates may have unique interactions to membrane 
proteins which are differentially expressed by ECs and VECs.  The unique cell-matrix 
interactions subsequently induce differential intracellular signaling pathways and 
may lead to differential cell phenotype and proliferation rate. 
Microarray results also suggested a higher expression of mitogenic mRNA in VECs 
e.g. the fibroblast growth factor, protein kinase C and jun D.  Furthermore, some 
endothelial markers are differentially expressed. For example, platelet-derived 
growth factor receptor (PDGF-R) and platelet endothelial cell adhesion molecule 
(PECAM) mRNA are found only in VECs.  Whereas vascular endothelial cell growth 
factor (VEGF)-B and vascular cell adhesion molecule (VCAM)-1 mRNA are expressed 
only in vascular EC (Farivar et al., 2003).   
Transcriptional profiles of VECs and aorta ECs exposed to laminar shear stress have 
also been compared (Butcher et al., 2006).  Under laminar flow, VECs increased 
expression of chondrogenic factors, compared to un-stimulated VECs. Whereas 
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aorta ECs illustrated higher expression level of osteogenic factors, compared to 
static ECs.  Additionally, VECs expressed higher amounts of anti-inflammatory 
mRNA but less pro-inflammatory mRNA when compared to vascular ECs.  
Phenotypic heterogeneity of ECs is not conserved to only cells from individual tissue 
or organs.  VECs on the aortic and ventricular side of the aortic valve also have the 
capacity to regulate valve/VIC function in different ways. 
 
1.3.3 Side-specific Heterogeneities of VECs  
Valve endothelial cells from the opposite sides of the valve are exposed to different 
types of flow and exhibit divergent gene expression.  A transcription profile of in situ 
porcine VECs revealed 584 genes differentially expressed by VECs on the aortic 
aspect of the valve and those on ventricular aspect (Simmons et al., 2005).  The 
disease-prone aortic side of the valve expressed less genes of inhibitors of 
calcification such as osteoprotegerin, C-type natriuretic peptide, parathyroid 
hormone and chordin, but compensated by higher expression of genes for 
antioxidants such as glutathione S-transferase and arachidonate 12-lipoxygenase as 
well as the oxidation related gene, endothelial NO synthase (NOS III).  aVECs and 
vVECs have also been shown to have a differential expression of some endothelial 
markers; expression ratio of aortic over ventricular side VECs of connexin 43 and 
von Willibrand factor (vWF) were -1.72 and 1.60, respectively (Simmons et al., 
2005).  
Subsequently, mRNA microarray of cultured human aVECs and vVECs which were 
exposed to their physiological shear patterns has been reported (Holliday et al., 
2011).  Although there are differences among experimental settings, in situ verses in 
vitro, and species of animal models, mechanosensitive gene expression is conserved 
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between the 2 studies.  More importantly, Holliday and colleagues identified side-
specific micro RNAs (miRNA).  miRNA-370 which has been reported to be up-
regulated during EndoMT (Castilla et al., 2011) has increased expression in vVECs 
exposed to laminar flow when it was compared to aVECs exposed to laminar flow.  
This result suggested that miRNA-370 expression was not flow-dependent but, in 
fact, differentially expressed in a side-specific manner (Holliday et al., 2011).  
However the comparison between laminar and oscillatory shear stress effect on 
miRNA-370 expression by vVECs was not validated.  
In addition to the gene array studies, in situ staining of Cx, a component of the gap 
junctions, have shown differentially expression by VECs from opposite sides of the 
valve (Inai et al., 2004).  Cx37, Cx40, and Cx43 are differentially expressed in 
vascular ECs depending on where the ECs are in the vascular tree.  Inai et al. 
reported 70-200-fold greater expression of Cx43 on the ventricular surface of the 
valve, but no difference in the expression of Cx37 and Cx40 of VECs on both sides.  
They also showed size-differences in VECs, with those on the ventricular surface 
being 35% to 65% smaller than those on aortic side. 
Endothelial nitric oxide production is stimulated by fluid shear stress.  Recent 
studies in human aortic valves revealed that VECs expressed NOS III enzyme in a 
side-specific manner, which is regulated by shear stress (Richards et al., 2013).  In 
non-calcified valves, VECs on the ventricular side expressed significantly higher 
levels of NOS III than the cells on the aortic side.  The expression of NOS III on 
calcified valves was also observed to have the same trend as cells on non-calcified 
valves.  However NOS III expression of VECs on both sides of the calcified valves was 
significantly reduced, compared to normal valves (Richards et al., 2013).  The 
production of NO by porcine aVECs and vVECs, exposed to their respective shear 
stresses or, kept under static conditions, was further investigated in situ.  By using 
cGMP as a surrogate marker for NO production, the authors also confirmed higher 
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production of NO by vVECs compared to aVECs.  These results were observed both 
from static valves and valves exposed to side-specific patterns of flow (Richards et 
al., 2013). 
The observed heterogeneities of VECs from each side of the valve are possibly due to 
the effect of the different mechanical forces exposed to the cells. While the 
ventricular surface experiences high shear stress, the aortic surface of the valve is 
exposed to low shear disturbed flow.  Sucosky et al. exposed 2 types of flow to VECs 
from both sides of the valve and revealed a different response of aVECs and vVECs 
to each pattern of flow (Sucosky et al., 2009).  The authors revealed that expression 
of mediators involved in pathological inflammatory responses, VCAM-1, ICAM-1, 
TGF-β1 and BMP-4, were not changed on vVECs exposed to both physiological force 
(laminar shear) and altered shear stress (oscillatory shear).  Surprisingly, aVECs had 
an increased expression of the same meadiators when they were exposed to laminar 
shear stress (Sucosky et al., 2009).  This work suggests different intrinsic properties 
of aVECs and vVECs are independent of the flow patterns to which they are exposed.  
This property could lead to differences in the regulation of cells within the valve in 
terms of the production of ECM components - which are spatially distinct in 
different regions of the valve.     
 
1.3.4  The extracellular matrix of the aortic valve and their 
functions  
The ECM represents the key structural elements of heart valves.  Up to 80% of total 
human valve proteins are ECM components which mainly comprises of collagen, 
GAGs and elastin (Bashey et al., 1967).  
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Collagen: Collagen constitutes about 43-55% of the human valve (Bashey et al., 
1967).  Collagen fibres are present in all 3 layers of the mature valves; however, 
they are most abundant and more organised in the fibrosa layer than those in 
ventricularis layer (Scott and Vesely, 1995).  The collagen fibres in the leaflet 
predominantly consist of type I collagen and some type III collagen.  They form large 
bundles in a tubular shape which align in a circumferential direction in the valve 
leaflet (Clark and Finke, 1974).  The fibres have high stiffness but limited 
extensibility so that they can bear high loading pressure, but not strain.  During 
diastole, the circumferential-aligned collagen maintains co-aptation by providing 
strength and stiffness to the valve (Sacks et al., 1998).  Additionally, they adapt their 
structures by crimping and corrugation to minimize the stretching in the radial 
direction during systole (Figure 1.4)(Scott and Vesely, 1995).  
Glycosaminoglycans (GAGs):  GAGs are poly-anionic carbohydrates which have 
hydrophilic properties.  They can absorb water and act like a sponge; hence the 
middle layer of the valve where they are located is termed the spongiosa.  The 
complex carbohydrate structures are biochemically classified e.g. heparan sulphate 
(HS) or heparin, dermatan sulfate (DS) and chondroitin sulfate (CS).   While DS and 
CS are the main GAG components in valve, HS represents approximately 20% of the 
GAGs in the aortic valve (Rothenburger et al., 2002).  When sulfated GAGs interact 
with the non-sulfated GAG, hyaluronic acid (HA), they produce long polysaccharide 
chains in which enable them to bind water in quantities that are 1000 times greater 
than their volume (J.Koolman and K.H.Roehm, 2006).  Due to their properties and 
location between the fibrosa and ventricularis, GAGs are believed to act as 
lubricator and shock absorber by dampening compressive forces and stress 
between the different layers of the cusp.  
Elastin: Elastin comprises of 13% of dried weight in the human aortic valve (Bashey 
et al., 1967).  Its fibres are a major component of the ventricularis layer and are 
 45 
 
arranged in sheets.   They are also present in scarce amounts in the fibrosa layer by 
forming a network around collagen bundles (Vesely, 1998).  Elastin fibres align in 
the radial direction in the ventricularis and fibrosa, perpendicular to the 
circumferentially arranged collagen fibres.  In contrast to collagen, elastin has high 
elastic properties but low stiffness.   As such, elastin maintains collagen fibre 
orientation through its network around the collagen bundles and contracts to 
minimize cusp area and facilitates valve opening during systole (Figure 1.4)(Vesely, 
1998). 
The unique composition and structure of the individual layers of ECM result in the 
anisotropic behavior of the aortic valve leaflets, which has less mechanical stiffness 
(more compliant) in the radial direction than in the circumferential direction.  Thus, 
the valve is capable of responding to the high strain, low stress in the radial 
direction, with minimal strain but significant pressure in the circumferential 
direction during every cardiac cycle, without permanent changes to the valve’s 
structure (Billiar and Sacks, 2000; Yap et al., 2010).  In addition to its load bearing 
role, the ECM also plays a key role in communicating with the cellular components 
of the valve to maintain ECM production and respond to chronic changes in 
hemodynamic pressures.  
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Figure 1.4 The intrefibre connection and configuration of collagen and elastin fibres inside an aortic 
valve cusp during a) diastole (on the left);  and b) systole (on the right).  Collagen bundles adapt 
their structures to create crimping and corrugation to reduce the stretchng in radial direction 
during systole whereas elastin is contracted to minimise to leaflet’s area of the aortic valve .  
Adapted from Schoen F.J and Scott et al. (Schoen, 2008; Scott and Vesely, 1995)  
 
Certain ECM components have been demonstrated to have the ability to maintain 
VIC phenotype in a quiescent fibroblastic state and modulate the production of TGF-
β by VICs (Cushing et al., 2005).  Porcine VICs cultured on the collagen-coated plates, 
significantly reduced the production of SMαA to 66% of that expressed by cells 
grown on tissue culture-treated polystyrene plates (TCP).  Whereas VICs grown on a 
plate coated with heparin, a GAG component, increased the expression of SMαA to 
258% of cells on untreated TCP.  The addition of heparin, which can interact with 
several growth factors, also has the effect of enhancing the absorption of TGF-β on 
the culture plate and increases the production of TGF-β by VICs.  Moreover, the 
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modulation of osteoblastic differentiation of VICs by ECM components has also been 
demonstrated (Rodriguez and Masters, 2009).  Porcine VICs cultured on collagen 
and heparin coated plates have a significant reduction in cell contraction and form 
less calcified aggregates containing apoptotic cells.  They also express less alkaline 
phosphatase (ALP), an osteogenic differentiation marker, when compared to the 
cells cultured on TCP plates (Rodriguez and Masters, 2009).  
Interestingly, the elasticity of ECM can modulate the activation of VICs.  In 2010, 
Kloxin et al. created a substrate with a gradient stiffness, by carrying out 
photodegradation at various time points.  They illustrated that, on the same 
substrate, VICs on the higher stiffness area are activated and expressed higher 
amounts of SMαA than those on the lower stiffness area (Kloxin et al., 2010).   The in 
situ modulation of substrate elasticity also confirmed that VICs are de-activated 
(expressed less SMαA) when the stiffness of the matrix was decreased locally. 
Since the ECM serves to maintain valve function and regulate VIC phenotypes, 
continual regulation by synthesis and degradation is important to the valve’s 
durability.    
 
1.4  Regulation of the ECM 
The ECM functions to allow the valve to withstand the cyclical nature of the 
changing loads of which it is exposed to during each cardiac cycle. The ECM is in 
continual contact with the cells within the valve and it therefore transduces the 
effect of these mechanical forces to the cells, which responding accordingly.  The 
transduction of forces to the cells via the ECM is believed to result in further ECM 
production and expression of matrix remodeling enzymes by VICs (Mendelson and 
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Schoen, 2006).  This allows the cells to constantly renew the ECM components in the 
aortic valve.  In general, the homeostasis of valve ECM of the valve relies on a 
dynamic balance between synthesis and degradation.  
 
1.4.1 Synthesis          
There is evidence indicating that VICs have a secretory function.  For example, they 
express soluble and insoluble matrix proteins, such as fibronectin and chondroitin 
sulphate, and the procollagen hydroxylating enzyme, prolyl 4-hydroxylase which is 
an essential enzyme for collagen synthesis (Messier, Jr. et al., 1994; Taylor et al., 
2000). 
Fibronectin is readily produced and localized adjacent to VICs in early passages of 
cultured cells.  With time, the amount of fibronectin is dramatically increased in 
confluent cultures of VICs and is diffused throughout the culture.  Likewise, 
chondroitin sulphate is also secreted in new cultures of VICs and continues in 
passaged cells.  However, it appears to be less adherent to the VICs compared to 
fibronectin.   
Prolyl 4-hydroxylase is also expressed by the VICs but restricted to spindle shaped 
cells, suggesting that it is produced by fibroblast-like VICs.  Moreover, electron 
microscopic examination of VICs illustrated the presence of secretor organelles such 
as Golgi apparatus, rough endoplasmic recticulum and free polyribosome (Messier, 
Jr. et al., 1994).  In situ detection of collagen synthesis is also observed in normal 
valves containing quiescent VICs and diseased valves containing activated VICs 
(Rabkin et al., 2001).    
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The elastic fibres, on the ventricular side of the valve, are composed of a variety of 
components including linking proteins, microfibrillar proteins (fibrillins) and the 
core protein elastin.  The comprehensive study on the expression of fibrillin (FBN) 
genes which involve in elastogenesis was performed in developing and aging valve 
tissues (Votteler et al., 2013).  FBN1 showed the different gene expression from the 
FBN2 and 3.  The expression of the FBN1 gene and protein continued through all 
developmental stages, whereas FBN2 was mainly produced during fetal 
development and had a reduced production in postnatal life (Votteler et al., 2013).   
 
1.4.2 Degradation  
In the face of continued ECM production by VICs, the degradation of existing ECM is 
important to maintain the optimal ECM content of the valve and thereby valve 
durability.  Proteolytic enzymes for ECM degradation are expressed by quiescent 
VICs and activated VICs, which were identified in normal and diseased mitral valves, 
respectively (Rabkin et al., 2001); for example, collagenases (MMP type 1 and 13) 
and gelatinases (MMP-2 and MMP-9).   However, elastases (cathepsin S and K) were 
found only around activated VICs.   
The expression and distribution of MMPs along with their inhibitors, TIMPs, are 
distinct among heart valves.  While MMP-1, TIMP-1 and TIMP-2 are expressed by 
cells in all four heart valves, MMP-2 is only expressed in the aortic and pulmonary 
valve.   However, MMP-3 and MMP-9 are not found in any heart valves (Dreger et al., 
2002).  Expression of MMP-1 is seen throughout the aortic valve while pulmonary 
valve positive cells are only observed in the belly and free edge areas.  TIMP-1 is 
localized in the commissures regions of all valves except for the pulmonary valve, 
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where it is found only in the belly region.  Unlike TIMP-1’s specific distribution, 
TIMP-2 is found throughout the leaflets of all four valves (Dreger et al., 2002).    
The expression of MMPs and TIMPs, in the study by Dreger et al., are predominantly 
localised around VICs.  However, VICs were stained only with SMαA on separate 
tissue sections rather than true co-localisation with double-staining.  MMPs and 
TIMPs are also found intermittently in endothelial cells in the valve (Dreger et al., 
2002).  Moreover, the living pulmonary autografts adapt to their new mechanical 
environment by increasing the production of MMP-13 (Rabkin-Aikawa et al., 
2004a), indicating the potential role of changes in mechanical force mediating ECM 
remodeling by VICs.  
 
1.4.3 Role of mechanical force  
Aortic valves experience a myriad of complex mechanical forces during the cardiac 
cycle.  For example, they experience stretch and transvalvular pressure during the 
diastole as well as the shear stress produced by blood flow during diastole and 
systole (Figure 1.5).  Animal studies have shown a capability of valves to renew their 
ECM in response to these mechanical forces.  Autoradiography has shown that the 
site of GAG and protein synthesis correlates to the distribution of the stress within 
the aortic valve (Schneider and Deck, 1981). 
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Figure 1.5 Mechanical forces during diastole and systole of an aortic valve. Heamodynamic 
generates various mechanical forces.  Whereas the aortic valves experince stretch and transvalvular 
pressure during the diastole, oscillatory and laminar shear stress are produced by blood flow 
during diastole and systole Adapted from Balachandran et al., (Balachandran et al., 2011)  
 
1.4.3.1 Stretch  
The aortic valve is stretched both circumferentially and radially.  During the 
diastole, the transvalvular pressure causes the valve cusps to extend and allow co-
aptation to occur between the adjacent cusps.  The cusps have a diastolic stretch 
ratio that is significantly higher in the radial than that in the circumferential 
direction (Yap et al., 2010).  Ex vivo aortic valve leaflets that are stretched in 
circumferential a direction (by 15% elongation) induce ECM remodeling and the 
expression of contractile VIC phenotypes (Balachandran et al., 2006).  
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Colourimetric-quantitative methods revealed that cyclically stretched leaflets have 
increased collagen content, reduced levels of GAGs, but no change in elastin levels 
when compared to static valves. While the structure of ECM layers is preserved 
during stretch, immunohistochemistry (IHC) showed an increasing expression of 
SMαA in VICs on the ventricular side (Balachandran et al., 2006). Likewise, in vitro 
porcine VICs increase their total collagen production when subjected to a cyclic 
stretch using the Flexercell machine.  VICs significantly enhance the production of 
both membrane-bound and secreted collagen when they are stretched by 14% for 2, 
3, 4 and 5 days.  This is associated with an increase in collagen III gene expression in 
the stretched samples (Ku et al., 2006). 
 
1.4.3.2 Pressure  
During normal diastole, transvalvular pressure, which is applied perpendicular to 
the leaflet area, varies from 80 mmHg to 120 mmHg.  Collagen fibres in the fibrosa 
layer mainly take up this load as previously described.  This cyclical pressure is 
considered to be one of the important mechanical forces that the cells respond to in 
secreting new matrix to maintaining the durability of the valve.   
Ex vivo porcine aortic valves cultured in a pulsatile culture system, at  physiological 
pressures (at 80-120 mmHg) and cardiac output (4.2 l/min), maintain their 
expression of ECM components (Konduri et al., 2005).  The content of collagen, 
sulphated-GAGs and elastin are not significantly changed from those within the 
fresh valve leaflets.  However, Konduri and colleagues also observed that GAGs and 
elastin content are significantly reduced in the samples kept under the static culture 
conditions.  
 53 
 
The production of ECM in the aortic valve can be regulated by the magnitude of the 
pressure that the valve is exposed to, rather than frequency with which it changes 
(Xing et al., 2004).  When the frequency was fixed at 70 cycles per minute 
(analogous to the average heart rate), increasing magnitudes of pressure induced 
increases in both collagen and sulphate-GAG synthesis.  However, there is no 
proportional relationship between the magnitude of compression and the amount of 
ECM synthesis.  As per the finding by Konduri et al, the tissues subjected to the 
physiological pressure (80-120 mmHg) maintain their collagen and GAGs 
production.  Compared to constant pressure, cyclic pressure significantly enhances 
the production of sulfated GAGs in porcine valve leaflets; suggesting the 
physiological mechanical environment is important to the control ECM synthesis 
(Konduri et al., 2005).   
Indeed, Merryman and colleagues have shown evidence of cellular responses to 
differing physiological pressure.  The function of VICs to synthesise collagen and 
thereby the stiffness of the valve was compared between valvular cells which were 
isolated from the higher (left) and lower pressure (right) sides of the heart.  A 
higher expression of HSP47 and SMαA is observed in VICs isolated from the higher 
transvalvular pressure side of the heart (Merryman et al., 2006).  There was a 
correlation between collagen synthesis, HSP47, and SMαA expression. This 
relationship is maintained when VICs were either in vitro or in situ.  Moreover, 
cellular stiffness of cultured VICs that are isolated from the left side of the heart 
were found to be significantly greater than those from the right sided heart valves 
(Merryman et al., 2006).   
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1.4.3.3 Shear Stress (Flow) 
The aortic valve cusps have their surfaces exposed to two patterns of shear stress 
during the cardiac cycle.  On the ventricular surface of the valve, the unidirectional 
pulsatile laminar shear stress occurs with high magnitude, ranging from 0 to 80 
dyn/cm2 (Weston et al., 1999).  In contrast, the low magnitude bidirectional 
oscillatory shear stress generated on the aortic surface of the valve, ranges between 
-8 to +10 dyn/cm2 (Figure 1.6)(Kilner et al., 2000; Sucosky et al., 2009) .  
 
Figure 1.6 Native shear stress velocities experienced by the aortic valve.  a) Oscillotory shear stress 
velocity experienced by aVECs on the aortic surface. b) Laminar shear stress velocity experienced 
by vVECs on the ventricular surface.  Adapted from Sun et al. (Sun et al., 2011). 
 
Ex vivo porcine valves were used to investigate the effect of shear stress on cell 
function.  DNA synthesis, protein and GAGs production were increased during static 
incubation.  Moreover, total protein synthesis by tissues exposed to steady flows at 
different magnitudes was significantly higher than seen in fresh tissue.  Regardless 
of the magnitudes and dynamics of the applied shear stresses, tissue under flow 
conditions sustained its cellular proliferation and GAGs synthesis at a similar extent 
to fresh tissue (Weston and Yoganathan, 2001).  These results illustrate that valve 
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cells responded to the flow by synthesising new proteins and retaining GAGs 
content similar to the native valve.   
Further ex vivo experiments were recently reported in a review article 
(Balachandran et al., 2011). They investigated the effect of the valve endothelial 
cells and the shear stress on the production of collagen and GAGs.  The endothelial 
cells were either intentionally removed from the valve (VEC-denuded valves) or 
kept intact.   Both the VEC-denuded and intact valves were then exposed to laminar 
shear stress at ranges of magnitudes.  In the endothelial-denuded valves, both 
collagen and GAGs were increased by the effect of shear stress.  However, in the 
intact valve leaflets, collagen content and GAGs were not affected by shear stress 
(Balachandran et al., 2011).   
These findings suggest that a “shielding effect” is provided by the VECs and the 
communication between VECs and VICs is important to maintain the balance of ECM 
production and degradation in the active valve.  
 
1.5  Evidence of ECs Regulation on the ECM Production 
by Underlying Cells 
Endothelial cells have been proven to sense mechanical forces and communicate 
with the underlying cells.  While well characterised for their regulation of vascular 
tone and inflammation, endothelial cells have also been shown to be able to affect 
the composition of the ECM.   
In 1981, Merrilees et al. seeded endothelial cells from the aorta on top of SMCs.   The 
production of HA and sulphated GAGs is significantly increased when compared to 
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the culture of SMC only (Merrilees and Scott, 1981).  When ECs are seeded on a 
porous membrane (Transwell®) and co-cultured with cardiac fibroblasts, there is 
increase in collagen synthesis by the fibroblasts by almost 2 fold compared to 
fibroblasts alone (Guarda et al., 1993).  In contrast to Guarda’s study, vascular ECs 
reduce the production of collagen by SMCs when they are seeded onto collagen type 
I or matrigel.  The SMCs experience a 40% reduction in collagen synthesis and a 
60% reduction of collagen type I gene expression when co-cultured with ECs 
(Powell et al., 1997).   
The expression of collagen type VIII, MMP-13, TIMP-3 mRNA by human hepatoma 
cell lines is increased when they are co-cultured with bovine pulmonary ECs, as 
compared to hepatoma cells alone (Ohno et al., 2009).  More recently, the synthesis 
of collagen is reduced when venous ECs were grown onto 3-D fibrin gels containing 
myofibroblasts (Pullens et al., 2009).   
Molecules released by ECs also show an effect on the production of ECM.  ET-1, an 
endothelium-derived peptide, affects vascular SMC function by increasing collagen 
type I production (Rizvi et al., 1996).  Similarly co-culture of vascular SMC and 
coronary artery endothelial cells increases the production of collagen type I but 
decreases synthesis of collagen type III.  However, when NO production by ECs was 
inhibited, both collagen type I and III are increased (Myers and Tanner, 1998).   
The function of ECs in the regulation of ECM production has been analysed in 
porcine VICs that are encapsulated in a collagen hydrogel and seeded with porcine 
VECs on the surface of the hydrogel.  The 3-D construct was then either exposed to a 
20 dyn/cm2 laminar shear stress or kept under static conditions.  The presence of 
VECs decreases the loss of GAGs in the hydrogel under both static and conditions of 
flow (Butcher and Nerem, 2006).  VICs also become less activated when they were 
co-cultured with VECs.   
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VECs have been demonstrated to have a role in the regulation of the mechanical and 
biological integrity of the valve (Butcher and Nerem, 2006; El-Hamamsy et al., 2009; 
Richards et al., 2013), as previously discussed.  Changes in the function of these cells 
may contribute to the disease process that results in the valve becoming calcified.  
 
1.6 Pathogenesis of the aortic valve disease and Therapy 
Aortic valve disease was originally believed to develop over time as a consequence 
of continuous exposure to hemodynamic and mechanical forces.  However recent 
evidences imply an active progression involving the mechanisms of inflammation, 
apoptotic and osteogenic calcification (Rajamannan et al., 2003; Lee and Chou, 1998; 
Tanaka et al., 2005).  These mechanisms compose of responses by valvular cells at 
molecular levels.    
 
1.6.1 Cellular and molecular mechanism  
Activated VICs which express SMαA are believed to differentiate into osteoblast-like 
cells and responsible for the accumulation of calcium and formation of calcified 
nodules in diseased valves (Osman et al., 2006; Mohler, III et al., 2001; Aikawa et al., 
2007), where as VECs may contribute to valve disease by expressing molecules that 
can both promote and protect calcification.  
Analysis of gene expression by side-specific VECs revealed that aVECs express genes 
associated with valve calcification at greater amount than vVECs (Simmons et al., 
2005).  In contrast, Kruppel-like factor2, which is expected to down regulate 
calcification, was increased by VECs subjected ventricular flow or the surrogate of 
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vVECs (Weinberg et al., ). Similarly, atheroprotective mediator like NOS III is greater 
increased by vVECs (Richards et al., 2013).  Dysfunction or imbalance of the function 
of VECs is believed to be associated with aortic valve calcification.   
 Inflammatory 
The theory that valve calcification is mediated through an inflammatory condition is 
supported by the presence of inflammatory cells, macrophages and T-cells within 
the cusps (Muller et al., 2000; Aikawa et al., 2007; Otto et al., 1994).  Eventually, VICs 
adopt osteoblastic phenotypes by the activation of cytokines produced by the 
inflammatory cells e.g. TGF-β1 and osteopontin (Rajamannan et al., 2003; O'Brien et 
al., 1995). 
 Apoptosis 
Apoptotic bodies in the aortic valve are considered as a source of calcium and lead 
to the formation of calcium nodules in calcified valves (Jian et al., 2003; Clark-Greuel 
et al., 2007). The apoptosis-dependent calcification is also believed to be stimulated 
through TGF-β1, under SMAD-dependent pathway (Jian et al., 2003; Clark-Greuel et 
al., 2007). 
 Osteogenic calcification 
The expression of osteoblast markers and a mineralisation of the matrix is 
stimulated by potential mediators including TGF-β1, BMP 2, Wnt, β-catenin and 
RANK.  The mechanism of these mediators is focused on the regulation of an 
osteoblast transcription factor, RUNX2 (Chester, 2014).  
Whereas TGF-β1 may contribute to osteogenic calcification by directly 
transdifferentiating VICs into osteoblast-like cells (Osman et al., 2006; Clark-
Greuel et al., 2007; Kennedy et al., 2009), BMP2 implicates bone formation and 
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calcification in aortic valves through Wnt pathway (Hruska et al., 2005).  The 
binding of Wnt to its receptor and co-receptor increases level of β-catenin.  This 
eventually activates the translocation of β-catenin into nucleus to form an active 
enhancer of RUNX2 (Pandur et al., 2002). 
The binding of RANK (receptor activator of NF- ϰB) and its ligand directly increases 
DNA binding of RUNX2 (Kaden et al., 2004). Subsequently, osteoclastogenesis is 
stimulated and extracellular calcium concentration is increased.   
 
1.6.2 Therapy 
At the present, the treatment for valvular calcification remains the surgical 
replacement with mechanical or bioprosthetic implants (Baxley, 1994). The 
procedures taken for valve replacements account for 22% of all cardiac surgeries 
(Iung and Vahanian, 2011) in which aortic valve replacements are by far the most 
among those valve procedures. 
Although surgical valve replacement is the only promising treatment, all valve 
substitutes have limitations; for example, calcification of the bioprosthetic and 
requirement of anti-coagulants for the patients who have mechanical implants.  
More importantly, the importance of living cells in the valve substitutes has been 
highlighted (El-Hamamsy et al., 2010) which has stimulated the need for a valve that 
contains living cells.  Tissue engineering of heart valves (TEHV) has the capacity to 
produce such a valve in the laboratory and is considered as an alternative solution 
for valve replacement. Suitable cells are required to regenerate a living functional 
heart valve and maintain the durability of engineered valve, similar to native aortic 
valves.  
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1.7  Hypothesis 
It is well known that collagen, GAGs and elastin, are stratified into 3 layers inside the 
aortic valve, and that specific distribution is important to valve structure and 
function.  Moreover ECM remodeling can be regulated by mechanical forces and cell 
to cell communication.  However, there have been no studies that have investigated 
which factors regulate ECM production by VICs.  In order to address this question, 
VECs phenotypes from the opposite sides of the aortic valve and the effect of side-
specific patterns of flow are necessary to be understood.  The informative data could 
help to choose an appropriate cell type to re-create the valve endothelial function on 
a tissue-engineered valve, in order to ensure that the engineered valve can maintain 
a similar ECM content, and in turn the durability associated with native valves.  
I hypothesise that, VECs are able to modulate the ECM components produced by 
VICs in the aortic valves.  Passive release of mediators and release in response to the 
specific patterns of flow that are experienced by the aortic and ventricular surfaces 
of the aortic valve may both contribute to this effect.  Moreover, the information of 
the response to particular patterns of shear stress could be used to derive stem cells 
into side-specific VECs.  The differentiated stem cells can serve as a potential source 
to endothelialise a tissue engineered heart valve.  
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1.8  Aims 
The specific aims of this works were: 
1. To establish a robust and repeatable method for isolation and culture of 
VECs from each side of the valve and compare the phenotypic 
characteristics of EC from the aortic and ventricular surfaces   
 
2. To investigate the effect of stable mediators released by aVECs and vVEC 
on VIC function with respect to: 
  Cell proliferation 
  Collagen synthesis 
  Collagen Cross linking 
  GAGs synthesis 
  Elastin synthesis and cross-linking 
3. To examine the effect of labile mediators produced by aVECs and vVECs in 
a non-contact co-culture with VICs on their ability to proliferate and 
produce ECM components  
 
4. To determine the effect of specific flow patterns on the functional effects 
of VECs on the ECM homeostasis in the aortic valve cusps  
 
5. To evaluate the suitability of adipose derived stem cells for use as a valve 
endothelial cells in tissue engineered valves.   
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2 CHAPTER 2 Side-Specific Valve Endothelial 
Cells  
2.1  Background  
While endothelial cells share basic functions in the control of vasomotor tone, 
permeability, innate and adaptive immunity, there is considerable heterogeneity  
among endothelial cells from different anatomical locations and organs throughout 
the body (Aird, 2007).  The EC heterogeneity results from the interaction of ECs 
with their microenvironment including cytokines, paracrine factors, growth factors, 
cells, ECM and mechanical forces.  Moreover, certain “site” specific phenotypes of 
ECs are epigenetically programmed and transmitted during mitosis which is 
independent of the extracellular factors (Aird, 2007).   
For example, the distinct transcription profiles of multiply passaged ECs were 
established from 14 different sites of the human vasculature (Chi et al., 2003).  ECs 
from large vessels expressed genes involving in the synthesis of ECM e.g. fibronectin 
and collagen type V.  In contrast, ECs from micro-vessels transcribed genes for 
basement membranes and the ECM binding proteins such as laminin and integrins.  
ECs which were isolated from skin expressed fibroblast growth factor and 
cholesterol-synthesis genes, whereas ECs from lung tissue expressed the gene 
encoding an enzyme for surfactant secretion.   These results suggest that the distinct 
expression patterns of ECs, referring to their specialised function of the respective 
tissue, are preserved thorough the generations in cell culture.   
In addition to gene expression, the distinct barrier function of ECs from different 
sites persisted in several passaged cells (Kelly et al., 1998).   In vitro pulmonary 
microvascular ECs form smaller intercellular gaps than pulmonary artery ECs 
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(similar to in situ observation) and are correspondingly  less permeable to large 
molecules (72 kMW).  A conclusive study for the dual roles of microenvironments 
and epigenetics was investigated by comparing gene expression profiles of in situ 
ECs to those of in vitro ECs.  The functional expression profiles of ECs isolated from 
tonsils showed that 37 genes were maintained in vitro after culturing, but 23 genes 
were down regulated.     
The heterogeneous phenotypes of VECs from the aortic and ventricular surface have 
also been established.  As mentioned earlier, DNA microarray of in situ aVECs and 
vVECs revealed differential expression of 584 genes (Simmons et al., 2005).  
Moreover, the differential production of Cx43 (Inai et al., 2004) and NOS III 
(Richards et al., 2013) was exhibited on the aortic valve surfaces by 
immunostaining. It is well established that, during the cardiac cycle, aVECs 
experience different mechanical shear stress from the vVECs and, in turn, the 
different microenvironment are considered to be the factor that determines the 
unique characteristics of EC on each side of the valve.  However, whether VECs from 
the opposite surfaces maintain their distinct phenotypes in cultures (in the same 
environment) has not been investigated yet. 
In order to pursue the heterogeneity of side-specific VEC phenotypes in vitro, a 
technique to isolate pure populations of VECs from the opposite surfaces 
independently is required.  Additionally, VEC phenotypes in situ are investigated in 
comparison to the VEC phenotypes in vitro by immunostaining and western blotting.  
Lastly, the secretory function of side-specific VECs to release cytokines will be 
examined.  
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2.2  Materials and Methods 
2.2.1 Porcine hearts 
Porcine hearts (24-36 months old) were obtained from a commercial 
slaughterhouse (Cheale Meats, Essex, United Kingdom). The Hearts were 
immediately placed in fresh ice-cold Hanks solution after their removal from the 
sacrificed animals and transported to the laboratory within 4 hours; 4-6 hearts were 
processed at a time  Aortic valve leaflets were dissected under sterile conditions in a 
laminar flow hood.  During the process, the cusps were handled with fine forceps to 
avoid damaging the endothelial cells on the valve surfaces.  The dissected cusps 
were then washed with phosphate-buffered saline (PBS) twice.  Up until being used, 
all 3 aortic cusps from each pig were kept in PBS separately to avoid mixing 
between individual animals.  Specific sides, aortic and ventricular, of the excised 
valves were identified by the fact that the aortic surface appears rough while the 
ventricular surface is smoother.  In order to obtain 3 types of cells (VICs, aVECs and 
vVECs), from the same pig, one leaflet was used to isolate each cell type from each 
valve used.  
 
2.2.2 Aortic and Ventricular VECs isolation and culture 
Since aVECs and vVECs are populated as monolayers on the opposite sides of the 
valve, a specific protocol was developed to selectively isolate each cell type.  In order 
to obtain and grow aVECs and vVECs from the same animal, a number of isolation 
protocols were tested, for example, enzyme absorbed filter papers, scraping and 
varying times of enzyme digestion.  A successful method was devised by adapting an 
enzymatic digestion and clonal expansion protocols.  Briefly, aVECs and vVECs were 
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isolated from a separate leaflet (of the same animal) by exposing one surface of the 
leaflet to the enzyme, as depicted below (Figure 2.1). 
 
 
Figure 2.1 Schematic picture of cell isolation mehthod.  Either aortic or ventricular surface of the 
cusps was exposed to the collagenase enzyme to isolate either aVECs or vVECs, whereas another 
cusp was removed VECs and isolated VICs. 
 
2.2.2.1 Enzyme digestion  
In order to isolate a particular type of VECs, the valve cusps were stretched on filter 
paper making sure that the side from which cells were to be isolated was facing 
upwards.  These tissues were then exposed to 600 unit/ml of Collagenase II (Sigma-
Aldrich, UK) contained in separate wells of a custom-made plate (used for the Cone-
and-Plate machine, see Chapter 5.3).  The cusps were subsequently fixed in position 
by screwing a lid (Figure 2.2) over the discs and incubating at various conditions e.g. 
incubation times (at 10, 20, 30 and 40 minutes) and rotating speeds (at 150 and 170 
revolutions per minute (RPM)) to optimize the isolation conditions.  
Side-specific VECs were successfully isolated at 37° C incubation for 30 minutes and 
by 170 RPM of shaking by an orbital shaker.  After enzyme incubation, VECs were 
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physically dispatched from monolayer by vortexing the plate at moderate vigor for 1 
minute.  In order to stop digestion process, aVECs and vVECs solution in the wells 
was transfered to plates containing Endothelial Growth Media 2 (EGM2) (Promocell, 
UK) supplemented with 20% fetal bovine serum (FBS).    
 
2.2.2.2 VECs purification (colony expansion) and culture 
Primary VECs were cultured for 5-7 days as to achieve enough cells to be able to 
differentiate them from contaminating VICs by morphology. Cobblestone-like 
colonies were selected under microscope and covered with cloning cylinders 
(Sigma-Aldrich, UK; Figure 2.2) while the colonies that had spindle and elongated 
shape cells growing nearby were discarded since these cells were most likely VICs. 
To prevent a subsequent leaking of solution from the cylinders, sterile grease 
(Sigma-Aldrich, UK) was applied at the bottom and pressed tightly on the culture 
plates.  VECs were isolated inside the cylinders by 50 μl of Trypsin (SAFC Bioscience, 
UK) and incubated at 37°C for 5 minutes.  To facilitate the growth of VECs, it is 
important to expand cells to the right degree of confluence, such that each colony of 
primary VECs was initially passaged into a single well of 24-well plate, without 
mixing between colonies.  Once reaching confluence, the VECs was serially passaged 
to a well of 12-well plate, a well of 6-well plate and so on.  
VECs were cultured with EGM2 media (which contained 0.02 ml/ml Fetal calf 
serum, 5 ng/ml Epidermal growth factor, 10 ng/ml Basic fibroblast growth factor, 
20 ng/ml Insulin-like growth factor, 0.5 ng/ml Vascular endothelial growth factor, 1 
μg/ml Ascorbic acid, 22.5 μg/ml Heparin and 0.2 μg/ml Hydrocortisone) 
(Promocell, UK) and supplemented with 20% FBS  (GE Healthcare, UK), 100 U/mL 
(1%) penicillin (Life Technologies, UK), 100 µmol/L (1%) streptomycin (Life 
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Technologies, UK) and 4 mmol/L (1%) L-glutamine (Invitrogen, UK).  Before 
culturing, all VEC plates were coated with attachment factor containing 0.1% gelatin 
(Invitrogen, UK) at 37° C for 30 minutes and then maintained at a 37° C in an 
incubator gassed with  (95% air/5% CO2).  VECs were expanded and used up to the 
4th or 5th passage. 
 
 
Figure 2.2 Materials for VECs isolation.  a) valve leaflets on filter papers for aVECs and vVECs 
isolation on the left and right hand respectively, b) the plate composed of wells containing 
collagenease enzyme, c) particular side of valve put over the well, fixed by the screwed lid and 
incubated with enzyme in the well, d) cylindrical disk to cover cobblestone-liked VEC colony and 
contain Trypsin solution. 
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2.2.2.3 Scanning Electron Microscopy 
VEC isolation method was validated using a scanning electron microscopy (SEM). 
After VEC isolation was finished, the valve cusps were pinned on a waxed plate 
containing 2.5% glutaraldehyde (Sigma-Aldrich, UK) to preserve structure of the 
valve and the remaining cellular components.  The fixed valves were washed with 
0.1M phosphate buffer two times.  The specimens were then post fixed with 1% 
osmium tetroxide (Agar Scientific ltd., UK) in 0.1M phosphate buffer for 1 hour 
followed by 2 times washing with the buffer.  The specimens were then incubated 
with 1% Tannic acid (Sigma-Aldrich, UK) in 0.1M phosphate buffer for 1 hour and 
washed again with the buffer twice. They were dehydrated by immersing the 
specimens in an ascending series of ethanol solutions starting from 25% up to 
100%. They were then dried in hexamethyldisilazane (Agar Scientific ltd., UK) and 
then air-dried.  Lastly the specimens were mounted on Stubbs with Acheson Silver 
Dag (Agar Scientific ltd., UK) and viewed in JEOL 6010 SEM microscope (Jeol, Japan).  
The cusps were examined by with the SEM, which was kindly completed by Dr. 
Padmini Sarathchandra. 
 
2.2.3 VIC isolation and culture 
In order to obtain pure VICs from aortic valve cusps, VECs from both sides of the 
valve leaflet were removed by incubation with 600 unit/ml collagenase II at 37° C in 
a water bath while being vigorously shaken for 15 minutes.  The leaflet was then 
removed from the enzyme solution and washed with PBS twice under sterile 
conditions.  It was then cut into small pieces by a sterile blade to increase the 
accessibility of the enzyme to digest the tissue and facilitate releasing of the VICs 
from the ECM of the valves.  To obtain VICs, the pieces of the leaflet were transferred 
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to a new falcon tube containing fresh 600 unit/ml collagenase II in PBS and digested 
at 37° C in a water bath for further 30-45 minutes.  After enzymatic digestion, 1 
volume of DMEM (Sigma-Aldrich, UK) containing 10% serum was added to stop the 
reaction and the residual tissue was removed by filtering through a cell strainer 
with a mesh size of 100 µm (vWR, UK).  Cells were collected by centrifugation at 700 
g for 5 minutes.  VIC pellet was resuspended and grown in DMEM with 10% FBS in a 
T25 flask (Sarstedt, USA). After 2 hours of incubation, floating cells were removed 
by changing the media. Once VICs were confluent, they were dislodged by 
incubating cells with 1% Trypsin solution for 3 minutes.  VICs were cultured in a 
bigger, T75 flask, and used up until passage 4-6.  
 
2.2.4 Cell phenotyping by immunocytochemistry 
VECs were not only identified by morphology but also immunocytochemistry (ICC) 
at passage 2, 3, and 4 or the passage before used, for further experiments.  Only cells 
that showed positive staining for endothelial cell markers such as CD31, vWF and 
VE-Cadherin, but were completely negative for SMαA were considered as pure 
endothelial cell colonies.  To perform ICH, VECs were seeded on gelatin coated 13 
mm coverslips (Thermo Scientific, UK) and cultured overnight in an incubator to 
allow the cells to attach on the coverslips.  Before the staining, cells on coverslips 
were washed with PBS 3 times for 3-5 minutes each and fixed with cold acetone for 
10 minutes.  Cells were then blocked with 3% bovine serum albumin (BSA) in PBS 
(known as blocking solution) for 30 minutes at room temperature to prevent non-
specific staining.  Primary antibodies were applied at appropriate concentration in 
1.5% BSA in PBS (1:100 dilution of CD31-FITC (Mouse Anti-Porcine, Serotec, UK), 
1:400 dilution of vWF (Rabbit Anti-Human, Dako, Denmark), 1:200 dilution of VE-
Cadherin (Rabbit Anti-Human, Cell Signaling, UK) and 1:200 dilution of SMα-A 
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(Mouse Anti-Human, Dako, Denmark) and incubated at room temperature for 1 
hour.  A negative control was incubated with blocking solution instead of the 
primary antibody.  Excess primary antibodies were removed by washing with PBS 3 
times for 3-5 minutes each, before applying the secondary antibody.  AlexaFluor 488 
Goat Anti-Mouse (Invitrogen, UK) and/or AlexaFluor 594 Goat Anti-Rabbit 
(Molecular Probes, UK) were incubated with cells at 1:1000 dilution in 2% normal 
goat serum at room temperature for 1 hour.  Non-bound secondary antibodies were 
washed twice with PBS containing 1:20000 dilution of DAPI (Sigma-Aldrich, UK) for 
10 minutes. Concurrently, nuclei were stained with DAPI during the washing.  
Coverslips were blotted to dry with tissue papers and mounted with Permaflour 
(Beckman Coulter, UK) on glass slides (Thermo-Scientific, UK). The cells were 
observed using a fluorescent microscope (Nikon, Japan). 
 
2.2.5 Cell phenotyping of in situ side-specific VECs by 
immunohistochemistry 
In order to understand phenotypes of valve endothelial cells, intact VECs on the 
fresh valves were also observed for EC markers by IHC technique and compared to 
the cells isolated by side-specific method described above.  
After aortic valves were dissected from sacrificed pigs, each leaflet of the valves was 
cut into 2 pieces; 1 was stained on the aortic side and another on the ventricular 
side.  Tissues were then held in place by pins on a wax plate, with the side to be 
studied facing upward. Briefly, every tissue section was fixed with 4% PFA, 
permeabilized by 0.5% Tritron X in PBS for 3 minutes, non-specific staining was 
blocked with 3% BSA in PBS for 30 minutes and immunostaining performed using 
the same methodology as section 2.2.4.  Following staining, tissues were moved to 
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cavity slides, with the side to be observed facing upwards to create a flat surface.  
Fluorescent staining was fixed by Permaflour and covered with coverslips.  The IHC 
was observed and captured pictures by the confocal microscope (Zeiss, Germany). 
 
2.2.6 Proliferation of side-specific VECs by MTS assay 
The proliferation rate of aVECs and vVECs after certain incubation times and media 
were investigated. It was important to seed a sub-confluent number of cells to avoid 
contact inhibition of cell growth.  Thus aVECs and vVECs isolated from 4 animals 
were seeded on a gelatin pre-coated 96 well plate at 2000 cells per well.  VECs were 
maintained in complete EGM2 media in the CO2 incubator overnight to allow 
attachment to the wells.  Triplicates of each cell isolate were changed to 0.4% FBS 
EGM2 media and used as a control.  Another set of triplicates was refreshed with 
EGM2 with 20% FBS.  VECs were cultured in the CO2 incubator for 48 hours before 
the proliferation was observed by using CellTiter 96® AQueous Non-Radioactive Cell 
Proliferation Assay (MTS assay; Promega, UK).  
The proliferation assay is composed of tetrazolium compound (MTS) and an 
electron coupling reagent (PMS).  The complex solution of MTS and PMS was 
prepared freshly under sterile condition before being used.  By gently mixing 2.0 ml 
of MTS solution with 100 µl of PMS, MTS/PMS solution was ready to be used at 20 µl 
per well of 96-well plate.  During the reaction, MTS is converted to UV-absorbable 
formaman product (absorption at 490 nm) by dehydrogenase enzymes found in 
metabolically active cells.  Consequently, it is important to keep cells alive while the 
reaction is performed by preparing 20 µl of MTS/PMS solution in 100 µl of culture 
media for each well. 
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At the start of the MTS assay, media over aVECs and vVECs were aspirated.  It is 
unnecessary to wash cells with PBS in order to prevent cell removal during washing.  
120 µl of MTS/PMS complex in EGM2 was added to every well.  To avoid light 
exposure, the plate was wrapped with foil and the reaction was carried out at 37°C, 
in a CO2 incubator for 45 minutes.   The amount of living cells was calculated from 
the relative amount of formaman products by measuring the absorption at 490 nm, 
using a microplate reader (Bio-Tek Instruments INC, USA). 
 
2.2.7 Isolation and protein extraction of side-specific VECs from 
fresh tissue 
Immediately after the porcine aortic valves were dissected and washed with PBS, 
VECs from the aortic and ventricular side were obtained on separate slides by snap 
frozen method.  Protein extraction was then performed to obtain protein for 
western blot analysis. 
To prepare for the snap frozen isolation, slides (Superfrost® Plus, Thermo 
Scientific, UK) were kept on dry-ice, for at least 15 minutes.  Two frozen slides were 
used per valve leaflet.  While one frozen slide was placed in contact with VECs on 
the aortic side, another slide was laid on the ventricular side, like a sandwich.  It was 
made sure that the leaflet was not folded when placed between the 2 slides.  Both 
frozen slides were then pressed, resulting in VECs attachment on them.  They were 
then moved to the area that had not been contacted with the valve, and the 
extraction of VECs repeated for minimum 3 times per a valve leaflet.   
VECs on the slides were then collected into an eppendorf for protein extraction.  5 µl 
of protein extraction buffer (RIPA buffer) which was prepared before used was 
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added on the slide.  The solution containing VECs were swept and pooled, in the 
middle of the slide, using a cell scraper (Sarstedt, USA).  The solution was then 
transferred by pipetting into a 1.5 ml microtube (VWR, UK) which contained 
another 5 µl of RIPA buffer.  Protein extraction by the reaction of RIPA buffer was 
performed on ice for 30 minutes time of incubation.  The samples were then 
vigorously vortexed at regular intervals.  The amount of protein of each sample was 
measured by BSA based assay as described below.  
Protein extraction buffer was prepared before used by mixing 10 ml of RIPA buffer 
or Radio Immuno Precipitation Assay buffer (Sigma-Aldrich, UK) with 1 tablet of 
protease K inhibitor (PKI, cOmplete Mini, EDTE-Free, Roche, USA).    
 
2.2.8 Western blot 
To investigate the heterogeneity between aVEC and vVECs, endothelial markers and 
other proteins were quantitatively compared with Western blotting technique 
which has been developed by members of the lab, Dr Paul Riem Vis and Dr. Najma 
Latif. Proteins extracts from VECs isolated and/or cultured (passage 4-5) from the 
aortic and ventricular sides of fresh aortic valves were separated by size in 
polyacrylamide gel. They were then transferred to a nitrocellulose membrane to be 
stained with specific antibodies.  The proteins of interest were detected by 
chemiluminescence and the bands developed on a film; the bands intensity which 
equates to the level of expression was assessed and normalised with the level of 
expression of a house-keeping protein, either GAPDH (38 kDa) or eEF2 (95 kDa), 
depending on their sizes which should not be similar to a size of any interested 
proteins.  The expression of interested proteins between aortic and ventricular cells 
was then compared. 
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2.2.8.1 Protein extraction and concentration  
Total protein from aVECs and vVECs isolated from fresh tissue were extracted by 
RIPA buffer as explained in the section 2.2.7.  For proteins extracted from cultured 
VECs in vitro, cells at passage 5 in a T25 flask were washed with PBS twice before 30 
µl of RIPA + PKI was added.  Cells were then scraped off the flask and collected into 
1.5 ml microtubes.  The extraction incubation was carried on ice for 30 minutes with 
vortex at intervals.  The debris was then removed by spinning the microtubes at for 
16060 g 5 minutes.  The supernatant which contained total proteins was stored at -
20°C if the quantification was not performed immediately.  
All samples were measured for the concentration of protein by Bicinchoninic acid 
(BCA) assay using bovine serum albumin (BSA) as a standard.  To make a calibration 
curve, BSA was prepared in triplicates at different concentrations, 0.50, 0.40, 0.30, 
0.20, 0.15, 0.10 and 0.05 µg/µl, at a total volume at 50 µl, in a 96-well plate.   
Samples were mixed with distilled water at the appropriate dilution in duplicate, to 
ensure that the samples to be tested would fall within the range of the standard 
curve.  50 µl of water was used as blank.  50 µl of standards, samples and the blank 
were then mixed with 200 µl of the mixture of CuSO4 (Sigma-Aldrich, UK) and BCA 
(Sigma-Aldrich, UK) at 1:50 ratio.  Protein in the reaction, which contained peptide 
bonds as well as certain amino acids e.g. tryptophan, tyrosine and cysteine, reduced 
Cu2+ into Cu+.  The reduced copper was then able to chelate with BCA and formed a 
purple complex.  To allow such reaction to occur, the 96-well plate was incubated at 
37 °C for 30 minutes and wrapped with light protection foil.  The absorbance of the 
purple complex at 562 nm was measured in each sample after finishing the 
incubation using a microplate reader (Bio-Tek Instruments INC, USA). The actual 
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concentration of protein samples was later calculated from the standard curve and 
their dilution factor. 
 
2.2.8.2 Sodium Dodecyl Sulphate - Polyacrylamide Gel Electrophoresis 
(SDS-PAGE) 
Proteins at different molecular weights, i.e. different length of polypeptides, were 
separated by their abilities to move within a polyacrylamide gel when an electrical 
current was applied.  The positioning of the protein in the gel is dependent upon its 
size.   To achieve this, proteins were mixed with SDS which is an anion detergent to 
denature secondary and non-disulfide-linked tertiary structure of proteins as well 
as to apply negative charge to the proteins proportionally to their polypeptide 
length/size.  SDS-coated proteins were then able to move towards the anode when 
the electrical current was supplied.  In a certain percentage of polyacrylamide gel, 
the longer polypeptide proteins migrated slower than the smaller proteins.   
To denature tertiary structure of proteins, they were additionally mixed with 
dithiothourseitol (DTT) (Sigma-Aldrich, UK) and NuPAGE LDS Running Buffer (Life 
Technologies, UK), containing not only SDS but also lithium dodecyl sulfate at a pH 
of 8.4, to reduce the disulfide bonds.  Loading volume was prepared at 20 µl for 
either 10 or 20 µg of total protein from each sample.  4 µL of Rainbow Marker (GE 
Health, UK) was also prepared in the loading buffer to be used as a molecular weight 
reference.  All samples and markers were heated at 70⁰C for 10 minutes before 
being quickly spun down and loaded on to polyacrylamide gels. 
Most of proteins of interest had a size in the range of 14-200 kDa and were 
separated in 10% NuPAGE Bis-Tris gels (Life Technologies, UK) and NuPAGE MOS 
SDS Running Buffer (Life Technologies, UK).  When vWF(250 kDa for monomer) 
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was investigated, 3-8% NuPAGE Tris-Acetate gel (Life Technologies, UK) and 
NuPAGE Tris-Acetate SDS Rnning Buffer (Life Technologies, UK) were used.  The 
gels were prepared with the proper buffer in the XCell SurelockTM (Invitrogen, UK). 
Denatured samples were loaded into each well and run at 200 V using a Power PAC 
300 (Bio-Rad, UK) power supply.  The current was stopped at the appropriate time 
to obtain protein separation referring to the separation of the Rainbow markers.  
 
2.2.8.3 Blotting 
Following SDS-PAGE, proteins within the gels were then transferred by an 
electroblotting method onto a nitrocellulose membrane (GE Health, UK) to allow the 
detection of specific proteins by immunostaining.   
 Transfer buffer was prepared by mixing NuPAGE Transfer Buffer (Life 
Technologies, UK) with 20% Methanol (10% methanol was prepared for large 
protein blotting) and distilled water.  Nitrocellulose membranes and filter papers 
were cut into appropriate size and soaked in transfer buffer along with sponges 
which were squashed firmly in the buffer to remove all bubbles.  The blotting stack 
was then assembled on the XCell IITM Blot Module (Invitrogen, UK).  On the cathode 
core, 2 sponges were placed, followed by 2 filter papers, gel, nitrocellulose 
membrane, 2 filter papers and finally 4 sponges.  In cases of transferring 2 gels, 1 
sponge was placed to separate from the first gel stack, followed by 2 filter papers, 
another polyacrylamide gel, nitrocellulose membrane, 2 filter papers and finally 2 
sponges.  The anode core was put on top and the assembled transfer stack was 
loaded into the blot module.  It was necessary to ensure that nitrocellulose 
membrane was placed between gel and the anode to allow proteins driven by the 
buffer to move from cathode to anode (the same direction as the current).  Transfer 
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Buffer was then added to soak the stack between the cathode and anode cores while 
distilled water was filled up outside the stack to prevent overheating.  Gels were 
blotted at 30 V for 80 minutes.      
To monitor the transfer efficiency, the membrane was stained with water soluble 
dye, Ponceau S (Sigma, UK) after electroblotting.  The membranes were removed 
from the transfer system and handled carefully by placing the surface exposed to the 
gel upward all the time.  Total proteins on the membranes were then stained with 
Ponceau S prepared at 0.1% (w/v) in 5% acetic acid.  The staining should show 
continuous bands, representing no air bubble interference which could prevent 
protein transferring and binding on the membranes.  The positions of markers were 
marked and the membranes were cut into small pieces to separate interested 
proteins according to their size.  Ponceau S was washed off the membrane by rinsing 
with distilled water and 1% Tween20-PBS (PBST) for a few times to provide the 
membranes for the next step.  
2.2.8.4 Protein Detection 
Before the expression of proteins was detected by immunostaining, non-specific 
binding was prevented by incubating membranes with the blocking solution (3% 
skimmed milk in PBST) for 30 minutes.  Primary antibodies were prepared in the 
blocking solution at the appropriate concentrations (Table 2.1) and applied to the 
membranes carrying interested proteins.  
Table 2.1 Primary antibody concentration used for Western blot 
Antibodies Manufacturing Host Dilution Expected Size 
vWF AbCam Rabbit 1/500 250       kDa 
NOS III Santa Cruz Rabbit 1/50 140       kDa 
eEF2 Cell Signaling Rabbit 1/1000 95          kDa 
Cox2 Santa Cruz Rabbit 1/200 70-72   kDa 
CD43 AbCam Mouse 1/1000 43          kDa 
GAPDH Chemicon Mouse 1/2000 38          kDa 
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Primary antibody staining was performed at room temperature for 1 hour or at 4⁰ C 
for overnight.  The unbound primary antibodies were then washed off by incubating 
the membranes with PBST twice, for 15 minute each.  The secondary antibodies 
linked with the reporter enzyme i.e. Horseradish peroxidase or HRP-linked enzymes 
(Dako, Denmark) were prepared at 1:1000 dilution in the blocking solution.  They 
were applied to the appropriate membranes and incubated at room temperature for 
1 hour.  The membranes were then washed 4 times with PBST for 15 minutes to 
remove the unbound HRP-linked secondary antibodies before they were pooled on 
a clean plate to be stained with enhanced chemiluminescence or ECL solution.  The 
ECL solution (GE Healthcare, UK) was freshly prepared by mixing solution A 
(Luminol Enhancer solution) and solution B (Peroxide solution) at 1:1 ratio and 
used to incubate all membranes for 5 minutes at room temperature to allow 
chemiluminescence reaction to happen. The substrates in the ECL solution were 
catalyzed by peroxidase enzyme in the vicinity of secondary antibody, in other 
words at targeted proteins, and produced a complex which emitted light.  The 
excess ECL solution was subsequently drained off the membranes and the light 
referring to the targeted proteins was detected on an X-ray film.  
 
2.2.8.5 Developing films 
A black-and-white photographic film (Amersham HyperfilmTM ECL, GE Healthcare, 
UK) was used to detect the light produced by HRP-antibody protein complex.  The 
film is coated with silver halide crystals which are sensitive to not only to X-rays or 
gamma rays but also light.  When the film is exposed to light, the crystals are divided 
into halide ions and Ag+ producing a “latent” image or a sensitive area.  The film can 
eventually turn into a virtually detectable image by light or the developer solution.  
At the optimal time in the developer solution, the light-exposed film can convert Ag+ 
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into pure metallic silver readily while maintain the silver halide crystal at the area of 
non-light exposure.  The silver halide crystals can be then washed off from the film 
by the fixer reagent.     
The ECL stained membranes from the previous step were mounted on a glass mirror 
and covered with cling film to prevent the dripping of ECL and the movement of the 
membranes during the developing step.  This developing step was then continued in 
a dark room to prevent the unnecessary light exposure.  The hyperfilms were placed 
over the membranes at a marked position in a cassette, for approximately 1 minute.  
They were then moved to be immersed under the developer (Agfa, UK) until the 
dark bands appeared.  All chemical was washed off by tap water and the reaction 
was stopped by removing non-reacted crystals from the films with the fixer (Agfa, 
UK).  The films were then washed with tap water, dried and the density of bands 
analysed.  
 
2.2.8.6 Quantification of band density 
The amount of protein present is proportional to the density of the bands on the 
film.  The films were scanned by the densitometer (Biorad GS710, AGFA ArcusII).  
The images were acquired and analysed the bands density by QuantityOne Software 
(Biorad).  To correct the amount of proteins loaded and proteins transferred on the 
membrane, the density of target proteins was normalized with the density of 
housekeeping protein(s) e.g. GAPDH and eEF2. 
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2.2.9 Protein array of side-specific VECs 
Molecules produced by VECs and secreted outside the cells were collected to 
investigate the heterogeneity between aVECs and vVECs in terms of cytokine 
production.  Cytokines which include the Interleukin (IL) family [IL-1β, IL-4, IL-6, 
IL-8, IL-10, IL-12], granulocyte macrophage-colony stimulating factor (GM-CSF), 
interferon gamma (IFNγ), transforming growth factor beta (TGFβ1), tumor necrosis 
factors alpha (TNFα) were observed by using Quantibody® Porcine Cytokine Array 
Kit (Raybiotech Inc., USA). The Quantibody Array uses enzyme-linked 
immunosorbent array (ELISA) based technology.  Briefly, the antibodies against 10 
cytokines were pre-immobilised on a glass chip.  The cytokines in sample media 
then bind to the antibodies on the glass chip and “sandwiched” with the biotin-
tagged cytokine specific antibodies that bind to different targets of the cytokines.  
Subsequently, streptavidin-labeled Cy3 dye is applied to bind the cytokine-
antibody-biotin complex trapped on the chip and visualised by a fluorescent laser 
scanner with Cy3 equivalent dye detector.  
106 cells of aVECs or vVECs were seeded on the culture plates and maintained with 
EGM2 media overnight.  The cultures were changed into low serum DMEM for 24 
hours to synchronise cell cycle before protein array was performed by adding 3 ml 
of fresh low-serum media.   Media collected from aVEC and vVEC cultures at 48 
hours incubation was concentrated by centrifugation through a polyethersulfone 
membrane (Vivaspin2, SartoriusStedium Biotech, Germany). 3 ml of fresh low 
serum media without VEC contact (used as a negative control) was concentrated in 
the similar method as media from VEC cultures. The concentrated media from every 
sample was adjusted to the total volume of 300 µl, in order to be able to calculate 
the total production of the cytokines.  
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100 µl Sample Diluent was used to block non-specific binding of the pre-coated 
antibodies by incubating the solution at room temperature for 30 minutes.  In the 
meantime, standard cocktails were prepared at different concentrations by serial 
dilution.  Sample Diluent was decanted after finishing the blocking incubation. 100 
µl of media control, sample media and standard cocktails were then incubated with 
the protein array chips for 90 minutes at room temperature.  Unbound molecules in 
each array were washed off with 150 µl of Washing Buffer I at room temperature for 
5 minutes, 5 times with gently shaking.  Afterwards, 150 µl of Washing Buffer II was 
added to each array to repeat the washing at room temperature for 5 minutes, twice. 
The Washing Buffer was removed completely from the array before 80 µl of the 
(biotin labelled) detection antibody cocktail was added.  The antibody-cytokine-
detection antibody complex was incubated at room temperature for 90 minutes.  
The unbound detection antibodies were then washed with 150 µl of Washing Buffer 
I for 5 minutes and 150 µl of Washing Buffer II for 5 minutes, 2 times at room 
temperature.  The Biotin on the cytokine complex was then detected by 80 µl of Cy3 
equivalent dye-conjugated streptavidin.  The binding reaction between streptavidin 
and biotin complex was incubated at room temperature for 60 minutes with light 
protection.  The solution was decanted and the unbound Cy3- Streptovidin was 
washed off with 150 µl of the Buffer I for 5 minutes at room temperature 5 times, 
followed by 15 minutes washing with the Washing Buffer I on a shaker and Buffer II 
for 5 minutes at room temperature.  The solution was then completely removed by 
centrifugation of the glass slide at 216 g for 3 minutes.   The amount and position of 
Cy3 on the chips represents the amount and types of the cytokines detected by a 
laser scanner equipped with a Cy3 wavelength (RayBiotech Service Department, 
USA). The dilution factor was used to calculate the total amount of the cytokines 
which were produced by 106 cells of VECs in a volume of 3 ml media. 
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2.2.10 Statistic analysis    
The proliferation of VECs in the complete media was normalised to that in serum 
starved cells, grown with 0.4% FBS EGM2, and reported as percentage over the 
control.  The proliferation rate of aVECs and vVECs, was compared using a Mann-
Whitney test and the data plotted using by GrapPad Prism 5. 
The data of protein expression was also scatter-dot plotted by GraphPad Prism5 and 
represented as optical density (O.D.) units over the housekeeping protein.  Mann-
Whitney Test was used to statistically compare the expression of specific proteins 
between aVEC and vVEC.  P value less than 0.05, 0.01 and 0.001 are represented by 
*, ** and ***.         
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2.3  Results  
2.3.1 Optimisation of Side-specific Valve Endothelial Cell 
Isolation Condition 
The reliable and reproducible method to isolate aortic and ventricular VECs, and 
VICs from the same animal was established.  The method was developed from 
previous protocols of using enzyme digestion and adapted from a clonal expansion 
method.  
When placing the valve on the isolation wells containing collagenase, there was 
spilling of the enzyme out of the wells.   This resulted in the lower level of the 
enzyme present after fixing the cusps in place with the lid of the chamber, and no 
contact of the valve surface to the enzyme.  Thus, the orbital shaker was 
implemented during the incubation to ensure surface contact of the enzyme with 
the valve surface.  
The isolation incubation time was evaluated at various time points, 10, 20, 30 and 
40 minutes (from 6 pigs for each time variations), by the appearance of VEC colonies 
on a culture plate (at day 2) and the ability to proliferate after the isolation process 
(Figure 2.3 and Figure 2.4).  
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Figure 2.3 Light Microscopic photographs of aVECs isolated by enzymatic digestion at 30 minutes 
and 170 RPM incubation.  VECs freshly isolated from the aortic surface of the porcine aortic valves 
demonstrated separate clusters of cells after the second day (left panel).  As the colony expanded, 
cells displayed more cuboidal shape of cells at day 7 (right panel) without contamination of 
elongated and spindle shape cells.  Pictures were taken from 2 out of 6 pigs at 100x magnifiction. 
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Figure 2.4 Light microscopy photographs of vVECs isolated by enzymatic digestion at 30 minutes 
and 170 RPM incubation.  VECs freshly isolated from the ventricular surface of the porcine aortic 
valves demonstrated separate clusters of cells after the second day (left panel).  As the colony 
expanded, cells displayed more cuboidal shape of cells at day 7 (right panel) without contamination 
of elongated and spindle shape cells.   Pictures were taken from 2 out of 6 pigs at 100x 
magnification. 
 
The results validated the optimal incubation time and optimal speed for orbital 
shaking at 30 minutes and 170 RPM.  aVECs and vVECs were removed from the 
valve surface by the collagenase following 30 minutes of incubation and appeared to 
adhere on the culture plates at day 2 as clusters of cells.  There were no VECs 
attached on the culture plates when they were isolated at the shorter periods of 
incubation (10 and 20 minutes). 
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Moreover, at the optimal isolation-condition (30 minutes – 170 RPM incubation), 
aVECs and vVECs proliferated and maintained their clusters.  VECs incubated at 40 
minutes were isolated and also attached on the plate; however, they proliferated at 
significantly slower rate than those isolated at 30 minutes.  More importantly, VECs 
isolated using the optimal conditions showed cuboidal morphology without the 
contamination of VICs, which have a distinctive spindle-elongated shape.  After the 
isolation conditions were optimised, cellular components of the valve, both on the 
area where it was exposed to the enzyme and the outside area, were investigated by 
scanning electron microscope (Figure 2.5).  
  
Figure 2.5 Scanning Electron photographs of the aortic valves after side-specific isolation. The area 
of the aortic surface (top) and the ventricular surface (bottom row) was investigated for the VEC 
components.  VECs were absent from the area where exposed to collagenase (left panel).  However, 
the remote area of the valves where VECs were not exposed to the enzyme (right panel) displayed 
the preserved VECs on both aortic and ventricular surface.  
The valve surface of the isolating area (exposed to the enzyme in the wells) 
contained no VECs, suggesting the success of the isolation at 30 minutes of the 
incubation time. The left panel of Figure 2.5, where VECs were removed by 
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collagenase revealed the structure of crimping collagen and elastin on the aortic and 
ventricular side, respectively.  Moreover, VECs were maintained on the area outside 
the enzyme contact.   
 
2.3.2 Phenotypes of side-specific VECs  
Immunostaining for endothelial markers vWF, CD31 and VE-Cadherin and VIC, 
myofibroblast marker SMαA, was performed on the aortic and ventricular sides of 
the fresh tissue as well as cultured aVECs and vVECs at passage 2, 3 and 4.  VICs at 
passage 5-6 were also stained for those antibodies and used as a negative control for 
endothelial markers but as a positive control for SMαA.  
As depicted in the Figure 2.6 and Figure 2.7, all aVEC and vVEC cultures were shown 
to have positive staining for CD31 and VE-Cadherin on their cell membranes; 
however, only certain cells were positive for vWF (staining in secretory vesicles and 
cytoplasmic organelles known as Weible-Palade body).  These characteristics were 
also observed in VECs on the fresh valve.  The reduction of EC markers (Figure 2.6 
and Figure 2.7) was observed in VECs at passage 3 for every isolation, n=4.  
Moreover, VICs showed negative staining for all endothelial markers (vWF, CD31 
and VE-Cadherin) but positive staining for SMαA. 
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Figure 2.6 Immuno-staining of endothelial markers expressed by aVECs and vVECs from in situ and 
in vitro.  Co-staining of endothelial markers (vWF in red, CD31 in green and nuclei in blue) was 
maintained in aVECs (left) and vVECs (right panel) on fresh tissue and over passage 2, 3 and 4 (a-h), 
n=4.  VICs were negative for all statining of the EC markers (i).  Scale bars equal to 50 µm.
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Figure 2.7  Immuno-staining of endothelial and VIC markers expressed by aVECs and vVECs from in 
situ and in vitro.  Nucleus was stained in blue.  Endothelial marker (VE-Cadherin, in red) and VIC 
marker (SMαA, in green) were co-stained in aVECs (left) and vVECs (right panel), (a-h).  Both aVECs 
and vVECs, n=4, from in situ and in vitro expressed VE-Cadherin but not SMαA.  In contrast, VICs 
were negative for VE-Cadherin (red) but positive for SMαA (green) in figure i.  Scale bars equal to 
50 µm. 
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2.3.3 Proliferation of side-specific VECs  
The ability of aVECs and vVECs to proliferate in the EGM2 media for 48 hours of 
incubation was compared (Figure 2.8).  The amount of cells cultured with 20% FBS 
in EGM2 was normalised to cells cultured with 0.4% FBS in EGM2 for 48 hours and 
reported as proliferation percentage over the control.   
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Figure 2.8 Growth rate of aVECs and vVECs.  The proliferation of in vitro aVECs and vVECs during 
48 hours incubation in complete EGM2 media was normalised to that of aVECs and vVECs under the 
starved condition. aVECs and vVECs from 4 animal models at passaged 4-5 were used for the 
investigation. 
 
Both aVECs and vVECs proliferated in EGM2 media.  The median of proliferation 
percentage, over control by aVECs was 139.1% while vVECs had a median of 
149.2%, of the control.  However, there was no significant difference of the 
proliferation between aVECs and vVECs (n=4, p=0.0571). 
 
 
 91 
 
2.3.4 Quantitation of potentially difffential markers for side-
specific VECs 
The expression of NOS III, vWF, Cx43 and Cox2 by aVECs and vVECs, was examined 
by western blot analysis and normalised to the production of house-keeping protein 
i.e. either GAPDH or eEF2 (depending on size of the target proteins).  The 
differential expression by VECs was investigated from both fresh cusps and the 
cultures (at passage 4-5), Figure 2.9. 
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Figure 2.9 Quantitative analysis of potential markers for side-specific VECs. Expression of NOS III, 
vWF, CX43 and Cox2 by side-specific VECs from in situ (left) and in vitro (right panel) was 
quantified by Western Blot and normalized with housekeeping protein, as reported in O.D. ratios to 
the housekeeping genes. n number for each analysis eqauls to data plots. 
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There was a trend towards significant differences between side-specific VECs, for 
expression of NOS III (in situ), p=0.0571 and vWF (in vitro), p=0.0556; however, the 
difference was not statistically different (n=4-6).  The median values of the O.D. 
Units are summarised in Table 2.2.  It was noted that there was no significant 
difference in all observations comparing the expression of endothelial associated 
proteins on each side of the valve.  
Table 2.2 Median value of O.D. Units by western blot analysis of in situ and in vitro VECs 
Proteins 
In situ In Vitro 
aVECs vVECs aVECs vVECs 
NOS III 0.491 0.276 2.521 1.763 
vWF 2.503 2.574 0.865 0.518 
CD43 1.370 1.524 1.481 1.396 
Cox2 3.152 3.231 3.446 4.814 
Note: All comparison beweet aVECs and vVECs within either in situ or in vitro group has p-value > 
0.05 
 
2.3.5 Cytokine Productions by side-specific VECs at resting 
state. 
Low serum media which was used to culture either aVECs or vVECs (at passage 4), 
was collected after 48 hours in contact with the cells.  The production of 10 
cytokines was investigated by protein array and compared to the basal level present 
in the low serum media.  5 out of 10 cytokines were detected by the array.  Those 
were IL-1β, IL-8, TGF-β1, IFNγ and TNFα (Figure 2.10).   
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Figure 2.10 Cytokine production by in vitro side-specific VECs.  aVECs and vVECs at passage 4-5 
were cultured with low-serum media for 48 hours and investigated for the production of cytokines 
released in the media by protein array.  There is no significant difference of cytokine 
modulationbetween aVECs and vVECs.  Whereas IL-1β, IL-8 and TGF-β1 were not present in the 
media control, the amount of IFNγ and TNFα in the media control were higher than media over VEC 
cultures.  
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Both aVECs and vVECs released IL-1β, IL-8 and TGF-β1 into the culture media at 48 
hours incubation of static culture.  These cytokines were not detected in the low 
serum media without the contact with VECs.  Moreover both aVECs and vVECs 
reduced the amount of IFNγ and TNFα present in the media.  The median value of 
the production and degradation of the cytokines by aVECs and vVECs are 
summarised in Table 2.3.   
Table 2.3 Median value (pg/106 cells of VECs) of the increased (+) and reduced (-) amount of 
cytokines in the media cultured with aVECs and vVECs in vitro as compared to the media without 
the contact with VECs. 
Cytokines aVECs   (pg/106 cells) vVECs    (pg/106 cells) 
IL-1β +2.670      +4.410 
IL-8 +8558 +13790 
TGF-β1 +1859 +1551 
IFNγ -3387 -5302 
TNFα -36485 -50601 
 
There were no significant differences in the production and degradation of the 
cytokines by VECs from the different sides. 
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2.4 Discussion  
There is increasing interests in the function of VECs from the opposite sides of aortic 
valve due to the preferential formation of calcific disease on the aortic surface of the 
valve.  However most of the investigations are in situ studies.  In order to examine 
the function of these cells in greater detail, the isolation and culture side-specific 
valve endothelial cells is essential.  In this work, a successful method to isolate and 
culture aVECs and vVECs from the same animal was developed by adapting existing 
enzymatic digestion methods and using a purpose built chamber.   Consequently, the 
potential phenotypic and functional differences between the two cell types were 
then investigated.  
One of the key steps in side-specific VEC isolation is to exclude VICs from the initial 
isolated cell population.  Magnetic cell sorting and fluorescence-activated cell 
sorting (FACS) have been widely used; however, these techniques depend on 
specific antibody labeling that was not available for porcine tissue.  An alternative 
prospective method is clonal expansion of cells which has been employed by others 
(Gould and Butcher, 2010) and our laboratory previously.  With this technique, 
VECs are required to be diluted and expanded from a single cell in a well.   As a 
result of the lack of cell-cell adhesion to promote cell growth, single VECs initially 
proliferated slowly.  It is noted that this condition contradicts the physiological 
conditions in which ECs line the vasculature as a continuous monolayer.  Thus, the 
colony expansion technique was adapted whereby groups of VECs, detached from 
valve cusps during the enzyme digestion, were grown on the plate and expand as 
clusters of the cells. 
SEM was used to validate the isolation of VECs from the valve surfaces that were 
exposed to collagenase.  VECs were successfully removed from the aortic and 
ventricular surfaces at the optimum condition of 170 orbital shaking for 30 minutes 
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at 37⁰C.  The scanned surface at the denuded area was absent of VECs and revealed 
the crimped collagen and elastin sheaths on the aortic and ventricular surfaces, 
respectively.  After detaching from the valve surface, the primary culture of VECs 
maintained a cobblestone-like morphology. However not every VEC had 
cobblestone structure at later passages.  This characteristic of cultured VECs has 
also observed in cells cultured from human pulmonary and calf atrioventricular 
valves (Paruchuri et al., 2006; Manduteanu et al., 1988).  
Phenotypes of aVECs and vVECs in cultures were investigated and compared to the 
phenotypes of those on the fresh valve (in situ).  Both aVECs and vVECs in vitro 
preserved endothelial phenotypes (by expressing CD31, vWF and VE-Cadherin) 
throughout several passages even when they were maintained in the culture 
conditions, without exposure to a physiological heamodynamic environment.   
Although vWF is widely considered as a specific endothelial marker, there is 
evidence showing a differential capacity of ECs from different sites and species to 
produce vWF (Giddings et al., 1983).  Porcine aorta ECs were weakly positive when 
stained with the vWF antibody, whereas the porcine umbilical vein ECs were 
consistently positive for vWF.  In this study, VECs in situ showed an inconsistent 
positive staining against vWF.  The granular fluorescent staining was localised in 
cytoplasm of certain VECs on each side of the valve.  Additionally, this characteristic 
was maintained for several passages in cultured aVECs and vVECs.  The possibility 
of the contamination by VICs was also examined by staining for SMαA.  The negative 
staining of SMαA in VECs assured the reliability of the isolation method to exclude 
the contamination by VICs, which express SMαA in culture.   
The ability of aVECs and vVECs to grow in complete EGM2 media, relative to those 
maintained in starved serum media over 48 hours, was not statistically different, 
although the p-value was near to significance.  Moreover, the doubling time of mixed 
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VECs from both sides of bovine heart valves has been reported at 36 to 42 hours 
(Manduteanu et al., 1988).  Consequently, side-specific VECs were not maintained in 
EGM2 media longer than 36 hours in subsequent experiments in order to reduce the 
differential effect of varied numbers of aVECs and vVECs in each experimental group 
(Manduteanu et al., 1988).   
There have been attempts to identify the phenotypic difference of in situ side-
specific VECs in terms of gene expression (Simmons et al., 2005; Holliday et al., 
2011) and protein expression (Richards et al., 2013; Inai et al., 2004). The 
transcription profiles of VECs isolated from the aortic and ventricular surface of 
porcine aortic valves revealed different gene expression patterns such as actin 
cytoskeletal organisation, transforming growth factor-β signaling, cell adhesion 
proteins (CD31), gap junctions (Cx43), specific endothelial proteins (NOS III and 
vWF), mediator of vascular calcification (BMP4) and skeleton development (fibrillin 
1) (Simmons et al., 2005).  However, it is noted that the porcine gene profile 
generated from the human microarray may provide some inaccuracy due to the 
species differences.  Recently, human aVECs and vVECs were exposed to oscillatory 
and laminar shear stress in vitro to mimic physiological conditions, as well as to the 
flow pattern experienced on the opposite-side of the valve to investigate the 
dependence of the type of flow on EC phenotype (Holliday et al., 2011).  In 
comparison to the porcine transcription profile, human mRNA expression of aVECs 
and vVECs shared the same trend of differential expression. Similarities existed in 
the differential expression of BMP4, cathepsin K, Asparagine synthetase, Histone 
deacetylase 1 and prostagladin endoperoxidase synthase 1. However, the semi-
quantitative analysis of mRNA expression of CD31, vWF and VE-Cadherin did not 
identify any significant differences between human aVECs and vVECs.  Additionally, 
there were no side-dependent differences of any mRNA expression detected in the 
study.  It was demonstrated that aVECs and vVECs did not show the same response 
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to the same pattern of flow (Holliday et al., 2011). These results suggested that the 
microenvironment i.e. shear stress could play an important role to those phenotypic 
difference observed in vivo.    
This study attempted to quantify the reported differential production of proteins by 
side-specific VECs and investigate whether the differential phenotypes were 
maintained in cultured cells, under the static condition.  Protein candidates such as 
NOS III, vWF, Cx43 and Cox2 were thus quantified by western blot analysis of in situ 
and in vitro VECs.   
NOS III stimulates the production of NO from L-arginine.  NO is postulated the 
function to protect the valve against calcification via decreasing the myofibroblastic 
phenotype of VICs in the ventricularis (Richards et al., 2013).  Human aortic valves 
have also been shown to have the higher production of NOS III in vVECs compared 
to aVECs, suggesting that this may contribute to the greater resistance of the 
ventricularis to the formation of calcific lesions compared to the disease prone 
fibrosa side.  However, these observations are different to those reported in porcine 
valves where higher mRNA expression of NOS III was seen on the aortic side 
(Simmons et al., 2005).  It is noted that NOS III was investigated at different level 
(protein vs mRNA production) as well as in the different species (human vs porcine) 
which may cause the discrepancy of data observed by studies by Richards et al.  and 
Simmons et al.  In this study, protein quantification of NOS III of porcine aortic 
valves showed a tendency of higher production on aVECs than vVECs, however 
there was no statistically significant difference in these data.  Moreover the side-
specific VECs cultured under static conditions for several passages also exhibited no 
difference of NOS III production between ECs isolated from the different aspects of 
the porcine aortic valve.    
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The pattern of shear stress experienced by ECs is an important factor in the 
regulation the expression of NOS III by bovine aortic and venous ECs.  The 
oscillatory shear stress (-3 to +3 dyn/cm2) dramatically increased the function of 
regulatory element (promoter) of the NOS III gene, compared to the unidirectional 
shear stress and static culture (Ziegler et al., 1998b).   In contrast, mRNA expression 
of NOS III was significantly increased in proportional to increases in the magnitude 
of unidirectional flow between 3 to 6 dyn/cm2.  This led to the conclusion that the 
oscillatory and unidirectional shear stress than exert differential regulation of NOS 
III expression (Ziegler et al., 1998b).  Although these experiments were performed 
with vascular ECs, that experience a lower magnitude of the shear stress that occur 
on the aortic valve, it indicates how complex of the regulation of NOS III 
transcription can be.  In addition, the regulation on the protein production and 
activity of NOS III by different flow patterns has not been studied.   
Von Willebrand factor (vWF) is a glycoprotein component of factor VIII that is 
produced by endothelial cells to help maintain the haemostasis.  vWF mRNA 
expression observed in porcine aortic valves was higher in aVECs than those in 
vVECs (Simmons et al., 2005).  Intracellular vWF can be detected, by 
immunostaining, as granules in cytoplasm.  Although vWF is widely considered as 
an endothelial marker as discussed earlier, the production of it was decreased in 
porcine ECs maintained in cultured for only 48 hours (Jaffe, 1982). The IHC and ICC 
revealed that both aVECs and vVECs in situ and in vitro produced vWF.  The 
quantitative analysis confirmed the production of vWF by VECs from in situ and in 
vitro of which there was no significant difference among side aspects.  Although 
there was a trend that in vitro aVECs had slightly higher production of vWF than 
those of vVECs, this difference was also not statistically significant.  
Cx43 is a component protein of gap junctions facilitating the propagation of 
electrical and chemical signals between cells.  mRNA of Cx43 has been demonstrated 
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to be up-regulated by the turbulent shear stress in certain areas of  arteries 
(Gabriels and Paul, 1998).  In addition, the expression of Cx43 mRNA on porcine 
aortic valves exhibited differential expression in which the higher expression of 
Cx43 was found on the ventricular surface (Simmons et al., 2005).  Likewise, the 
staining of the gap junctions on the mouse aortic valve also showed higher 
expression of Cx43 on the surface exposed to laminar flow.  The semi-quantitative 
analysis showed a broad range of the expression of 70-200 folds greater on the 
ventricular surface (Inai et al., 2004).  In this study, however, there was no 
significant difference of the Cx43 protein between aVECs and vVECs, both from in 
situ and in vitro analysis.  The difference between this result to the semi-quantitative 
analysis of gene expression of porcine valves and of protein production of murine 
valves may relate to the numbers of valves studies and requires further 
investigation. 
Cyclooxygenase-2 (COX-2) is also referred to prostaglandin H synthase-2.  Its 
function is to synthesise Prostaglandin I2 (PGI2) or prostacyclin, a potent inhibitor 
of platelet aggregation and a powerful vasodilator (Morita, 2002).  There are several 
factors that could regulate the COX-2 expression by endothelial cells; for example, 
the down-regulation by glucocorticoids and anti-inflammatory cytokines (IL-4 and 
IL-10) and the up-regulation by growth factors, cytokines and mechanical stress.  
One of the COX-2 promoters that responds to shear stress is the cAMP-responsive 
element (CRE) (Inoue et al., 2002).  Asynchrony of shear stress and strain reduce the 
expression of COX-2 mRNA and the secretion of prostacyclin by bovine aortic ECs 
(Dancu et al., 2004).  Although the investigation of in situ VECs can be a surrogate 
marker for in vivo mechanical environment, there was no significantly difference of 
COX-2 production by the VECs freshly isolated from the tissue and cultured cells 
from the aortic and ventricular side. This preliminary observation was the first 
investigation of the expression of COX-2 in porcine aortic valve.   
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Cytokines are a group of short–life soluble molecules (peptides, proteins and 
glycoproteins) which are produced by various immune cells and vascular cells 
(Sprague and Khalil, 2009).  They act in picomolar to nanomolar concentration to 
modulate functions of ECs and vascular SMC with a subsequent effect on remodeling 
of ECM.  Cytokines can be generally categorized as: Interleukins (ILs), Interferons 
(IFNs), Transforming growth factors (TGFs), Tumor necrosis factors (TNFs), Colony 
stimulating factors (CSFs), Lymphokines, Monokines and Chemokines. 
The ability of vascular ECs to produce cytokines in response to external chemical or 
mechanical (both physiological and pathophysiological) stimuli has been 
established (Sprague and Khalil, 2009).  However the differential function to release 
cytokines by side-specific VECs has not been studied yet. In this study, the 
production of cytokines by aVECs and vVECs was performed using a protein array 
that detected interleukin (IL) family [IL-1β, IL-4, IL-6, IL-8, IL-10, IL-12], 
granulocyte macrophage-colony stimulating factor (GM-CSF), interferon gamma 
(IFNγ), transforming growth factor beta (TGFβ1) and tumor necrosis factors alpha 
(TNFα).   
At resting state (without any immune activation and heamodynamic stimuli), both 
aVECs and vVECs released detectable levels of IL-1β, IL-8 and TGFβ1 (pro-
inflammatory and atherogenic molecules) which are known to affect the migration, 
proliferation and activation of ECs and SMCs (Sprague and Khalil, 2009).  In 
contrast, the media from VEC cultures had a reduced amount of some pro-
inflammatory molecules such as IFNγ (inhibits ECM synthesis by SMC) and TNFα 
(suppresses adhesion molecule expression and increases permeability of ECs).  This 
decreased amount of the cytokines was relative to those the levels of the low serum 
media without the contact with VECs. This effect may be related to the 
sensitivity/variability of the assay, or suggest that VEC degrade these cytokines.  
The potential mechanisms involved in this effect were not pursued further. 
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GM-CSF that affects the growth and proliferation of monocytes, macrophages, and 
granulocytes (Sprague and Khalil, 2009) was not detected in this study.  This could 
be explained by the non immunity-activation condition with which VECs were 
maintained for the study.   IL-4, IL-6, IL-10 and IL-12 were also not detectable in this 
assay and have not been reported to be produced by any ECs before (Sprague and 
Khalil, 2009).  
This study demonstrates that VECs can modulate the cytokine production of the 
inflammatory factors (IL-1β, IL-8, TGFβ1, IFNγ and TNFα); however there is no 
significant difference of those productions between VECs from the different aspects 
of the valve.  Similarly, aVECs and vVECs, on the valve, that were exposed to their 
physiological flows also produced inflammatory markers at the non-different level 
(Sucosky et al., 2009).  However, the expression of imflammatory molecules was 
increased when aVECs were exposed to the reverse flow from the normal condition.  
The lack of difference of cytokine production, seen in these studies, might be due to 
an inherent ability of the cells to produce the inflammatory molecules when they are 
maintained under non-activated conditions.  
 
2.4.1 Limitations of the study 
The differential cellular isolation and the attempt to identify the side-specific VECs 
markers in these studies have some limitations.  
The isolation technique developed by this study allows aVECs, vVECs and VICs to be 
obtained from different cusps of an aortic valve.  This study is based on the 
assumption that there is no phenotypic difference of cells from the same aortic 
valve/animal.  Thus, the left-, right- and non-coronary leaflets were randomly 
selected for cellular isolation.    
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The amount of cytokines in the media, without contact with VECs, should be 
compared between 0 and 48 hours incubation, in order to include the possibility 
that TNFα and IFNγ are degraded independent of cellular function.   
The experiments in this study were carried out under static, non-activated 
conditions.  Further experiments are required to investigate the influence of flow 
and immune stimulation on the ability of VECs to release cytokines and chemokines 
in order to obtain a clear picture of the physiological and pathophysiological role of 
cytokine production by VECs.  However, the cost of the Porcine Protein Array kit 
limited the number of experiments that could be conducted. 
Finally, the quantitative analysis of the potential markers and the cytokine 
productions were performed at low sample number, due to cost and time limitation. 
Consequently, it is impossible to achieve conclusive results.  However, the result 
data from low n-number can be useful for Power Analysis and predict the sample 
size for later experimental design.  For example, means and standard deviation of 
the ratio value of NOS III expression by in situ VECs (Figure 2.9) were used to 
calculate sample size and the effect size (the difference between the null hypothesis 
the alternative hypothesis) by G*Power programme 
(http://www.gpower.hhu.de/en.html).  The significant difference is predicted to be 
achieved if the sample size of aVEC and vVEC is bigger than 12 pigs for each group 
(at effect size=1.64, p-value=0.05 and the probability of accepting the null 
hypothesis=0.05).  
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2.5  Conclusions and Future Directions 
In conclusion, the efficient and repeatable method to isolate side-specific VECs and 
VICs from the same aortic valve is established.  This enables the study of aVEC and 
vVEC function in separated conditions in vitro.  Both aVECs and vVECs maintain 
their endothelial phenotypes (expressing vWF, CD31 and VE-Cadherin) between 
passages.  Moreover the quantitative analysis of the potential markers for side-
specific aVECs and vVECs was investigated.  The conclusive method to “screen” for 
the unique phenotypes among aVECs and vVECs could be achieved using 
proteomics.  Protein patterns (2-D gel electrophoresis) of aVECs and vVECs from 
both in situ and in vitro could be compared to each other in order to identify the 
protein profile produced by VECs under different conditions.  Mass spectrometry 
could also be used to identify the unique proteins found under physiological 
conditions and to assess if inherent differences in cell phenotype are maintained 
independently of the mechanical forces exposed to the cells.  In addition, these 
experiments would demonstrate the function of VECs (in cultures) to secrete 
cytokines that can affect function of VECs themselves, nearby interstitial cells and 
the surrounding ECM.  In these studies, nevertheless, markers showing differential 
expression and the release of cytokines by aVECs and vVECs were not reliable 
identified.  The differential characteristics of aVECs and vVECs to regulate the 
function of VICs require further investigation. This thesis will attempt to identify 
functional differences in the functional effects of aVECs and vVECs on the ability of 
VICs to secrete ECM proteins.  
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3 CHAPTER 3 Effect of Conditioned Media by 
Side-Specific VECs    
3.1 Background 
It is well acknowledged that vascular ECs secrete a myriad paracrine factors that 
have an influence on the proliferation and function of cells such as smooth muscle 
cells and fibroblasts (Sprague and Khalil, 2009).  The endothelial cells produce a 
source of molecules that can stimulate and inhibit the proliferation of underlying 
cells.  For example, concentrated serum-free media which was pre-cultured with 
bovine aorta ECs (at later passages) increases the proliferation of bovine SMCs 
(Gajdusek et al., 1980).  In contrast, the 20% serum media used to maintain the 
primary culture of bovine aorta ECs has reduced the replication of growth-arrested 
bovine SMC (Castellot, Jr. et al., 1981).   
These contradictory observations from those different experimental settings could 
be explained by the different cellular conditions of ECs.  The density of ECs was 
recently reported to determine the stimulatory or inhibitory effect on cell SMC 
proliferation (Dodge et al., 1993). Media, with 10% serum, containing EC-derived 
factors that were collected from the sparsely cultured aorta ECs stimulated the 
proliferation of SMCs.  In contrast, when the same ECs grew until they reach 
confluence, the media collected from the dense culture of ECs inhibited the 
proliferation of SMCs (although it was prepared with a fresh 10% serum media at 
the same conduct as the sparsely cultured ECs before being used to culture SMCs) 
(Dodge et al., 1993).    
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In addition to the effect on proliferation, the media containing EC-derived factors 
also affects the regulation of the ECM production by SMCs and fibroblasts.   
The production of collagen by the cardiac fibroblasts was increased when they were 
cultured with the conditioned-media (CM) obtained from the pre-incubation with 
endocardial ECs (Kuruvilla et al., 2007).  Regardless of the species difference, the CM 
achieved from bovine ECs increased the production of collagen by human 
fibroblasts in a concentration-dependent manner (Villanueva et al., 1991).  
Moreover, bovine aorta EC-CM increased the de novo synthesis of GAGs by SMCs in a 
concentration and TGF-β dependent manner (Ciolino et al., 1992).  The production 
of GAGs was diminished when the TGF-β antibody was added into the EC-CM.  The 
evidence that TGF-β is the active factor in CM and responsible for the increasing 
production of GAGs was supported by the culturing of porcine SMCs with bovine EC-
CM (Merrilees and Scott, 1990).   
In the previous chapter, VECs were demonstrated to be able to secrete and/or 
modulate the concentrations of a range of different cytokines. It is hypothesised 
that, under non-stimulated (non-activated) conditions, VECs can also produce 
molecules that have effects on the VICs, similar to the function of ECs found 
elsewhere in the vascular system.  In this study, investigations were carried out into 
the ability of side-specific VEC-derived molecules to regulate the proliferation and 
production of ECM components of VICs.  Low serum medium is pre-incubated with 
either aVECs or vVECs to make aVEC-CM or vVEC-CM.  These CM were examined for 
their ability to affect the proliferation of VICs.  Additionally the effect of VEC-CM on 
the production of ECM components by VICs was also quantitatively assessed.  
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3.2  Materials and methods  
3.2.1 Valvular Endothelial Cell Conditioned Media (VEC-CM) 
To investigate the effect of factors released by VECs under resting conditions on 
VICs, aVECs and vVECs were isolated (as previously described in the section 2.2.2) 
and  grown in 25 cm2 flasks until reaching confluence (at about 1.5 x 106 cells).  
Freshly prepared DMEM with 0.4% FBS was then added and left in contact with the 
cells for 6, 12, 24 or 48 hours.  Thereafter, the VEC-CM was collected and prepared 
at different dilutions (1:50, 1: 20, 1:10, 1:5, 1:2 and undiluted) and added to cultures 
of VICs to investigate whether VEC-CM has a concentration-dependent effect.  The 
effect of VEC-CM on VIC proliferation and ECM production was also investigated.   
A low serum DMEM media was used to generate the VEC-CM, so as the basal growth 
factors necessary for culturing VICs could be maintained but with little or no 
mitogenic factors present that might mask effects of mediators produced by the ECs.  
Consideration was also given to the endothelial phenotype of VECs that were 
maintained with low serum DMEM.  Thus, endothelial markers such as VE-Cadherin 
and vWF were examined in VECs cultured low serum DMEM for the longest culture 
period of, 48 hours. The expression of the markers was investigated by the 
immunostaining technique and compared to those of the same VEC isolations, which 
were cultured with the endothelial media.   
 
3.2.2 VIC proliferation under the effect of VEC-CM by MTS assay 
VEC-CM at 6, 12, 24 and 48 hours time points were diluted with DMEM containing 
0.4% serum at 1:50, 1:20, 1:10, 1:5 and 1:2 to investigate its effect on VIC growth.  
VEC-CM at each time points and concentration were incubated with VICs seeded at 
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3.0 x 103 cells/well in 96-well plates for 48 hours. The VICs were cultured from the 
same animal as the VEC used to make the CM.  Fresh 0.4% FBS DMEM was used to 
culture VICs to serve as a negative control, whereas complete DMEM with 10% FBS 
was used a positive control for the proliferation.  
The proliferation of the VICs in response to the incubation with VEC-CM was 
assessed by MTS assay (section 2.2.6).  
 
3.2.3 The effect of VEC-CM on the content of ECM by VICs 
aVEC-CM and vVEC-CM generated over 48 hours at 1:5 dilution was prepared by 
diluting the media with fresh low-serum media.  It was then used to culture VICs, for 
48 hours, to investigate the effect of VEC-CM on the ability of VIC to produce ECM 
proteins.   
The VICs were seeded at 5.2 x 105 cells per well of 6-well plate and maintained in 
complete DMEM.  After reaching confluence, the culture media was removed and 
VICs were washed twice with PBS before being staved with 0.4% FBS DMEM 
overnight.  The media was aspirated and 3 ml of VEC-CM at the dilution of 1:5 was 
subsequently added to culture VICs.   A newly prepared low-serum media was for 
the controls.  After appropriate media were applied, the VICs were cultured for 48 
hours in the 95% air/5% CO2 incubator.  The media over VICs was then collected for 
assessment of the amount of collagen and GAGs, while elastin levels were measured 
in the VICs.  
 
 
 110 
 
3.2.4 Collagen content by VICs in vitro 
Soluble collagen can be measured by Sircol assay (Biocolor, UK), which is a dye-
binding method.   The quantity of collagen is proportional to the amount of the 
Sirius Red dye that binds specifically to [Gly-X-Y] repeating units in a helical 
structure of collagen type I, II, III, IV and V.  In the presence of alkali reagent (0.5 M 
sodium hydroxide), Sirius Red dye is released from collagen and has a peak of 
absorption between 550-555 nm.  By measuring the absorbance at 550 nm using a 
BioPhotometer (Eppendorf, UK), the amount of Sirius Red can be quantified and 
correlated to the amount of collagen using the a standard curve of known collagen 
concentrations.  
Collagen concentrations in the media were measured after 48 hours incubation with 
VEC-CM.  The amount of collagen production stimulated by aVEC-CM and vVEC-CM 
was compared to the control (VICs isolated from the same animal but incubated 
with just low-serum DMEM).  To exclude the possible amounts of collagen in the 
VEC-CM, the collagen concentration in the 1:5 dilution of VEC-CM was also 
quantified.  
To avoid the variations in the concentration of collagen due to the evaporation of 
media from the culture wells during the experiment, all each culture well was 
topped up to 3 mlof distilled H2O.  Duplicates of each sample (1 ml) were 
transferred to clean 1.5 ml micotubes and then mixed with 200 μl of Isolation and 
Concentration reagent containing polyethalene glycol in a Tris-HCl buffer at pH7.6 
at 4° C for overnight.  Collagen was then precipitated by centrifugation at room 
temperature at 13684 g for 10 minutes and the supernatant was removed.  1 ml of 
Sircol dye (Sirius Red) was added to the blank (100 µl of distilled water) and all 
experimental samples including collagen reference standards prepared at 5, 10 and 
15 μg, at total volume of 100 µl.  Samples were gently shaken at room temperature 
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for 30 minutes to allow Sirius Red bind to the collagen.  The collagen-dye complex 
was separated from unbound dye by centrifugation at 13684 g for a further 10 
minutes.  The supernatant was carefully removed by pipetting.  Collagen-dye pellet 
was then washed with 750 μl of ice-cold Acid-Salt Wash Reagent containing acetic 
acid, sodium chloride and surfactants.  All samples were spun down at 13684 g for 
10 minutes to precipitate the complex again.  The wash reagent was carefully 
aspirated with a fine needle syringe.  The collagen-dye complex was released by 250 
μl of Alkali Reagent and the measured absorbance at 550 nm.  The collagen 
concentration present in the sample was then calculated by using the standard 
curve and expressed as the total amount of collagen produced by ~5.2 x 105 VICs. 
 
3.2.5 GAGs content by VICs in vitro 
Blyscan kit (Biocolor, UK), a colorimetric method, was used to quantify the amount 
of sulphated proteoglycan and glycosaminoglycan.  At acidic pH, Blyscan Dye or 1,9-
dimethyl-methalene blue proportionally binds to sulphate-GAGs.  Subsequently the 
dye is released to a free form by dissociation reagent containing chaotropic salt in 
an aqueous propanol and it has a peak absorption at 656 nm.  The amount of GAGs 
in the samples is calculated from the amount of dye that is recovered from 
sulphated-GAGs.    
In order to concentrate GAGs secreted by VICs, the media from VIC cultures was 
freeze-dried (HETO Dry Winner, Denmark) overnight.  VEC-CM (without contact 
with VICs) was also concentrated to investigate the amount of GAGs produced by 
VECs. Freeze dried samples were subsequently resuspended with 500 μl of distilled 
water prior to being used in the Blyscan assay. 
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75 μl of samples were taken to carry out GAGs quantification.   GAGs standards at 1, 
2, 3 and 5 μg, and the experimental samples were prepared up to 100 μl with 
Millipore distilled H2O.  100 µl of dH2O was used as a blank of the assay.  1 ml of the 
dye was added to all the samples and gently shaken for 30 minutes at room 
temperature to allow the dye bind to the sulphated-GAGs present.  Insoluble GAGs-
dye complex was centrifuged at 16060 g for 12 minutes.  An unbound dye in 
supernatant was carefully aspirated using a fine-needle syringe.  The dye was 
dissociated from a GAGs-dye pellet by resuspending with 1ml Dissociation Reagent.  
The amount of the dye corresponding to the amount of GAGs and was measured the 
absorbance at 650 nm by BioPhotometer plus (Eppendorf, UK).  The total amount of 
GAGs was calculated from the standard curve and, following correction for the 
dilution factor used for sample preparation, was calculated as μg.   
 
3.2.6 Elastin content by VICs in vitro 
Tropoelastin is a monomer of elastin and can be quantified by a dye-binding assay, 
Fastin kit (Biocolor, UK).   5,10,15,20-tetraphenyl-21H,23H-porphine tetra-sulfonate 
(TPPS) in the Fastin Dye binds to the basic and non-polar amino acid sequences of 
α-elastin in a soluble form.  The amount of TPPS bound is proportional to the 
amount of elastin in the sample and is measured by the absorption of light at 513 
nm.  
Tropoelastin is exported by microfibril glycoprotein and bound on the outer surface 
of the cell, hence measurements were made on the VICs, rather that the media.  α-
elastin matrix on the cell membrane of VICs was subsequently extracted into water-
soluble form by oxalic acid.  
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After 48 hours of incubation either with aVEC-CM or vVEC-CM or fresh low-serum 
media, VICs were washed gently with PBS twice and scraped out of the plate with 
200 µl of 0.25 M Oxalic acid added.  Cell suspension was then transferred to a 1.5 ml 
microtube and another 800 µl of 0.25 M oxalic acid was added into the culture wells 
to collect all VICs that may have been left on the plate.  The extraction of elastin was 
performed at 100°C by placing the microtubes on the heat box.  After 1 hour of 
heating, the microtubes were centrifuged at 9503 g for 10 minutes.  Soluble elastin 
in the supernatant was then transferred into new microtubes and ready to be 
assayed.  The extraction was then repeated twice by adding another 1 ml of 0.25 M 
oxalic acid into the pellet and re-heating the microtubes for 1 hour.  
Triplicates of the heat extraction from each sample were added with 1 equal volume 
of precipitating reagent containing trichoroacetic and hydrochloric acids.  Elastin in 
samples and standards, which were prepared at 2.5, 5, 10, 20, 40, 80 and 100 µg, 
were precipitated at room temperature for 15 minutes and centrifuged at 9503 g for 
10 minutes.  Distilled water was used as blank for the assay.  After centrifugation the 
supernatant was then removed carefully by inverting microtubes and tapping the 
tubes on a clean paper towel.   
1 ml of Dye reagent was added to the α-elastin that remained at the bottom of 
microtubes and dispersed by vortexing.  The binding reaction between elastin and 
TPPS dye was performed at room temperature for 90 minutes with gentle shaking.  
Unbound TPPS was separated from the elastin-dye complex by centrifugation at 
9503 g for 10 minutes until the complete removal of the supernatant was possible.  
Thereafter, 250 µl of Dye Dissociation Reagent containing guanidine HCl and 
isopropanol was added into every sample to release TPPS from α-elastin.  100 µl of 
each reaction was then transferred in duplicate into wells of 96-well plates to enable 
the absorbance of TPPS at 513 nm to be measured by the microplate reader. The 
concentration of elastin in each sample was calculated using the standard curve.   
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3.2.7 Data and statistic analysis 
Proliferation, collagen, GAGs and elastin production of VICs under VEC-CM were 
represented as a percentage change by comparing the test sample to its individual 
control.  Data was expressed showing mean±SEM and plotted using Excel for the 
proliferation studies.  For collagen, GAGs and elastin experiments, the median was 
presented by the bar in the Box and Whiskers Plot, using GraphPad Prism 5.   The 
top of the box represents the third interquartile (IQ3) whereas the bottom of the 
box shows the first interquartile (IQ1).  The top and bottom whiskers illustrate the 
maximum and minimum value, respectively.   Data was statistically analysed using 
Kruskal-Wallis Test which is a non-parametric one-way ANOVA.  The data were then 
compared in a pair-wise manner using Dunn’s post-hoc Test.  P value less than 0.05, 
0.01 and 0.001 are represented by *, ** and ***. 
Non-parametric Spearman test was used to analyse the correlation between the 
dilution of each CM and VIC growth.  Spearman's correlation coefficient (r) indicates 
the strength of the relationship between the two variables using a monotonic 
function.  “r” equals to -1 or +1 when there are no repeated data and the variables 
are a perfect monotone function.  P value less than 0.05 suggests the real correlation 
which is not due to random sampling.   
 
 
 
 
 
 115 
 
3.3 Results  
3.3.1 Phenotypic characterisation of VECs in low serum DMEM 
The expression of endothelial markers such as VE-Cadherin and vWR by VEC 
isolates grown in EGM2 media and, later, in the low serum DMEM for approximately 
72 hours were examined.  
Both aVECs and vVECs that were cultured in the endothelial media were positively 
stained for VE-Cadherin and vWF (Figure 3.1 and Figure 3.2).  Moreover, the 
expression of those endothelial markers was maintained in both aVECs and vVECs 
when the media was changed to with low serum DMEM, from which the conditioned 
media was.  The morphology of VECs appeared to retain the cobblestone shape in 
the low serum DMEM. 
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Figure 3.1 Endothelial phenotypes of aVECs with EGM2 media and low serum DMEM media.  The 
expression of VE-Cadherin (top row) and vWF (bottom row) was positively stained in red colour by 
aVECs, at passage 4-5, which were cultured in EGM2 and subsequently maintained in low serum 
DMEM. 
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Figure 3.2 Endothelial phenotypes of vVECs with EGM2 media and low serum DMEM media.  The 
expression of VE-Cadherin (top row) and vWF (bottom row) was positively stained in red colour by 
vVECs, passage 4-5, which were cultured in EGM2 and subsequently maintained in low serum 
DMEM. 
 
3.3.2 Effect of VEC conditioned media on VIC proliferation 
The effect of aVEC-CM and vVEC-CM that was collected at after 6, 12, 24 and 48 
hours in contact with the respective VEC cultures was diluted to give a 
concentration range of 1:50 to 1:2. The effect of these dilutions was investigated on 
VIC proliferation (at 48 hours) and compared to the response of VICs in low serum 
media without VEC contacts (Figure 3.3).    
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The VEC-CM generated over 48 hours shown evidence of a concentration-dependent 
increase in the VIC cell number.  Both aVEC-CM and vVEC-CM at 48 Hours had an 
increased effect on VIC proliferation, Spearman r = 1 and p-value = 0.02.  The 
maximum effect was seen at a dilution of 1:2 by aVEC-CM and vVEC-CM at 
184.74±5.47% and 199.25±2.60% of control, respectively.  However, there was no 
difference between the effect of aVEC-CM and vVEC-CM (p>0.05, n=3).  In addition, 
the sub-maximum effect was observed at a dilution of 1:5 by aVEC-CM and vVEC-CM 
at 169.05±4.26% and 179.28±7.23%, respectively.  However there was still no 
difference among VIC controls and those cultured with VEC-CM (p>0.05, n=3).   
There appeared to be an effect with time taken to generate the CM but the effect 
seen was not consistent.  For example, the CM from the contact with VECs for 6 
hours seemed to increas the proliferation of VICs but the correlation is not real as 
demonstrated by p=0.90. The VEC-CM at 12 hours appeared to decrease the 
proliferation of VICs when the concentration of VEC-CM was increased (inverse 
correlation at p=0.02).  Moreover the effect of VEC-CM at 24 hours was variable, 
without the concentration dependence (p=0.95).  The maximum effect on the 
proliferation of VEC-CM at 24 hours was found at the dilution of 1:10.  
These results suggested that 48 hours was the optimal amount of time that VECs 
could generate growth factor in the CM to have a consistent effect on the 
proliferation of VICs.  Moreover the sub-maximum effect by VEC-CM at the dilution 
of 1:5 would allow the increasing or decreasing effects on VIC response possible to 
be observed.  Thus the VEC-CM was prepared at after 48 hours in contact with side-
specific VECs at a 1:5 dilution to use in further investigations relating to the 
modulation of ECM proteins in VICs.   
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Figure 3.3 The effect of VEC conditioned media on VIC proliferation.  VICs were cultured with aVEC-
CM and vVEC-CM, n=2-3, generated at 6, 12, 24 and 48 hours and diluted with fresh 0.4% FBS 
DMEM at various concentration, 1:50, 1:20, 1:10, 1:5 and 1:2.  All proliferation was examinated by 
MTS and compared to the effect of 0.4% serum DMEM. Graps were plotted by mean ± SEM using 
Excel and analysed the concentration-dependent effect by Spearman test.  Whereas the VEC-CM at 
12 and 48 hours showed the decreasing and increasing correlation, respectively, the VEC-CM at 6 
and 24 hours had no concentration-depedent effect to the proliferation of VICs. 
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3.3.3 The effect of VEC-CM on the content of collagen 
The production of collagen by VICs cultured with 0.4% FBS DMEM and VEC-CM, 
obtained at 48 hours, at a 1:5 dilution, were quantified after 2 days incubation with 
the CM (n=6).  As demonstrated in the Figure 3.4, vVEC-CM significantly increased 
the production of collagen by VICs (median = 137.1%) as compared to the effect of 
VICs in 0.4% FBS DMEM, p=0.0240.  Although media collected from the aVECs also 
increased the production of collagen by VICs (116.5%), this effect was not 
statistically significant.  
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Figure 3.4 Collagen production by VICs incubated with conditioned from aVECs and vVECs.  VICs 
were cultured with 0.4% FBS DMEM (the control) or conditioned media collected from aVECs and 
vVECs (n=6).  Percentage of the amount of collagen produced by VICs cultured with VEC-CM was 
calculated relative to the 100% production by the control, obtaining from the same valve.  vVEC-CM 
significantly increased the amount of collagen as compared to the control.   
 
3.3.4 The effect of VEC-CM on the content of GAGs 
The effect of VEC-CM on the production of secreted GAGs by VICs was investigated 
by comparing to the effect to low serum DMEM.  The median values of GAGs 
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production by VICs in aVEC-CM and vVEC-CM culture were 114.5% and 121.3%, 
respectively, as shown in the Figure 3.5. The effect of the conditioned media 
collected from aVECs was not statistically different from those collected from vVECs.  
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Figure 3.5 GAG production by VICs incubated with conditioned from aVECs and vVECs.  VICs were 
cultured with 0.4% FBS DMEM (the control) or conditioned media collected from aVECs and vVECs 
(n=6).  Percentage of the amount of GAGs produced by VICs cultured with VEC-CM was calculated 
relative to the 100% production by the control, obtaining from the same valve.  There was no 
significant difference among VEC-CM treatments and control.  
 
3.3.5 The effect of VEC-CM on the content of elastin 
VICs were cultured with DMEM with 0.4% FBS, aVEC-CM and vVEC-CM for 48 hours 
and the production of elastin bound on the outer side of cell membrane was 
investigated.  The percentage of elastin production by the CM was compared to the 
effect of low serum DMEM.  Median values of the elastin for aVEC-CM and vVEC-CM 
were 148.6% and 152.1%, respectively.  Although aVEC-CM and vVEC-CM showed 
an increase in elastin production compared to the control, there was no statistically 
significant difference observed between them (Figure 3.6). 
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Figure 3.6 Elastin content of VICs incubated with conditioned from aVECs and vVECs.  VICs were 
cultured with 0.4% FBS DMEM (the control) or conditioned media collected from aVECs and vVECs 
(n=6).  Percentage of the amount of elastin produced by VICs cultured with VEC-CM was calculated 
relative to the 100% production by the control, obtaining from the same valve.  There was no 
significant difference among VEC-CM treatments and control.  
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3.4 Discussion 
The durability and function of valve tissue mainly depends on the ability of VICs to 
maintain the integrity of the ECM.  Using porcine VICs and VECs, communication 
between these two cell types has been previously investigated (Butcher and Nerem, 
2006).  It was found that VECs decrease the proliferation of VICs and the expression 
of SMαA by VICs as well as the reduction of GAGs.  Although it is well known that 
VECs on the aortic and ventricular side of the aortic valve are exposed to different 
patterns of blood flow, the differential ability of aVECs and vVECs to communicate 
with VICs has not yet been studied.  In this study, accumulation of molecules 
released into the culture media by VECs at different time points were investigated to 
establish they have an effect on the proliferation of VICs.  In addition, the effect of 
vVECs on the modulation of collagen content produced by VICs was studied.  
During the generation of the CM, side-specific VECs were cultured with DMEM 
containing 0.4% FBS, in order to exclude the effect of factors within serum which 
may directly affect the response of VICs.  Incubation in this low serum media had no 
appreciable effect of the phenotypic markers associated with ECs.  After 72 hours 
incubation in the media, aVECs and vVECs, were seen to preserve the expression of 
the endothelial markers VE-Cadherin and vWF.   
VEC-CM had some effect on the proliferation of VICs, but the pattern of this 
stimulation was inconsistent with different effects at different time points and 
dilutions of the CM.  However, the  concentration-dependent effect on the increasing 
proliferation of VICs was observed in the VEC-CM collected over 48 hours.  In 
addition, 48-hour incubation was sufficient to investigate the modulation of ECM in 
the valves (Balachandran et al., 2006).  The maximum proliferation of 48-hour VEC-
CM was seen with a 1:2 dilution of the VEC-CM.  In order to be able to observe any 
increasing and decreasing effect by CM, it is better to use a sub-maximum level 
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stimulation.  Thus, a 1:5 dilution of VEC-CM was selected to be used in further 
experiments.  It is noted that when the proliferation of VICs by the aVEC-CM and 
vVEC-CM at 1:5 dilution are compared to the negative control (VICs at growth 
arrested state), there is no statistical difference among this group (data not shown).  
This highlights the fact that the effect of VEC-CM on the modulation the ECM 
proteins will not be affected by changed number of VIC in these experiments.  
In contrast to the effect seen at 48 hours of VEC-CM, the effects mediated by CM 
generated at earlier time point was inconsistent.  The contradicting effect of the 
VEC-CM collected at 6 and 12 hours may be a result of the different rates of release 
by individual cultures of VECs.  Similarly, vascular EC-CM collected from sparse EC 
culture stimulated the SMC growth, while dense ECs from the same culture inhibited 
the proliferation of SMCs (Dodge et al., 1993).  Moreover, the concentration 
“independent” effect of any VEC-CM accumulated for 24 hours was also observed in 
vascular EC-CM (Dodge et al., 1993). 
These data could also be explained by the fact that VECs may produce the 
combination of mitogenic and inhibitory factors at certain time points.  The net 
combination among those counter-acting factors, at various dilutions may give rise 
to the variable results.  It may take the longer time period in order to accumulate 
enough growth factors in the media to produce consistent effect. 
 In addition to the proliferation, the modulation of VEC-derived factors on the 
amount of collagen was also investigated by using VEC-CM that had been in contact 
with VECs for 48 hours and prepared at 1:5 dilution. vVEC-CM significantly 
increases the amount of secreted collagen by VIC culture.   However, the amount of 
collagen remains the same as VIC control when VICs were cultured with aVEC-CM.  
The differing response of collagen production by VICs to the aVEC-CM and vVEC-CM 
suggests the distinct regulation by aVEC and vVEC derived factors in the CM.   
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While there is an observable effect of vVEC-CM on collagen content in the media 
additional experiments are needed to clarify what steps in the collagen synthesis 
process or the inhibition of collagen degradation that are modulated by vVEC-
derived factors that ultimately result in this increase.     
The transcription of collagen genes by vVEC-CM could be investigated by measuring 
mRNA of collagen type I and III genes.  Additionally, the regulation at either 
transcriptional or translational levels could be further investigated by applying 
inhibitors of those processes i.e. Actinomycin D and cycloheximide, respectively.   An 
alternative method would be to look only at newly synthesised collagens by using 
radiolabeled proline, which is incorporated preferentially into newly synthesised 
collagen in the form of hydroxyproline.  However while the use of radiolabel 3H-
proline is a more sensitive assay for collagen synthesis, it is expensive, has a number 
of safety issues and not all the facilities were available at our laboratory at the time 
these experiments were performed. Moreover, the regulation of collagen 
degradation should be further studied to understand whether vVEC-CM inhibits the 
degradation of collagen and, in turn, increases the amount of collagen as compared 
to the VICs alone.  Thus the production of MMPs e.g. MMP-1, 2 and 13 and their 
inhibitors, TIMPs, should be investigated using zymography to compare the 
activities of MMPs in to aVEC-CM and control media.  
 In this study, the effect of VEC-CM on the production of secreted collagen was 
quantified using a dye-binding assay which binds to all the collagen isoforms found 
in the valves i.e. collagen type I and III.  Although the dye is claimed to bind 
specifically to [Gly-X-Y]n, the helical structure of the collagens, preliminary data 
demonstrated that 10% FBS in fresh DMEM can non-specifically precipitate the dye.  
Thus all the ECM quantification was carried on by VICs cultured either with 0.4% 
FBS DMEM or by VEC-CM made from the low serum media.  
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Additionally, this study only measured the collagen released into the media which 
had previously been suggested to represent the majority of collagens released in 
these types of in vitro experiments (Myllyharju and Kivirikko, 2004; Villanueva et 
al., 1991).  However, valve cells have been shown to be as efficient at incorporating 
the soluble collagen into the cells layer as releasing them into the media over 2 day 
period (Ku et al., 2006).  
It is recommended to measure surface attached collagen by using acid-pepsin to 
release collagen into soluble form.  An alternative method would be to analyse aged 
covalent crossed-link collagen using an acid hydrolysis method (6 N HCl, 110° C, 18 
Hours).  Under this harsh condition, protein would be broken down into amino acid 
and passed through ion-exchange chromatography to quantify the amount of 
hydroxyproline, a collagen marker, and then referred to the amount in the 
standards.  However, there is likely to have some degree in inefficiency in this 
extraction process and the low levels measured in the current experiments may not 
have been suitable for this technique.  Although the current experiments may not 
give an accurate measure of all the collagen produced by the cells, the methodology 
used does provide an index of collagen production and shows a clear relative 
difference in the collagen production secreted by VICs in response to aVEC-CM and 
vVEC-CM.   
The regulation of collagen production by EC in vascular system has been well 
established.  The effect of aorta and endocardial EC-CM on increasing the production 
of collagen by SMCs and cardiac fibroblast has been investigated (Villanueva et al., 
1991; Kuruvilla et al., 2007).  Villanueva et al. demonstrated that the amount of 
secreted collagen was significantly increased when the fibroblast were cultured 
with EC-CM for 24 hours, whereas the amount of membrane-bound collagen was 
minuscule and slightly higher than those of the fibroblast control.  The authors also 
predicted the responsible molecule for the induction of collagen production would 
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be heat-stable molecule and have molecular weight of 8 -10 kDa.  Such a molecule 
could be TGF-β, which has been shown to be present in EC-CM by Kuruvilla and 
colleagues (Kuruvilla et al., 2007).  Moreover TGF-β in the CM was also 
demonstrated to reduce the proliferation of cardiac fibroblasts.  Correspondingly in 
the previous chapter, TGF-β was detected in the media collected from the incubation 
with both aVECs and vVECs for 48 hours.  However the question of whether TGF-β 
contributes to the increasing collagen production by vVEC-CM warrants further 
investigation by using neutralising antibodies against TBF-β. 
GAGs are one of the ECM components important to the heart valve and vessel 
structure.  The investigations of EC-derived factors revealed that EC-CM increased 
the production of GAGs by vascular SMCs (Ciolino et al., 1992; Merrilees and Scott, 
1990).  TGF-β was also identified as the inducer in EC-CM that activates the de novo 
synthesis of GAGs by SMCs (Ciolino et al., 1992; Merrilees and Scott, 1990).  
Moreover, the pulse-chase analysis of the secretion and degradation of radiolabeled 
35[S]-labeled GAGs confirmed that the increasing amounts of GAGs seen were not 
due to an effect of EC-CM on the secretion and degradation of existing GAGs but a 
synthesis of new proteins present in the media (Ciolino et al., 1992).  In addition, 
80% of the incorporated radioactivity was associated with the medium fraction, 
after 24 hours incubation.  
As established in studies with valve cells, VECs have been shown to reduce the loss 
of GAGs by VICs, which were encapsulated in a collagen gel and exposed to laminar 
flow (Butcher and Nerem, 2006; Ciolino et al., 1992).  In the investigation of the 
effect of VEC-CM, all sulfated GAGs in the media were collected and quantified using 
the dye binding method.  The dye binds to sulphated polysaccharide component of 
proteoglycans and glycosaminoglycans e.g. chondroitin (4-, 6-), keratin, dermatan 
and heparin sulfates, which are the main GAGs component in the aortic valve 
(Rothenburger et al., 2002).  The results reveal that VEC-CM collected after 48 hours 
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in contact with aVECs and vVECs, maintains the amount of secreted GAGs equal to 
the amount found in growth-arrested VICs.  Even so, it is unclear, in this experiment, 
whether both VEC-CMs are unable to stimulate the synthesis of GAGs by VICs or 
they have an effect to protection against the degradation of GAGs that are produced 
by VICs under resting conditions.  This effect may be influenced by the fact that in 
these experiments the VICs are maintained in a quiescent, growth arrested state.   
Similar to the effect of VEC-CM on GAG production, VEC-CM does not change the 
amount of tropoelastin produced by VICs when compared to the VICs cultured with 
low serum media, without VECs contact.  The tropoelastin, in this study, was 
extracted from α-elastin bound on the VIC membranes and quantified by the dye 
binding method.  The amount of elastin secreted in the media was also investigated 
by using an ELISA technique, which has higher sensitivity (able to detect the 
minimum amount of elastin at 0.62 µg/ml) than the Fastin kit (able to detect a 
minimum amount of 2.5 µg/ml).  However, elastin could not be detected in the 
media of any experimental samples using ELISA (data not shown).  It has been well 
established that the entire intracellular synthesis of elastin is completed within 20 
minutes; however, once the fibre of elastin is formed, the remodeling process is 
much slower and can take time up to a year (Starcher, 1986).  Thus the conclusion 
from this study is any elastin which is produced by VICs in a growth-arrested state, 
is in the membrane bound form and its content is not modified by the effect of VEC-
CM.  
These results show an interaction between VECs and the VICs that reside within the 
valve.  In addition, the results suggest the differing capability between aVEC-CM and 
vVEC-CM in regulating collagen content.  Further experiments to characterise 
molecules in the CM, which are responsible for such function are required.  For 
example, the VEC-CM can be treated with trypsin, proteinase K, heated up or 
blocked using antibody against potential mediators such as TGF-β and ET-1 
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(Kuruvilla et al., 2007; Dodge et al., 1993).  The treated VEC-CM will then be used to 
culture VICs and any changes in the modulation of ECM by VICs will be determined.  
Although this experiment reveals the effect of VEC-derived factors on the regulation 
of VIC proliferation and collagen content, it is not suitable to allow short-lived 
molecules, which are degraded over the 48 hours collection period to have an effect 
on VIC response.  Therefore, further experiments to culture VICs in the vicinity of 
VECs are required to include the additional potential effects of labile mediator 
released by VECs.  
 
3.4.1 Limitations of the study 
There are few limitations in these experiments.  The CM is usually limited by certain 
time points of the collection.  This then means the method cannot include the 
extensive production of cytokines, which may be unstable at such collecting time or 
may require a longer period of the production time than the time of maintaining 
cells on low serum media may allow.  Moreover the effect of low serum in the media 
might alter cellular activity and influence the responsiveness of both VEC and VIC.   
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3.5  Conclusions and Future Directions 
The mitogenic effect of VEC-derived factors on the proliferation of VICs is 
demonstrated in these experiments.  The increasing of cell numbers in VICs cultured 
with either aVEC-CM or vVEC-CM is established in the CM collected at different time 
points i.e. at 6, 12, 24 and 48 hours.  Both aVEC-CM and vVEC-CM share a similar 
effect on the regulation of VIC proliferation without statistical differences between 
the different dilutions or time points at which the CM was obtained.   
Whether side-specific VECs differentially regulate the production of ECM by VICs is 
also elucidated.  The vVEC-derived factors significantly increases the amount of 
collagen secreted into the media by VICs when compared to VICs cultured with low 
serum media.  Both aVEC-CM and vVEC-CM maintain the production of GAGs and 
elastin by VICs to the same extent as control.   
In these experiments, the side-specific VECs reveal the function to regulate the 
proliferation and ECM production of VICs by the molecules that are stable for 48 
hours.  However the role of short-life molecules, which may affect the response of 
VICs, is neglected by this experimental setting.   Thus VECs will be co-cultured with 
VICs in order to allow the continuous communication between VECs and VICs and 
thereby be able to assess any functional changes of VICs induced by VEC.                                                                                                                                                                                                                                             
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4 CHAPTER 4 Paracrine Effect of VECs on VIC 
Function by Co-Culture 
4.1  Introduction 
Previously in Chapter 3, soluble mediators secreted by VECs and accumulated in the 
media over 48 hours were seen to regulate the proliferation and production of ECM 
proteins by VICs.  However the investigation of the effects mediated by VEC-CM may 
exclude some VEC-derived factors that are degraded in the media during the 
collection period or during storage prior to use.  There are numerous methods for 
culturing ECs adjacent to other cells such as fibroblasts, SMCs or VICs.  These 
methods have the advantage over CM in that the communication between the cells 
occurs in real time.   
Direct contact between ECs, from the aorta, and SMCs revealed an increasing 
synthesis of sulfate-GAGs, when compared to the ECs and SMCs alone (Merrilees and 
Scott, 1981).  Although the cells responsible for the greater production could not be 
identified due to mixing of the cells together, the direct contact of this 2-D co-culture 
had the benefit of direct cell-cell communication through membrane junction 
proteins (Merrilees and Scott, 1981).   
The paracrine effect of ET-1, NO and TGF-β which were produced by ECs on co-
cultured adjacent cells can also be investigated by growing ECs on a permeable 
membrane inserted into a culture well and culturing other cells underneath the 
membrane (Powell et al., 1997; Rizvi et al., 1996; Merrilees and Scott, 1990; Ciolino 
et al., 1992; Kolpakov et al., 1995).  Aortic ECs have different effects on the 
regulation of collagen production by different types of cells such as SMCs and 
fibroblasts.  While the ECs increase the production of collagen when co-cultured 
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with fibroblasts (Guarda et al., 1993), they have also been reported to reduced the 
production of collagen by adjacent SMCs (Powell et al., 1997). 
Venous ECs were examined for their effect on the regulation of ECM production by 
myofibroblasts, which were encapsulated in the 3-D scaffold.  The scaffold that was 
seeded with the ECs on the surface had a reduced amount of collagen but 
maintained the amount of GAGs when compared only to the scaffold containing 
myofibroblasts (Pullens et al., 2009).  Recently, when the effect of laminar shear 
stress was studied in heart valve cells, mixed VECs from both sides of the valve 
protected the lost of GAGs in the scaffold containing VICs under both static and flow 
conditions (Butcher and Nerem, 2006).  However, the regulation of side-specific 
VECs on the VIC function has not been examined.  
Thus, in the present study, VICs will be co-cultured either with aVECs or vVECs 
grown on a permeable membrane, above a population of VICs.  The effect of VECs on 
the proliferation and production of ECM components by VICs will be investigated 
and compared to the VIC cultures without VECs on the insert.    
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4.2  Materials and Methods 
4.2.1 Co-culture of VICs and VECs by Transwell® 
The effect of aVECs and vVECs on the VICs’ functions was further observed by using 
Transwell® Permeable Supports (Corning, UK).  VECs were grown on the 
Transwell® insert made from polyester microporous membrane (0.4 µm pore size 
at 1x108pores/cm2).  
The insert was later hung over a culture plate containing VICs grown onto the base 
of the well.  By using these supports it is practical to have a co-culture of VICs and 
VECs without direct cell contact.  Thus the continuous effect of released factors by 
VECs on VIC function e.g. proliferation, ECM gene expression and ECM production 
can be examined.  
 
4.2.2 Cell phenotyping of VECs on the insert membrane  
VECs on the insert both with and without VICs (at the bottom wells) were 
characterised EC phenotypes after 48 hours of incubation.  The polyester membrane 
was cut out off the insert of the co-culture system and held with a forceps to avoid 
the damage of VECs.  The immunostaining against vWF, CD31, VE-Cadherin and 
SMαA were conducted in the similar way as section 2.2.4. 
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4.2.3 VIC proliferation under the effect of co-culture condition 
by MTS assay  
The VICs were seeded at 3.0 x 103 cells per well of a 96-well plate, while 8.5 x 103 
cells of aVECs and vVECs were separately seeded on the insert of Transwell® with a 
surface area of 0.143 cm2.  After the cells had become confluent, the insert 
containing VECs was placed into the culture plates over VIC culture.  DMEM with 
0.4% FBS was used to culture both VECs on the insert and VICs on the plates.  At the 
same time, VICs were cultured at the identical condition without VECs being present 
on the insert and served as the control, as depicted in the Figure 4.1.   
  
Figure 4.1 Co-culture model.  aVECs (middle) and vVECs (right) are cultured on the permeable 
membrane insert without the direct contact with VICs.  VIC culture which have not  VECs on the 
inserts serves as the control.  All cells on the inserts and the bottom wells are maintained with 0.4% 
FBS in DMEM and co-cultured for 48 hours before the amount of ECM compernents will be 
quantified. 
 
Complete DMEM was used to culture VICs (without VECs on the insert) to ensure 
that they could proliferate under the experimental conditions, these cells served as a 
positive control.  VICs and VECs were co-cultured for 48 hours in a 95% air/5% CO2 
incubator.  At the end of the incubation period, both inserts containing VECs and 
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those with no-cells were removed from the culture plates.  The proliferation of VICs 
was consequently measured by using MTS assay as already described in the section 
2.2.6. 
 
4.2.4 The effect of VEC co-culture on the production of ECM by 
VICs 
aVECs and vVECs were co-cultured with VICs that were isolated from the same 
animal/aortic valve.  aVECs and vVECs were cultured separately on larger 
permeable membrane with a surface area of 4.67 cm2 in area at a density of 2.8 x 105 
cells per insert.  
VICs were seeded at a density of 5.2 x 105 cells per well of a 6-well plate.  3 ml of 
DMEM with 0.4% FBS was added to VIC culture and while 1.5 ml of the media was 
added on the insert containing VECs.  The cells were maintained in co-culture for 48 
hours.  Upon completion, the media over VIC culture was collected to be analysed 
for the amount of collagen and GAGs while VICs were collected for the investigation 
of elastin production and ECM gene expression.  Moreover, the wells that had only 
VECs on the insert, with no VIC on the base of the well, were also used so an 
assessment of ECM proteins release directly from VEC could be made.  
Due to the possibility of media evaporation and changing the concentration of ECM 
in the media, media over VIC culture (including the media in 6-well plate of negative 
control) was topped-up with distilled water to 3 ml (equal to the starting volume). 
Subsequently, a volume of media was taken for collagen and GAG assay and 
calculated back for the total ECM production in 3 ml of media.  From the same co-
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culture settings, VICs were washed with PBS twice before the extraction of mRNA 
and elastin were begun.   
 
4.2.4.1 Collagen production by VICs in co-culture model 
The quantity of collagen was examined using a Sircol kit after 48 hours of the 
incubation as described in section 3.2.4. 1 ml of each sample was taken to perform 
the assay.  The amount of collagen in samples was calculated relative to the amount 
of absorption of standard curve.  The total production from 5.2 x 105 VIC cells was 
then calculated by allowing for the dilution factor.    
 
4.2.4.2 GAGs production by VICs in co-culture model 
1 ml from a total of 3 ml of media collected from the different cultures was 
concentrated by being freeze dried overnight.  It was then resuspended in a volume 
of 500 µl of distilled water to quantify the amount of secreted GAGs by Blyscan kits 
as described in section 3.2.5.  
Triplicates of 75 µl of every sample were made up to a volume of 100 µl with 
distilled water before starting the assay and then compared to the amount of GAGs 
relative to the standard curve.  The total amount of GAGs produced by VICs or VECs 
on the insert was eventually calculated back by allowing for the dilution factor used 
to dilute sample media.    
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4.2.4.3 Elastin production by VICs in co-culture model 
Membrane bound tropoelastin was extracted from the VICs’ membrane by using hot 
oxalic acid, quantified by the Fastin kit as described in section 3.2.6.  The total 
production of elastin from 5.2 x 105 VICs at different co-culture conditions was 
quantified by comparing the absorption of the dye to the standard curve and then 
multiplying the value to allow for the dilution factor. 
 
4.2.5 Reverse Transcription and Real Time - Polymerase Chain 
Reaction (RT-PCR) of ECM genes 
The ability of VIC to produce ECM proteins in response of co-culturing with VECs 
was also investigated at a transcriptional level.  Gene expression of selected ECM 
components was observed after 48 hours of co-culturing with either aVECs or vVECs 
and then compared to VICs culturing in the absence of VECs.  
  
4.2.5.1 RNA isolation 
The co-culture system was stopped after a period of 48 hours by separating the 
inserts and the 6-well plates which contained VICs from each other.  The VICs were 
washed twice with PBS and removed from the plates with Trypsin.   After 5 minutes 
of incubation with Trypsin at 37°C, DMEM media with 10% FBS was added to stop 
the reaction.  VICs were collected by centrifugation at 700 g for 5 minutes and the 
supernatant was removed carefully by aspiration. The RNA of VICs was 
subsequently obtained by using RNeasy Mini Kit (Quigen, Uk), otherwise cell pellets 
were kept at -80°C and the extraction performed at a later date. .  
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To break cells and nuclear membrane, 350µl of fresh RLT buffer containing 
Guanidine Thiocyanate and β-mercaptoethanol was added and mixed by pipetting 
up and down.  350 µl of 70% ethanol, which was prepared by mixing molecular 
grade ethanol with DEPC treated water (Sigma-Aldrich, UK), was then added to the 
lysate.  This 700 µl solution was then transferred to an RNeasy spin column placed 
in a 2 ml collection tube.  Released RNA was selectively promoted to bind to the 
RNeasy column’s membrane in the presence of ethanol.  The contaminants were 
flushed through the membrane by centrifugation at 8000 g for 15 seconds and the 
flow-through in the collection tube was then discarded.  
The column membrane was then washed with 350 µl of RW1, centrifuged at 8000 g 
for 15 seconds and the flow-though was discarded.  DNA bound on the membrane 
was specifically digested by DNaseI (Qiagen, UK) to ensure that the DNA did not 
interfere with absorbance at 260 nm during the RNA quantification step.  As 
recommended by the manufacturer, 10 µl DNaseI stock solution was mixed with 70 
µl Buffer RDD by pipetting.  
The prepared enzyme was then added to the column and incubated at room 
temperature for 15 minutes for the DNA digestion reaction to take place.  DNaseI 
was then washed from the membrane with 350 µl of RW1 buffer.  Centrifugation at 
8000 g for 15 seconds was performed again to remove unbound remnants and the 
flow-through was discarded.  The column was subsequently was washed twice with 
RPE containing ethanol.  
The second washing was extended, the spinning time being increased to 2 minutes 
to ensure that the ethanol was removed completely and did not interfere 
subsequent steps.   The flow-through was discarded with the collection tube and the 
membrane column was transferred to a new collection tube. To eliminate all 
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remnants of RPE, the column was then spun at full speed for 1 minute, after which 
the membrane column was removed to a clean and labeled 1.5 ml microtube.  
Finally RNA was eluted from the membrane by adding 30 µl of RNase free water 
directly to the membrane and centrifuged at 8000 g for 1 minute.  The eluted RNA 
was handled on ice during quantification and cDNA synthesis or stored at - 80°C to 
be used later.  
 
4.2.5.2 cDNA synthesis 
RNA was quantified and the purity was assessed by its absorbance at 260/280 nm, 
before complimentary DNA (cDNA) was synthesised.  A 2 µl sample of RNA was 
diluted with 58 µl of TE buffer (10 mM Tris, 1 mM EDTA; pH 8.0) and its absorbance 
at 260 and 280 nm was measured by a double beam spectrophotometer, GeneQuant 
II (Pharmacia Biotech, UK).  
The RNA concentration was calculated from the rule that 1 unit of absorbance at 
260 corresponds to 44 µg of RNA per ml.  It is important to note that this equation 
(1 unit of A260 = 44 µg/ml RNA) is based on an extinction coefficient calculated for 
RNA at neutral pH.  In addition, the ratio of A260/A280 used to assess the purity of 
RNA is influenced significantly by pH; A260/A280 is higher when pH increases from 
5.4 to 7.5 as A280 decreases when A260 is unchanged.  Thus TE buffer at pH 8.0 was 
used as a diluent when measuring its absorbance to ensure an accurate reading. 
Pure RNA should have a ratio of A260/A280 in the range of 1.9-2.1.  Since protein 
absorbs at 280 nm, a value lower than 1.9 indicates there is protein contamination.  
It is recommended that soon after quantification, RNA is used for making cDNA; 
when this was not possible RNA was kept at -80°C.  
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100 ng of total RNA was used as the templates to make cDNA by MultiScribe™ 
Reverse Transcriptase (Applied Biosystems, UK) composing of 1x RT buffer, 5.5 mM 
MgCl2, 500 μM each dNTP, 2.5 μM Random hexamers, 0.4 U/μl RNase inhibitor and 
1.25 U/μl MultiScribe reverse transcriptase.  The reaction was prepared at a total 10 
μl and cDNA synthesis was performed by the Techne PHC-3 PCR machine (Techne, 
UK).  The reaction was started with primer binding at 25°C for 10 minutes, and then 
the cDNA was extended at 48°C for 30 minutes.  
The last step was denaturing reverse transcriptase at 95°C for 5 minutes. After 3 
steps of synthesis were completed, cDNA was diluted with RNA graded water to 2 
ng/μl and kept at -20°C.  
 
4.2.5.3 Amplification efficiency and RT-PCR of 6 ECM genes 
6 genes involving ECM production were selected to examine the VICs functions.  
Primers were used that were tagged with reporter and quencher from TaqMan® 
Gene Expression Assays (Applied Biosystems) for Collagen1α1 (COL1A1), 
collagen3α1 (COL3A1), Chondroitin sulfate proteoglycan 4 (CSP4), Hyaluronan 
synthase 2 (HAS2), Fribillin 1 (FBN1) and Fribillin 2(FBN2) genes. The 
manufacturer would not disclose the sequences of these primers.  
Various amounts of cDNA (4, 6, 8 and 10 ng) were prepared for the RT-PCR reaction 
to evaluate the amplification efficiency of target genes compared to that of 
endogenous gene, 18s RNA.  All samples for RT-PCR were set up in a total volume of 
20 μl composing of 1x Taqman® Fast Universal PCR Master Mix (Applied 
Biosystems, UK), 1x of 18s primers, 1x of target gene’s primers and cDNA.  The 
amount of cDNA was prepared at various amounts for the amplification efficiency 
investigation or at 6 ng for co-culture samples.  The reaction was performed by 
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Applied Biosystems 7500 Fast Real-Time PCR System for 40 cycles.  Each cycle, 
cDNA was denatured at 95°C for 15 seconds then primer binding and cDNA 
extension were achieved at 60°C for 60 seconds.    
 
4.2.6 Data and statistic analysis 
The results of the proliferation and the production of ECM by VICs were represented 
as a percentage change from the control values.  The data was represented by Box 
and Whiskers plot using GraphPad Prism 5.  Median value from each condition was 
expressed by a bar in the middle of the box and statistically compared using 
Kruskal-Wallis and Dunn’s test. 
The amplification efficiency of the RT-PCR was analysed by plotting the ∆CT value 
against increasing amounts of cDNA.  The slope of validated genes should be lower 
than 0.1. The expression of ECM genes was analysed by ∆∆CT using a control from 
each animal as a reference at 1 fold expression.  The data was scatter-dot plotted by 
GraphPad Prism 5when.  The level of expression was statistically compared by 
Kruskal-Wallis and Dunn’s test.  P value less than 0.05, 0.01 and 0.001 are 
represented by *, ** and ***.    
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4.3  Results  
4.3.1 Phenotypic characterisation of VECs in co-culture with 
VICs 
Phenotypes of VECs were characterised after co-cultured with VICs, with low serum 
DMEM for 48 hours, in comparison to the phenotype of VECs in the culture without 
VICs.  aVECs and vVECs were stained with antibodies against EC proteins such as 
CD31 (represented in green colour) and vWF (in red colour), as shown in Figure 4.2.  
Both aVECs and vVECs maintained EC phenotypes by expressing both CD31 and 
vWF, regardless of the presence of adjacent VICs and the absence of EC growth 
factors. 
 
Figure 4.2 Expression of endothelial markers by VECs co-cultured with and without VICs.  After 48 
hours  of incubation, both aVECs  and vVECs were positvely stained against the antibodies of CD31 
(represented in green staining) and vWF (in red staining), n=5.  The left row displayed VECs 
cultured on the permeable membrane without VICs whereas VECs on the right row demonstrated 
the cultures which had adjacent VICs grown underneath, for 48 hours.  
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Moreover, the co-expression of VE-Cadherin and SMαA were also observed (Figure 
4.3).  Both aVECs and vVECs were negatively stained with the antibody against 
SMαA (green colour), despite of the presence of VICs in the co-culture.  However VE-
Cadherin staining (red colour) was faint but not relative to nuclei (in blue); 
suggesting non-specific staining and not related to the effect of co-culture with VICs. 
 
Figure 4.3 Expression of endothalial and interstitial marker by VECs co-cultured with and without 
VICs.  VECs were weakly stained for VE-Cadherin (in red) and negative for SMαA (in green) after 48 
hours of the incubation either with (the right panel) and without VICs (the left panel), n=5.  All 
nuclei was stained in blue, 
 
4.3.2 The effect of VEC co-culture on the proliferation of VICs  
The regulation of VECs on the proliferation rate of VICs was investigated and 
compared to the growth rate of VICs cultured without VECs.  All cells were 
maintained with low-serum DMEM and their proliferation was measured at 48 
hours after the co-culturing or incubation.  The results showed that both aVECs and 
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vVECs did not change the proliferation rate of VICs, at 48 hours of co-culturing 
(Figure 4.4). 
Control aVEC vVEC
0
50
100
150
200
%
 o
f 
V
IC
 g
ro
w
th
 o
v
e
r 
C
o
n
tr
o
l
 
Figure 4.4  VIC proliferation in the presence of side-specific VEC co-culturing.  VICs were co-
cultured with either aVECs or vVECs (represented as aVEC  and vVEC, respectively) for 48 hours.  
Their proliferations were normalised to the control (VICs alone) at 100% proliferation.  The median 
values were presented by bars and the statistic comparison was conducted by Kruskal-Wallis and 
Dunn’s Test, n=8. 
 
4.3.3 The effect of VEC co-culture on the production of collagen 
by VICs 
The amount of collagen produced by 5.2 x 105 VICs under different conditions was 
investigated.  The collagen content of the control (VICs cultured with low-serum 
DMEM and in the absence of VECs), was normalised to 100%. The effect of VEC co-
culturing for 48 hours was expressed as a percentage of the control (Figure 4.5).  
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Figure 4.5 The effect of VEC co-culturing on the content of collagen by VICs.  The amount of collagen 
in the media over VIC cultures was quantified at 48 hours of co-culturing.  aVEC and vVEC  
represent the VIC cultures in the presence of aVECs and vVECs, respectively, on the permeable 
membrane.  The control is VICs cultured with low serum DMEM alone.  Data is represented in the 
percentage of collagen production over 100% production by individual controls.  Median value 
among each group is represented by the bars and statistically compared by Kruskal-Wallis and 
Dunn’s test (n=6). 
 
VICs significantly increased the amount of secreted collagen when they were co-
cultured with vVECs for 48 hours (p=0.0268), as compared to the VICs alone.  The 
median value of percentage of collagen produced was increased to 149.7% and 
208.5% by aVECs and vVECs co-culturing, respectively.  However there was no 
significant difference between the effect of aVECs and vVECs.  
 
4.3.4  The effect of VEC co-culture on the production of GAGs by 
VICs 
Similarly, the amount of GAGs was quantified among VIC cultures which were either 
VICs cultured alone, that served as the control or in co-culture with either aVECs or 
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vVECs.  The amount of GAGs secreted by 5.2 x 105 VICs in the co-cultures was 
normalised to the control from the same animal.   
vVECs increased the amount of secreted GAGs (Figure 4.6) produced by VICs.  The 
median value of the percentage of GAG production was significantly increased to 
197.6% by the vVEC co-culture (p=0.0222).  Although there was an increasing trend 
seen up to 150.8% by the aVEC co-culture, this was not a statistically significantly 
different from the control and the vVEC co-culture group.  
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Figure 4.6 The effect of VEC co-culturing on the content of GAGs by VICs.  The amount of GAGs in the 
media over VIC cultures was quantified at 48 hours of co-culturing.  aVEC and vVEC  represent the 
VIC cultures in the presence of aVECs and vVECs, respectively, on the permeable membrane.  The 
control is VICs cultured with low serum DMEM alone.  Data is represented in the percentage of GAG 
production over 100% production by individual controls.  Median value among each group is 
represented by the bars and statistically compared by Kruskal-Wallis and Dunn’s test (n=6). 
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4.3.5 The effect of VEC co-culture on the production of elastin 
by VICs 
The tropoelastin that bound on to the VIC membrane was investigated.  The amount 
of elastin produced by VICs under the VEC co-culture effect is depicted in the Figure 
4.7.   
Side-specific VECs had no effect on the amount of elastin which was produced by 
VICs over 48 hours of co-culturing.  Neither were there any differences in the elastin 
content of aVEC (104.2%) or vVECs (110.1%) co-cultures.  
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Figure 4.7 The effect of VEC co-culturing on the content of elastin by VICs.  The amount of elastin in 
the media over VIC cultures was quantified at 48 hours of co-culturing.  aVEC and vVEC  represent 
the VIC cultures in the presence of aVECs and vVECs, respectively, on the permeable membrane.  
The control is VICs cultured with low serum DMEM alone.  Data is represented in the percentage of 
elastin production over 100% production by individual controls.  Median value among each group 
is represented by the bars and statistically compared by Kruskal-Wallis and Dunn’s test (n=6).  
 
The possibility that ECM components, produced by VECs, could “cross-contaminate” 
with the production by VICs was also examined.  aVECs and vVECs were seeded on 
the permeable membrane inserts without the VIC culture.  The media underneath 
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the inserts was collected at 48 hours so that the amount of ECM proteins could be 
measured. The quantification of collagen, GAGs and elastin was conducted in a 
similar way as the co-culture experiments.  However, there were no detectable 
levels of the ECM components produced by VECs. The detection limit of collagen, 
GAGs and elastin assays were at 2.5, 1 and 0.625 µg/ml, respectively.  
 
4.3.6 The effect of VEC co-culture on the expression of ECM 
components’ genes by VICs 
In order to complement the studies on ECM proteins release by VIC, expression of 
mRNA for each gene was also assessed.  The expression of mRNA for ECM proteins 
by VICs was investigated after 48 hours of incubation (control) and co-culturing 
with either aVECs or vVECs.   
Before the gene expression was investigated by comparative ∆CT (∆∆CT) method, the 
amplification efficiency of target genes was validated.  The ∆CT value between each 
target gene and 18sRNA were plotted on a graph against varied dilutions of the 
template.  The slopes of the amplification efficiency of COL1A1, COL3A1, CSP4, 
HAS2, FBN1 and FBN2 were 0.0037, 0.0501, 0.0507, 0.0901, 0.0169 and 0.0107, 
respectively (Figure 4.8).  All gradients that are less than 0.1 show that all target 
genes have approximately equal amplification efficiency to the reference gene and 
can be investigated expression by ∆∆CT.  
 
 150 
 
 
Figure 4.8 Amplification efficiency of 6 ECM genes. ΔCT (CT of target gene – CT of 18s) was plotted 
graph against increasing amount of cDNA.  Slope of each gene expression less than 0.1 represents 
equal amplification efficiency between endogenous control and target genes.   
 
The relative expression of ECM genes is represented by ∆∆CT.   The median values of 
∆∆CT (n = 5-6) from the co-cultures of aVEC and vVEC are shown in Figure 4.9.  The 
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vVECs co-culturing significantly increased the expression of fibrillin 1 (FBN1) mRNA 
by VICs, when compared to the control.  The median value of aVEC and vVEC co-
culturing were 1.902 and 2.100 fold respectively.  However, there were no statistical 
differences between side-specific VEC co-culturing. 
 
Figure 4.9 Relative gene expression of VICs co-cultured either with aVECs or vVECs. VICs co-
cultured with aVECs and vVECs for 48 hours by Transwell, 0.4 µm pore size, were investigated the 
expression of COL1A1, COL3A1, CSP4, HAS2, FBN1 and FBN2.  Relative gene expression (ΔΔCT) of 
co-culturing was compared to 1 fold expression of the individual controls.  The  ΔΔCT among three 
groups was statistically compared using Kruskal-Wallis and Dunn’s Test, n=5-6.   
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4.4  Discussion   
The regulation of side-specific VECs on the production of ECM components by VICs 
was carried out using a co-culture model.  The amount of collagen is increased by 
the effect of vVEC co-culture, similar to the effect of vVEC-CM, whereas the increased 
amount of GAGs can be found only by the co-culture of VICs with vVECs.  Moreover 
the investigation of ECM gene transcription reveals the increased expression of 
FBN1 mRNA by vVEC co-culturing. 
Although the conditioned media experiment provided interesting initial data on the 
potential effects of VECs on the production of ECM by VICs, the presence of any 
degradable mediators in the EC-CM could be lost over the time period required to 
collect the media.  Therefore the co-culture of VICs and VECs using Transwells was 
performed.  The effect by co-culture for 48 hours was chosen to be comparable with 
conditioned media experiments.  VECs were cultured on the inserted membrane, of 
0.4 μm pore size, to make sure that there was no VECs migrated to the bottom of the 
well where the cultured VICs were.  
The phenotypes of VECs were investigated after co-culturing, during which the time 
the interaction between VECs and VICs is allowed to occur.  Although VECs are 
cultured with low serum media and adjacent to VICs, both aVECs and vVECs 
maintained their EC phenotypes, as shown by immunostaining of vWF and CD31.  
However there is no explicit staining of VE-Cadherin by aVECs and vVECs.   This may 
be due to the effect of being in contact with the porous polyester membrane of the 
inserts.   
The negative staining of SMαA by VECs both cultured with and without VICs 
demonstrates no contamination of VICs in the VEC population.  Interestingly, there 
is an expression of SMαA by aVECs and vVECs, from one animal, after co-cultured 
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with VICs by (data not shown), suggesting the ability of the two cell types to 
communicate and potentially initiate EndoMT.  The induction of EndoMT involves 
the putative TGF-β1 signalling pathway.  TGF-β specifically induces the 
translocation of Snail1, not Snail2, into nucleus (Li and Jimenez, 2011) and it, in 
turn, increases the expression of Snail1 gene.  The up-regulation of Snail1 causes the 
acquisition of mesenchymal phenotype, SMαA, but inhibition of EC phenotype i.e. 
CD31 and VE-Cadherin (Piera-Velazquez et al., 2011). 
Investigations of the mechanisms involved in this potential EMT response were 
outside the scope of this study. However, it is an intriguing observation and suggests 
that VICs may recruit additional VICs from the VEC population via the release of 
soluble mediators.  
The proliferation of VICs in the presence of VECs on the permeable membrane 
remained the same as VICs that were cultured with growth-arrested media, for 48 
hours, without VECs.  The maintained proliferation in the presence of side-specific 
VECs is consistent with the previous observation that cultured VICs with VEC-CM 
but in contrast to the observations on the effect of the mixed-VECs, where VICs 
which were encapsulated in a collagen gel were seen to have reduced amount of 
cells in the presence of the mixed-VECs on the gel’s surface, as compared to the 
amount of VICs without VEC seeding (Butcher and Nerem, 2006).  The lack of 
influence on the proliferation of VICs assures that the effects of VECs on the 
modulation of ECM components are independent of an increase in the number of 
VICs present in the culture.   
Co-culturing with vVECs significantly increased the amount of collagen that is 
secreted into the media by VICs.  Although, there is no significant difference 
between the site-specific VECs, these results are in agreement with the effects seen 
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with vVEC-CM on collagen content in VIC cultures, suggesting that a stable mediator 
in both models used mediates this effect.   
Nonetheless, the effects of ECs on the collagen production by co-culturing can vary 
depending on cell types.  Coronary artery ECs increased the amount of collagen 
secreted in the media by SMCs (Myers and Tanner, 1998).  Moreover, ECs from the 
aorta also increased the production of collagen by cardiac fibroblasts (Guarda et al., 
1993), whereas they reduced the production of collagen by SMCs (Powell et al., 
1997).  
EC-derived paracrine compounds such as ET-1 and NO were shown to have the 
function of regulating the production of collagen by vascular SMCs and other 
mesenchymal cells.  Exogenous ET-1 had a concentration-dependent effect on 
increasing the production of collagen by dermal fibroblasts (Kahaleh, 1991).  More 
specifically, it increased the amount of collagen type I that was secreted into the 
media by vascular SMCs and both secreted collagen type I and III by aorta SMCs 
(Rizvi et al., 1996).  
In contrast to ET-1, NO donors reduced the production of collagen by the aorta 
SMCs, in a dose-dependent manner (Kolpakov et al., 1995) and diminished the 
amount of secreted collagen type I by coronary SMCs (Rizvi and Myers, 1997).  In a 
later study, EC-derived NO was demonstrated to have an inhibitory effect on the 
production of collagen by coronary artery SMCs.  The amount of secreted collagen 
type I was dramatically increased when the activity of NOS and COX were inhibited 
in the EC-SMC co-culture (Myers and Tanner, 1998).  
The discrete effect on the production/amount of collagen suggests an intricate 
interaction between several (endothelial) paracrine compounds that can affect both 
the production and degradation of collagen.  Moreover, a particular paracrine factor 
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can regulate the production of different ECM component differently.  The antibody 
used for neutralising the activity of TGF-β had no effect on the collagen production 
by SMCs (Powell et al., 1997).  In contrast to the regulation of collagen, TGF-β 
modulated the production of GAGs by increasing the amount of s-GAGs produced by 
SMCs (Ciolino et al., 1992; Merrilees and Scott, 1990).  Moreover, the exogenous 
TGF-β can modulate the production of different types of GAGs (HA and s-GAGs) in 
the concentration-dependent manner (Merrilees and Scott, 1990). 
In the study, the vVEC co-culture significantly increases the amount of GAGs 
secreted in the media by VICs, when compared to the control and the aVEC co-
culture.  This paracrine effect is consistent with the increasing synthesis of GAGs of 
the EC-SMC co-culture (Merrilees and Scott, 1981).  The increasing amount of GAGs 
can possibly be as a result of TGF-β produced by co-cultured vVECs; as previously 
shown in the Chapter 2, VECs can produce TGF-β.  However, it is noted that there 
was no significant difference among the side-specific VECs in terms of TGF-β 
production.  
Since the amount of GAGs measured in the media is the net effect of degradation and 
synthesis, it is likely that vVECs produce non-stable paracrine factors that affect the 
homeostasis of GAGs differently from aVECs.  As a result, an increasing amount of 
GAGs is observed when VICs are cultured in the vicinity with vVECs only and this 
effect is not observed by vVEC-CM. 
In contrast to the present study, the co-culturing of venous ECs did not modulate the 
amount of GAGs produced by myofibroblasts that were encapsulated in a 3-D fibrin 
gel (Pullens et al., 2009).  Additionally, under both static conditions and when 
laminar shear stress was applied, mixed VECs prevented the loss of GAGs in a 
hydrogel that contained VICs (Butcher and Nerem, 2006).  Although these studies 
did not identify the regulatory function of ECs, they did demonstrate that the 
 156 
 
homeostasis of GAGs may not be modulated only by ECs, but also by the unique 
interaction of cells to the microenvironment. 
The influence of VECs on the production of elastin by VICs is also investigated using 
the co-culturing model.  Whereas the amount of secreted elastin cannot be detected 
by ELISA technique (data not shown), the membrane-bound elastin can be isolated 
from the VIC culture and quantified by dye-binding method.  The amount of elastin 
produced by VICs is not affected by the VEC co-culturing and VEC-CM (as shown in 
the previous chapter).  This could be a result of a balance effect between synthesis 
and degradation of elastin by VECs or it could be that VECs do not influence the 
production of elastin at all.  Thus the degradation of radiolabeled elastin that is 
synthesised before starting the VEC co-culture, along with the incorporation of a 
radiolabeled component into newly synthesised elastin after the VEC co-culturing 
begins, should be investigated to address these questions.  
There is the possibility that the investigated ECM components are the product of 
VECs.  The measurement of collagen, GAGs and elastin produced by VECs was 
investigated by the same co-culture system apart from that there was an absence of 
VICs at the bottom well.  The results demonstrated that there are no ECM 
components measurable with the assays that are produced by VECs and might 
transfer through the permeable membrane at the bottom wells.   
The amount of ECM proteins investigated in these studies may be influenced by 
VECs affecting either synthesis, degradation or the secretion process.  To identify at 
if synthesis or degradation is modulated by VECs, the inhibition of transcription and 
translation by Actinomycin D and cycloheximide as well as the production of MMPs 
and TIMPs by zymography technique could be performed.  Although the regulation 
of the degradation and secretion of the ECM is not pursued in this current study, the 
modulation of the gene expression is of interest and was investigated.  
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We chose to look at COL1A1 and COL3A1 encoding collagen alpha-1 type I and III 
since is found predominantly on aortic side of the valve.  In addition, CSPG4 
expressing chondroitin sulphate proteoglycan 4, and HAS2, encoding the enzyme to 
synthesize hyarolunan, is an important gene for GAGs, that are found in the middle 
part of the valve.  Lastly, FBN1 and FBN2 express fibrillin 1 and 2 which are main 
components of elastic microfibrils found on ventricular portion of the valve.  
The semi-quantitative gene expression analysis revealed no significant effect of 
aVECs and vVECs on the expression of collagen (COL1A1 and COL3A1) and GAG 
(CSP4 and HAS2) genes by VICs.  These results suggest that the increasing amount of 
collagen and GAG proteins observed in the media are not modulated by VECs at the 
transcription process and therefore it is unlikely that VEC induce de novo synthesis 
of any of the proteins encoded for by these genes.  A greater amount of collagen and 
GAGs by vVEC co-culture may be regulated by increasing the translation of existing 
mRNA for collagen and GAGs or by reducing the degradation of ECM proteins in the 
media.  This question remains to be studied.  
 It is noted that elastin comprises of only 13% of dried weight in the human aortic 
valve (Bashey et al., 1967) and its remodeling process can take up to a year 
(Starcher, 1986). Moreover, the expressions of elastin and tropoelastin genes are 
not detectable in porcine tissue because of the lack of species-specific primers. Thus, 
this study focused on the expression of fibrillins.   
Fibrillin is part of the glycoprotein family, which is proposed many functions.  It 
provides a microenvironment which regulates the tropoelastin/elastin cross-linking 
process (Sabatier et al., 2009).  Fibrillin 1 (encoded by FBN1 gene) maintains 
valvular structural integrity by tethering VICs to elastin and collagen (Fedak et al., 
2002).  In contrast, fibrillin 2 (FBN2) is predicted to regulate the assembly of the 
elastic fibre at the early process (Carta et al., 2006).  
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In the present study, the expression of FBN2 by VICs is not regulated by the 
presence of VECs.  In contrast, the presence of vVECs up-regulates the expression of 
FBN1 by cultured VICs. These results are coherent to the finding that FBN2 is down-
regulated in mature human aortic valves whereas FBN1 is expressed throughout all 
developmental stages (Votteler et al., 2013).   
However the discrete results between the sustained amount of elastin protein and 
the increased expression of FBN1 mRNA maybe a consequence of a different 
regulatory pathway of elastin and fibrillin.  Moreover, the regulation, by side-
specific VECs, at the translation of elastin mRNA and the secretion/degradation of 
elastin proteins remains unclear. 
 
4.4.1 Limitations of the study 
There are number of limitations to this study.  The mechanisms for the increased 
production of collagen and GAGs by VICs in co-cultured with vVECs, are not studied.  
The RT-PCR results do not demonstrate the up-regulation of the genes which are 
important for collagen and GAG production by aVECs or vVECs.  However, the 
regulation at the translational level of mRNA, secretion and degradation of collagen 
and GAGs remain to be studied.  In order to pursue such questions, VICs will have to 
be treated with cycloheximide to inhibit the total protein translation.  3[H]proline 
and 35[S]sulfate can be used to track the secretion of collagen and GAGs, 
respectively.  Lastly, the production, by VICs, of enzymes involved in the ECM 
degradation such as MMPs and TIMPs could be investigated by zymography. 
Moreover, it remains to be elucidated which molecules that the VECs modulate the 
VIC function.  ET-1, NO and TGF-β are EC-derived paracrine agents which modulate 
the production of ECM by fibroblast and vascular SMCs. Their functions on VICs 
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production of ECM proteins could be investigated by applying their inhibitors to the 
VEC-VIC co-cultures.  In addition, the levels of these mediators released into the 
media by VEC could also be determined. 
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4.5  Conclusion and Future Directions 
In conclusion, side-specific VECs elaborate substances that have a different 
paracrine effect on the functions of VICs that are cultured in vicinity with them for 
48 hours.  vVECs increased the amount of collagen secreted into the media by VICs, 
although no side-specific difference was observed.  Interestingly, the amount of 
secreted GAGs was significantly increased only by vVEC co-culture when compared 
to the control and aVEC co-culture.  However, the amount of elastin in the aVEC and 
vVEC co-culture remained at the same level as the control.  In addition, both aVECs 
and vVECs sustained the proliferation of VICs when they were co-cultured on the 
permeable membrane.  This result suggests that the VEC paracrine effect on the 
increasing amount of collagen and GAGs is mediated independently of the VIC 
proliferation.  Thus the interaction between VECs and VICs may be important to 
heart valve structural remodelling. 
However, the effect of shear stresses with regard to side-specific VECs needs be 
investigated to determine whether there is any heterogeneity in the response of 
VECs to the flow patterns, which are experienced from either side of the valve.  
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5 CHAPTER 5 Effect of Shear Stress and VECs 
5.1  Introduction 
Mechanical shear stress mediates vasotonicity of vessels by regulating structural 
and functional properties of cells at genetic, molecular and cellular levels.  ECs 
response to shear stress by redistributing cytoskeleton and changing the expression 
of growth factors and vasotonic molecules, as well as modulate the phenotypes of 
neighbouring cells (Topper and Gimbrone, Jr., 1999; Davies, 1997).  Under both 
static and shear stress conditions, VECs significantly reduce the expression of SMαA 
by VICs, as compared to the expression by VICs cultured in a 3-D scaffold alone 
(Butcher and Nerem, 2006).  
The response of ECs to mechanical forces has also been shown to regulate the 
production of ECM of adjacent tissue.  Vascular ECs and mechanical tension 
stimulate total production of collagen and elastin in the pulmonary arteries (Tozzi et 
al., 1989).  The intact-ECs tissue segments which were applied the strain had an 
increased production of collagen and elastin.  Whereas the same effect was not 
found on the tissue that were removed ECs (Tozzi et al., 1989).   
VECs on the aortic valve surfaces are also exposed to shear stresses during every 
cardiac cycle.  However, there are few studies investigating the response of VECs to 
the patterns of shear stress experienced by each surface of the valve and whether 
these cells have the ability to affect the ECM in the valve.   
The effect of laminar shear stress on the production of GAGs has been studied in the 
porcine aortic valve leaflets ex vivo (Weston and Yoganathan, 2001).  It was 
demonstrated that the leaflets which were subjected to the laminar flow maintained 
the amount of GAG synthesis to a similar extent to that of fresh tissue.  In contrast, 
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the leaflet kept in a static mechanical environment had an increased production of 
GAGs and total proteins (Weston and Yoganathan, 2001).  The importance of 
interactions between VICs and VECs has also been investigated. Under both static 
and flow conditions, the presence of VECs maintained the amount of GAGs in the 
scaffold, containing VIC, at a significantly higher amount than the scaffold without 
VECs (Butcher and Nerem, 2006). 
It is reasonably certain that VECs and VICs respond to their hemodynamic 
environment, which may influence/determine their ability to interact with VIC and 
affect the ECM of the valve.   Nonetheless, the response of side-specific VECs to the 
unique shear stress patterns and their effect on VICs function has not been 
investigated.  There is, however, an interesting observation revealing the flow-
independent response of VECs from the different aspects of the valve (Sucosky et al., 
2009).  aVECs and vVECs on the valve segments responded differently to the same 
patterns of shear stress, in terms of the expression of inflammatory molecules 
(Sucosky et al., 2009).   
This study has already investigated the ability of VEC to release stable mediators 
and those with a potentially shorter viability in a co-culture model that affect the 
ECM production by VICs in culture.  This chapter now aims to investigate whether 
there is a differential response by VECs to the heamodynamic environments 
experienced by the aortic side (AS) and ventricular side (VS) of that valve that 
regulates ECM production by the underlying tissue.  With reference to levels of 
collagen, GAGs and elastin, this study aims to expose each side of the valve to the 
physiological pattern of flow that it experiences as well as the reversed pattern of 
flow seen by the opposing side.  Oscillatory flow, normally generated on the aortic 
side in vivo, is referred as the aortic flow (AF) and, similarly, the laminar shear 
stress on the ventricular side is referred as the ventricular flow (VF).  Modulation of 
the ECM content using intact valve cusps will be measured after exposing the 
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surfaces of the valve to the respective patterns of flow using a purpose built 
bioreactor, Cone and Plate Machine (Sucosky et al., 2008).    
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5.2 Materials and Methods 
5.2.1 Porcine aortic valve tissue 
Porcine hearts were obtained from the same slaughterhouse (Cheale Meats, UK) as 
previous experiments.  3 leaflets of aortic valves were dissected under sterile 
condition with minimal contact to the surface of the valves.  All leaflets, separated 
among animals, were washed with PBS minimum twice.  A round-shaped cutter (at 
the diameter of 10 mm) was then used to dissect the identical portions of the valve 
from the “belly” area of each leaflet into 2 pieces (Figure 5.1).  Tissues were kept 
with DMEM containing 0.4% FBS under sterile conditions before used for further 
experiments.  
 
Figure 5.1 The counterpart area of an aortic cusp.  The belly from the counterpart areas of the cups 
were bisected by a rounded-shaper cutter.  One piece of the tissue was conducted as a reference 
and another was to be mounted on the Cone-and-Plate machine to expose to the shear stresses.  
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5.2.2 ECM production of aortic valves under various mechanical 
conditions 
To understand how mechanical shear stresses and side-specific VECs regulate the 
production of ECM components, tissues dissected from the same leaflet were 
cultured under different mechanical conditions.  One piece of tissue was used as a 
reference by statically maintaining the tissue for 48 hours, while another piece of 
tissue, from the same leaflet, was exposed to VF (laminar shear stress) or AF 
(oscillatory shear stress), one flow at a time, using a  Cone-and-Plate machine.  Both 
pieces of tissue were handled under sterile conditions throughout the experiments 
and cultured with DMEM containing 0.4% FBS at 37°C, in a 95% air/5% CO2 
incubator.  Experiments were performed where the AS or VS were tested in turn, 
with each side being exposed to both patterns of flow.  In addition, the ECM content 
of fresh tissue (immediately after dissection from the heart) was also investigated to 
show the respective amounts of ECM prior to any intervention.  The experimental 
design is depicted in the Figure 5.2.  
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Figure 5.2 Diagram of the experimental design.  The cusps were fixed by Cone-and-Plate lid and, 
thus, exposed only one side to the flow.  The tissue on the plate then experienced either their 
normal or changed flow (from the physiological condition) at a time.  The counterpart area of the 
same cusps were then used as the “fresh tissue” reference or maintained at the static condition for 
48 hours and used as another reference (control at static condition). 
 
5.2.2.1 Cone-and-Plate machine 
In order to study the effect of shear stress patterns on valve tissue, the Cone-and-
Plate device was developed by the Biomedical Engineering Department at the 
Georgia Institute of Technology.  The machine can replicate the oscillatory and 
laminar shear stress at the same magnitudes and patterns as experienced by the 
aortic valve in vivo.  The machine is mainly composed of a cone made of Delrin at 
179° cone angle and 80mm in diameter. This sits above a cylindrical plate 
containing 9 equi-angularly spaced cylindrical wells.  Within the wells, cylindrical 
stainless-steel holders can be placed at different heights in order to be able to 
mount the valves of varying thickness on the holders and ensure the valve surface is 
maintained at the same distance from the cone.  The different shear stress patterns 
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can be then generated by a different pattern of rotation of the cone.  To fix the 
position of the tissue, a plate cover with the nine holes (of a diameter of 5-7 mm) 
openings in identical positions as the tissue is secured over the plate by a number of 
screws.  During their exposure to the flow, tissues were maintained by nutrients 
with a constant supply of DMEM containing 0.4% FBS from a bottle that allows O2 
and CO2 exchange to occur (Figure 5.3). 
 
 
Figure 5.3 The shear stress generating device.  9 pieces of tissue were mounted on “The plate” 
under the sterile condition and covered by “The cone” which generates the shear stress by the 
connected rotor.  The plate contains the channel of “Media input” that connects to a bottle 
containing low–serum media, known as the “Media reservoir”.  The media was circulated by the 
“Peristalic pump” into the plate through the media input and outward through the “Media output” 
channel.  The pH of the media was controlled by the CO2 system through the 0.2 µm “Gas 
exchanging filter”. 
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Nine pieces of tissue were mounted on the aforementioned plate. For each 
experiment the tissues were carefully placed on either aortic or ventricular side so 
that only one surface was exposed to the flow.  To verify the effect of flow patterns 
independently from side-specific VECs, an each side of the tissue was also exposed 
to the flow physiologically seen by the other side of the valve.  Tissues were exposed 
to shear stress for 48 hours, after which they were removed from Cone-and-Plate 
machine and trimmed with the 5 mm round shape-cutter to ensure that only the 
tissue area exposed to the flow was collected.  Tissue samples were immediately 
placed in microtubes and dried at 40⁰ C on a heating metal overnight.  Dried tissues 
were then cut into small pieces ~1x1 mm inside the microtubes and weighed before 
extraction and measurement of ECM components.   
 
5.2.2.2 Collagen content of aortic valve tissue 
Tissue subjected to either shear stresses or static culture was extracted the collagen 
by using 10 mg/ml of Pepsin enzyme for 2 days.  All dried tissue at a known weight 
was prepared in a 1.5 ml microtube with 1 ml of Pepsin in 0.5 M acetic then added.  
The tubes are then shaken vigorously by Multitube Vortexer (Lab-tek International 
LTD, New Zealand) for 2 days.  All microtubes were then spun at 13684 g for 1 
minute to remove tissue debris.  Supernatant restraining collagen was then 
transferred into a new microtube and mixed with 100 µl of Acid Neutralising 
Reagent containing Tris-HCl and NaOH (Sirkol kit).  The collagen in the sample was 
then precipitated and assayed the content by the same protocol as described in 
section 3.2.3.   
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5.2.2.3 GAGs content of aortic valve tissue 
All samples were dried at 40°C and weighed before GAG solubilisation was started.  
They were subsequently incubated with 1 ml of 20 mg/ml papain in an extraction 
buffer (0.2 M sodium phosphate buffer pH 6.4, 800 mg/ml sodium acetate, 400 
mg/ml EDTA, sodium salt and 80 mg/ml cysteine HCl).  The extraction reaction was 
performed at 60°C in a water bath while vigorously shaking for few hours.   After the 
tissue was dissolved, all the tubes are spun at 800 g for 1 minute to segregate tissue 
debris at the bottom.  100 µl (triplicates) of supernatant was then transferred into a 
new microtube to carry on the measurement of GAGs by Blyscan kit, as described in 
section 3.2.4. 
 
5.2.2.4 Elastin content of aortic valve tissue 
The insoluble elastin obtained in fresh tissue and the tissues that had been 
subjected to either shear stress or static condition was extracted and converted into 
a soluble form, α-elastin, by using hot oxalic acid.  After cutting it into small pieces 
and weighing, every piece of dried tissue was added to 1 ml of 0.25 M oxalic acid and 
heated at 100⁰C for 1 hour.  The soluble elastin, which was released into the 
solution, was collected into a new microtube after spinning the residual tissue down 
at 9503 g for 10 minutes.  The extraction was repeated twice and elastin content 
was subsequently measured by using Fastin kit, as described in section 3.2.5.  The 
amount of elastin from 3 extractions from each sample was then added up to 
calculate elastin content per mg of dried tissue.  
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5.2.3  Data and statistic analysis 
The amount of collagen, GAGs and elastin was reported in µg per mg of (dried) 
tissue and represented in the box-and-whiskers plot by Graphpad Prism 5.  The 
band inside the box depicts the median.  The top and bottom of the box display the 
third and the first quartiles, respectively, and the length of the box is the 
interquartile range (IQR).  In these studies, the whiskers illustrate the maximum and 
minimum of the data set. 
The groups of data were analysed statistically by a non-parametric one-way ANOVA 
or Kruskal-Wallis Test.  The multiple pair-wise tests were further evaluated by 
Dunn’s Test.  P value less than 0.05, 0.01 and 0.001 are represented by *, ** and ***.  
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5.3  Results 
In these studies, the effect of shear stresses on the modulation of ECM has been 
investigated.  The amount of ECM in the tissue that was cultured under normal 
shear stresses (AS/AF and VS/VF) was compared to the leaflets kept at static 
condition or static control (SC), for 48 hours.  Additionally, the amount of ECM in 
fresh tissue (FT) was also referred to those in the native valves.  Further insights in 
the effect of side-specific VECs and the flow patterns were studied by investigating 
the response of VECs to the reverse pattern of flow (AS/VF and VS/AF).  
 
5.3.1 The effect of shear stresses on the content of collagen  
The leaflets that were maintained at SC for 48 hours did not significantly change the 
amount of collagen from those of FT.  The median values of collagen content of FT 
and SC were 4.632 and 4.948 µg collagen/mg dried tissue, respectively.  When the 
AS was exposed to the AF the amount of collagen significantly increased to 32.56 µg 
collagen/mg dried tissue as compared to the FT.  In contrast, when the VS was 
exposed to VF there was an increasing trend of collagen content to 13.98 µg 
collagen/mg dried tissue, but this was not statistically different from FT or SC 
samples, p<0.05 (Figure 5.4).  
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Figure 5.4  The effect of shear stresses on the amount of collagen in the aortic valves.  The amount 
of collagen was reported in µg collagen per mg dried tissue from fresh tissue (FT), static control 
(SC) for 48 hours and the mimicked physiological flow conditions for 48 hours on the aortic side 
(AS/AF) and ventricular side (VS/VF).  The median values were statistically analysed by Kruskal-
Wallis Test and pair-wise compared by Dunn’s Test.  The amount of collagen in AS/AF samples was 
significantly higher than FT samples, n numbers of each group were FT=6, CS=6, AS/AF=9 and 
VS/VF=9.  
 
5.3.2 The effect of side-specific VECs and shear stress patterns 
on the content of collagen 
The side-specific VECs and flow patterns were studied to assess their effect on the 
content of collagen in the valve, Figure 5.5.  The median values of collagen content in 
the leaflets subjecting their AS to the AF and VF were 32.56 and 16.28 µg 
collagen/mg dried tissue, respectively.  There was a trend of decreasing amount of 
collagen when the ventricular side was exposed to the flow patterns.  The median 
values of VS/VF and VS/AF were 13.98 and 7.039 µg collagen/mg dried tissue, 
respectively.  However there was no significant different effect, either by specific 
sides or flow patterns, on the amount of collagen in the aortic valves. 
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Figure 5.5  The effect of side-specific VECs and flow patterns on the amount of collagen in the aortic 
valves.  The amount of collagen was investigated of the valves that were exposed the surfaces to the 
normal flow (AS/AF and VS/VF) and changed flow (AS/VF and VS/AF) for 48 hours. The median 
values were statistically analysed by Kruskal-Wallis Test and pair-wise compared by Dunn’s Test.  
There was no statistically significant difference among all groups, n numbers of each group were 
AS/AF=9, AS/VF=8, VS/VF=9 and VS/AF=6. 
 
5.3.3 The effect of shear stresses on the content of GAGs 
The amount of GAGs was significantly reduced when the leaflets were kept at the 
static condition for 48 hours as compared to the fresh tissue as demonstrated in the 
Figure 5.6.  The median value of FT was 32.68 µg GAGs/mg dried tissue and it was 
reduced to 21.37 in the SC samples.  The amount of GAGs was increased in the 
tissues that where the AS was exposed to the AF for 48 hours.  The median value of 
47.14 µg GAGs/mg dried tissue for AS/AF tissue was significantly higher than that 
seen in FT and SC (p<0.05 and p<0.001, respectively).  However the amount of GAGs 
remained non-significantly different to FT or SC in the tissues where the VS was 
exposed to VF.  The median value for VS/VF was 33.33 µg GAGs/mg dried tissue.  
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Figure 5.6 The effect of shear stresses on the amount of GAGs in the aortic valves.  The amount of 
GAGs was reported as µg GAGs per mg dried tissue from fresh tissue (FT), static control (SC) for 48 
hours and the mimicked physiological flow conditions for 48 hours on the aortic side (AS/AF) and 
ventricular side (VS/VF).  The median values were statistically analysed by Kruskal-Wallis Test and 
pair-wise compared by Dunn’s Test.  The amount of GAGs in AS/AF samples was significantly 
higher than FT samples and SC while those amount in SC samples was significantly reduced from 
FT, n numbers of each group were FT=24, CS=20, AS/AF=6 and VS/VF=6. 
 
5.3.4 The effect of side-specific VECs and shear stress patterns 
on the content of GAGs 
The effect of flow patterns and side-specific VECs on the amount of GAGs was 
observed and shown in Figure 5.7.  The median value of the AF on the AS was 47.14 
µg GAGs/mg dried tissue and it was significant diminished when the same pattern of 
flow was generated on the VS to 28.39 µg GAGs/mg dried tissue (p<0.001).  
However the effect of VF appears to maintain the amount of GAGs at the non-
significantly changed level from other samples in which the median values of VS/VF 
and the AS/VF were 33.33 and 35.08 µg GAGs/mg dried tissue.  
FT SC AS/AF VS/VF
0
10
20
30
40
50
60
70
*
****
u
g
 G
A
G
s/
m
g
 D
ri
e
d
 T
is
su
e
 175 
 
Moreover, the side-specific effect was not prominent.  There was no significant 
difference observed when the AS/AF was compared to AS/VF and the VS/VF was 
compared to VS/VF, although there was a trend of decreasing amount of GAGs when 
the AS and VS were exposed to the reverse flow. 
 
Figure 5.7 The effect of side-specific VECs and flow patterns on the amount of GAGs in the aortic 
valves.  The amount of GAGs was investigated of the valves that were exposed the surfaces to the 
normal flow (AS/AF and VS/VF) and changed flow (AS/VF and VS/AF) for 48 hours. The median 
values were statistically analysed by Kruskal-Wallis Test and pair-wise compared by Dunn’s Test.  
The amount of GAGs in VS/AF was significantly optimised from the AS/AF samples.  All samples had 
n numbers = 6.  
 
5.3.5 The effect of shear stresses on the content of elastin   
The amount of elastin found in the SC was significantly reduced when compared to 
those in the fresh tissue (p<0.0001) and the leaflet where the VS was exposed to VF 
(p<0.01).  The median value of SC was 56.20 µg elastin/mg dried tissue which was 
decreased from 75.70 µg elastin/mg dried tissue of FT and 74.13 µg elastin/mg 
dried tissue of VS/VF group (Figure 5.8).  Although there was a trend of decreasing 
amount of elastin in AS/AF group, the elastin content remained non-significantly 
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different from the controls and had the median value at 62.37 µg elastin/mg dried 
tissue.  
 
Figure 5.8 The effect of shear stresses on the amount of elastin in the aortic valves.  The amount of 
elastin was reported as µg elastin per mg dried tissue from fresh tissue (FT), static control (SC) for 
48 hours and the mimicked physiological flow conditions for 48 hours on the aortic side (AS/AF) 
and ventricular side (VS/VF).  The median values were statistically analysed by Kruskal-Wallis Test 
and pair-wise compared by Dunn’s Test.  The amount of elastin in VS/VF samples was significantly 
higher than SC while those amount in SC samples was significantly reduced from FT, n numbers of 
each group were FT=28, CS=19, AS/AF=8 and VS/VF=9. 
 
5.3.6 The effect of side-specific VECs and shear stress patterns 
on the content of elastin 
When VF was generated on the AS, it significantly increased the median value of 
elastin content to 76.18 µg elastin/mg dried tissue as compared 62.37 µg elastin/mg 
dried tissue to when the AS was exposed to AF (p<0.05), as demonstrated in Figure 
5.9.  The increased amount of elastin when the AS was exposed to VF was similar to 
when the VS was exposed to VF.  However, when AS/AF was compared to VS/VF, 
there was no significant difference observed.  Moreover when the VS was exposed to 
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AF there was more variance in the measurement of elastin content than the VS/VF 
group, but the median value of 72.43 µg elastin/mg dried tissue remained non-
significantly different from the VS/VF group. 
 
 
Figure 5.9 The effect of side-specific VECs and flow patterns on the amount of elastin in the aortic 
valves.  The amount of elastin was investigated of the valves that were exposed the surfaces to the 
normal flow (AS/AF and VS/VF) and changed flow (AS/VF and VS/AF) for 48 hours. The median 
values were statistically analysed by Kruskal-Wallis Test and pair-wise compared by Dunn’s Test.  
The amount of elastin in AS/VF was significantly increased from the AS/AF samples.  n numbers of 
each samples were AS/AF=8, AS/VF=6, VS/VF=9 and VS/AF=9. 
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5.4  Discussion 
The effects of shear stress and the effect of side-specific VECs to different flow 
patterns were examined with respect to their ability to influence the ECM 
components of intact valves.  Whereas the particular response of aVECs to the aortic 
flow increases the production of collagen and GAGs, the ventricular flow maintains 
the amount of elastin in the valve, in a side-specific independent manner.  
Side-specific VECs have been demonstrated (in the previous chapters) to regulate 
the amount of ECM components produced by VICs, in vitro under static conditions.  
However, the aortic valve resides in a dynamic environment and is exposed to 
mechanical forces during every cardiac cycle.  Moreover the effects of stretch and 
pressure have been demonstrated to affect the production of ECM components in 
the aortic valve (Balachandran et al., 2006; Balachandran et al., 2009; Konduri et al., 
2005).  However, the biological response of side-specific VECs to the mechanical 
shear stress patterns to which it is exposed have not been previously investigated.  
In these studies, the effects of mechanical shear stresses are incorporated into the ex 
vivo investigations.   
The influence of specific flow patterns can be examined by exposing one particular 
surface of the valves to the shear stresses by using the Cone-and-Plate machine 
(Sucosky et al., 2008).  The device can generate both the aortic (oscillatory) and 
ventricular (laminar) shear stresses and exclude other mechanical forces such as 
stretch and compression that the valve may experience.  For the investigation of the 
effect of shear stress, fixing of the leaflets on metal bullets using a lid has the 
advantage of having no increase in pressure and tensile force on the valve 
specimens.  The device allows the study of a single flow effect, in comparison to the 
native valve where both AF and VF occur continuously on the opposite surfaces of 
the valves is not possible.  However, the regulation of side-specific VECs, which are 
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independent of shear stress patterns, can be investigated by applying the opposing 
pattern of flow to either side of the valve.  
In these experiments, the variation of ECM components on a valve cusp is minimised 
by dissecting the pieces from the belly region that are symmetrically adjacent to 
each other, so that they have very similar fibre structure throughout the area to be 
exposed to flow or used as the control (Sacks et al., 1998).  
The importance of mechanical stimulation to maintain the ECM components in the 
valves is demonstrated by comparing the leaflets that were cultured under static 
conditions to the fresh tissue.  After being kept in a condition which is absent of 
mechanical forces for 48 hours, the amount of GAGs and elastin were significantly 
reduced, which is consistent with the observations in studies on valves by other 
authors (Konduri et al., 2005).  In contrast, the amount of collagen remains the same 
extent between SC and FT samples.  The similar result can also be observed in other 
experiments (Balachandran et al., 2006; Konduri et al., 2005) and is explained by 
the equal amount and activity of enzymes involving in collagen degradation.  The 
authors found that the production of collagenase and the activities of gelatinase 
(MMP-2/9) of SC for 48 hours remained the same as the FT (Balachandran et al., 
2006; Konduri et al., 2005).  
Collagen is the major ECM component of the fibrosa layer, on the aortic side, of a 
native aortic valve.  The normal physiological flow on the aortic side (AS/AF) is 
demonstrated in these studies to significantly increase the collagen content during 
48 hours of flow incubation.   While in static conditions over 48 hours, the amount of 
collagen in the valves is unchanged as compared to FT.  
There appears to be a shift in the balance between synthesis and degradation in the 
AS/AF samples towards more production and/or less degradation.  The greater 
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amount of the collagen produced by the AS is not evident when the AS is exposed to 
VF.  This may be due to fact that VF on the VS of the porcine aortic valves increased 
the collagenase activity of MMP-2 and 9, when compared to the control under static 
conditions (Platt et al., 2006b).  The expression of MMP-2 and 9 and their 
collagenase activities, should be investigated further to determine if these effects 
are due to changes in synthesis or degradation.  
In addition to the MMP-2 and 9, cathepsin K and L, which have both collagenase and 
elastase activities, were reported to be flow-sensitive ECM remodelling enzymes.  
The production of cathepsin K and L by the ECs from the mouse aorta was increased 
by aortic flow (Platt et al., 2006a; Platt et al., 2007).  Nevertheless, these enzymes 
may not prominently involve in the degradation of collagen in the valve tissue for 
two reasons.  Firstly, cathepsin L is an active elastase rather than collagenase, which 
was confirmed by the prominent loss of elastin degradation but only minor 
reduction of gelatine degradation activity in siRNA-cathepsin L knockdown cells 
(Platt et al., 2006a).  Secondly, the collagenase activity of cathepsin K in response to 
the aortic flow has the same efficiency as the static control (Platt et al., 2007).  These 
observations could explain why the significant reduction of collagen was not 
observed in the aortic-flow exposure valves during these studies, although 
cathepsin K and L were reported to be increased by AF when compared to VF. 
In addition, the sustained amount of collagen observed in VS/VF samples, the same 
as FT and SC, suggesting there is an equilibrium between the degradation and 
production of collagen.  These results, however, are different from the in vitro 
observations that revealed the increasing amount of collagen was induced by vVEC-
CM and vVECs co-culturing.  These might be due to the unique response of VECs to 
the flow patterns, in terms of collagen production and/or degradation that is not 
seen in the two static models investigated earlier in this thesis.   
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It is noted that collagen measured in this study is unlikely to be the covalent cross-
linked or mature collagen because the Sirkol dye binds to the [Gly-X-Y]n of the 
helical structure of collagen.  The collagen was released from the valve in a soluble 
form, by the digestion for 2 days with pepsin, which digests the non helical 
telopeptide part of the collagen fibre.  However the collagen content in FT and CS, in 
this study is much less than those amount found by other research groups 
(Balachandran et al., 2006; Konduri et al., 2005).   
Similar to the response on the collagen content, shear stresses is important to 
maintain the amount of GAGs in the valve.  The physiological conditions experienced 
by the aortic side (AS/AF) can increase the amount of GAGs.  The increased amount 
of GAGs seems to be a specific response of AS to AF and cannot be generated by AF 
on the VS.  It is demonstrated by the significantly reduced amount of GAGs in VS/AF 
samples in comparison to the effect of AF on the AS.  
Steady laminar shear stress maintained the amount of GAGs in the magnitude 
independent manner, as was previously demonstrated by another laboratory 
(Weston and Yoganathan, 2001).  The side of the aortic valve leaflets that were 
exposed to the ventricular flow was not identified in their studies.  However, the 
similar results are observed in the current study, in that both VS/VF and AS/VF 
maintain the amount of GAGs when compared to the native valves.  
The responses of the VS to flow patterns are, nonetheless, different from the effect 
of vVEC co-culturing, which enhanced the content of GAGs to a higher level than 
VICs culturing alone.  The increasing amount of GAGs by static vVECs may be due to 
the absence of a shear stress mediated effect that causes degradation or inhibition 
the production of GAGs.  However this hypothesis should be further investigated 
before a firm conclusion can be made. 
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Elastin is the major ECM component on the ventricularis layer on the ventricular 
side of the aortic valve.  These studies reveal the regulation of VF on the amount of 
elastin in the side-specific VECs independent manner.  The VF on the VS maintains 
the elastin content at the same level as the native valves.   Thus it is not surprising 
that the amount of elastin produced by in vitro VICs remains unchanged by culturing 
VICs with static VECs and VEC-CM.   
Mechanical shear stress plays an important role in the regulation of the elastin 
content in the valves.  The amount of elastin is significantly reduced when 
mechanical forces are absent for 48 hours, but can be restored to the same level as 
FT by applying VF on the VS.  However, this response is not observed by the AF 
effect on the AS.  This may be attributed to the activities of shear-sensitive elastase, 
cathepsin K and L, since their activities are inhibited by ventricular flow but 
increased by the aortic flow (Platt et al., 2006b; Platt et al., 2006a; Platt et al., 2007).  
This is further supported by the evidence that the VF effect on the amount of elastin 
is independent of side-specific VECs.  
The content of elastin when VF is applied to the AS is significantly increased (when 
compared to the AF on the AS) up to the similar level that can be found when VF is 
applied to the VS.  This suggests that aVECs response to the VF is to increase the 
inhibition activity of elastases relative to the AF.  This is similar to the reaction of 
mouse vascular ECs to AF and VF (Platt et al., 2006a; Platt et al., 2007).  vVECs, 
however, do not significantly reduce amount of elastin in response to the AF.  The 
ability to decrease the elastin content was not seen in all valve tested.  Thus, the 
number of the experiments and the time that the valves are exposed to flow 
patterns should be increased to confirm the response of the VS to AF. 
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5.4.1 Limitations of the study 
There are some experiments which could not be performed in this study due to the 
limited availability of equipment and time.  The magnitude and patterns of shear 
stresses that were generated by cone-and-plate machine were designed to mimic 
the physiological paradigm.  However, the actual flow rate in this system was not 
pursued because of the lack of the required equipment to make these measurements 
in our laboratory.  For example, an ultrasonic flow probe and a digital flow meter 
would be needed to measure the actual flow rate and pressure in the bioreactor.  
The study has therefore relied on the published work that documents the 
development and capability of the Cone-and-Plate machine (Sucosky et al., 2008). 
It would have been ideal for the effect of flow patterns on one side of the valve to be 
investigated from the same leaflet and exposed to both AF and VF on the same day.  
As only one cone-and-plate is available (i.e. the ability to expose a single chamber to 
a single pattern of flow) this was not possible.  Steps were taken however to try and 
pair the observations by taking identical samples from each valve, one which acted 
as the SC and the other exposed to flow. 
The ECM components observed in these studies could be the total amount produced 
by VECs and VICs.  Moreover, it could not exclude the effect of VECs on the side that 
did not get exposed to the flow.  For that reason, the localisation of collagen, GAGs 
and elastin, including flow-sensitive ECM remodelling enzymes, should have been 
observed in order to investigate the response of VECs and VICs to the shear stresses 
in further detail.  In these studies, the localisation of collagen type I and III only in 
the AS/AF samples were performed (data not shown) due to the limited time for 
observations to be made. 
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In addition, synthesis and degradation of the ECM components from each condition 
were not investigated. RT-PCR of collagen, GAG, elastin and matrix remodelling 
enzymes could also be performed to examine the newly synthesis of the ECM 
components at the transcription level. Incubation of the valve cusps with 
radiolabeled proline, acetate and valine could also be employed as a more sensitive 
measure of the synthesis of collagen, GAGs and elastin, respectively.  The production 
of matrix remodeling enzymes, MMPs, TIMPs, and cathepsins, involved in the 
degradation of ECM components could be confirmed by immunostaining.  Moreover, 
their activities could be examined in different ways.  For example, the activities of 
gelatinase and elastase could be measured by zymography or fluorescein-
conjugated gelatin and elastin.  Specific activity of cathepsin L can be further 
investigated by detection the fluorescent product AMC (amino-4-methylcoumarin), 
which is linked to the synthetic substrate, specific to cathepsin L, and commercially 
available. This is clearly where future work needs to be performed to accurately 
determine the balance between synthesis and degradation under each of the flow 
conditions and on each of side of the valve.  
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5.5  Conclusions and Future Directions 
These studies demonstrate that side-specific VECs respond differently to the same 
shear stress patterns and such interactions are important to the regulation of ECM 
components, although the molecular mechanism regulating this process still 
requires further study.   
Shear stress plays an important role in the regulation of collagen, GAGs and elastin, 
as was demonstrated by the decreasing amount of ECM from the leaflets in the 
absence of any mechanical forces when compared to the fresh valve.  The specific 
responses of AS to the AF to increase the content of collagen and GAGs cannot be 
replicated by a single effect of cell type or flow pattern.  The AS ECs do not enhance 
the amount of collagen and GAGs in response to the VF.  Moreover, the AF on VS 
does not induce the induction of the ECM component, but instead reverses the effect 
of the AS/AF.  In contrast to the response on collagen and GAGs, VF is a crucial factor 
in maintaining the amount of elastin in the valve, independent of the specificity of 
VECs.   
Although AS ECs have a unique interaction with the AF, they tend to have a similar 
ECM regulation as VS ECs when they response to the VF.  In contrast, VS ECs do not 
respond to the changed flow or AF in a similar manner as AS ECs. 
Thus, side-specific VECs and their responses to the particular patterns of shear 
stresses are important to the regulation of ECM components.  Such understanding is 
imperative to the creation of tissue-engineered heart valves that must be created 
from the “right” cells to produce the specific ECM components and, in turn help 
develop and maintain the integrity and durability of the valves.     
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6 CHAPTER 6 Adipose-Derived Stem Cells as a 
Potential Source of Valve Endothelial Cells 
for Heart Valve Tissue Engineering  
6.1  Background  
As part of TEHV, EC source is required that will match side-specific VECs in terms of 
the ability to respond to the flow patterns and regulate the specific ECM 
components as previously shown in chapter 5.  
Adipose-derived stem cells (ADSCs) are potentially a suitable cell for use in 
regenerative medicine and tissue engineering applications.  Abdominal ADSCs can 
be isolated in abundant quantities with a minimally invasive procedure (e.g. via 
liposuction) and can be autologously acquired from a patient; thus minimising the 
chance of immunogenic rejection.  More importantly, ADSCs have the potential to 
differentiate into many types of cells, for example, cardiomyocytes, endothelium, 
myocytes, chondrocytes, neuronal-like cells and osteoblasts (Gimble et al., 2007). 
ADSCs have been successfully differentiated into ECs by many stimulants.  These 
include matrix coated culture plates, media for culturing ECs, VEGF and shear stress 
(Bassaneze et al., 2010; Cao et al., 2005; Martinez-Estrada et al., 2005; Zhang et al., 
2011).  The ADSCs that express fetal liver kinase (FLK-1, a receptor for VEGF) were 
differentiated into ECs by culturing on the collagen IV-coated flasks supplemented 
with the endothelial growth media 2 (EGM2) (Martinez-Estrada et al., 2005).  The 
similar EC differentiation method was carried on by Cao et al. (Cao et al., 2005) by 
culturing ADSC FLK-1+ cells on a Matrigel coated plate with EGM2 in addition of 50 
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ng/ml of VEGF.  The ADSC FLK-1+ cells were able to express CD31, VE-Cadherin and 
NOS III as well as take-up LDL. 
The effect of shear stress on the EC differentiation by ADSCs was also investigated 
(Bassaneze et al., 2010).  After exposure to the laminar shear stress, the ADSCs 
significantly increased the production of NO and VEGF but failed to express EC 
markers e.g. vWF, CD31 and FLK-1.  Recently, the effect of EGM2 and shear stress 
was revealed to increase the production of NO and EC markers by ADSC CD31-
/CD45- cells (Zhang et al., 2011).   
This study aims to differentiate ADSCs into VECs by shear stress and VEGF, and use 
the differentiated ADSCs as a potential source of VECs for tissue engineering of heart 
valves.  It is hypothesised that the aortic and ventricular shear stress patterns can 
differentiate ADSCs into side-specific VECs.  Furthermore, the differentiated ADSCs 
can regulate the function of VICs to produce ECM components.  Thus, the ADSCs that 
express CD34 will be isolated and cultured on gelatin coated plates with EGM2.  
Subsequently, the ADSCs will be supplemented with VEGF in low-serum EGM2 and 
exposed to the AF and VF using the Cone-and-Plate machine.  The EC differentiation 
of the ADSC cells will be assessed by their ability to uptake low-density lipoprotein 
(LDL) and express of EC markers. The side-specific phenotypes of the EC-
differentiated cells will be investigated by the differential expression of EC markers, 
vWF, CD31 and NOS III.  Their expressions previously suggested the distinct 
phenotypes among aVECs and vVECs in porcine (Simmons et al., 2005).  In addition, 
the response of the differentiated ADSCs to flow patterns will compared to the 
characters of native side-specific VECs, in terms of the regulation on ECM contents, 
as demonstrated in chapter 5.  
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6.2  Materials and Methods 
6.2.1 Isolation of Adipose derived stem cells from adipose 
tissue 
The abdominal adipose tissue was obtained from 3 patients who underwent 
abdominal liposuction.  ADSCs were isolated from the adipose aspirate as previously 
described (Colazzo et al., 2011).  The isolation involved mixing the adipose aspirate 
with an equal volume of 0.9% NaCl and allowed to settle for 5 minutes.  The fat 
phase was separated and set at the top of the aqueous/blood layer.  This step was 
repeated until the fat phase turned a more yellow colour.  The fat tissue was then 
digested by one volume of 0.15 % (w/v) of collagenase A (Roche) in saline and 
mixed well at 37°C for 1 hour.  The collagenase activity was then inactivated by 
adding FBS for one in tenth volume of digested tissue.  After the digestion, the 
bottom phase now contained the stromal vascular fraction (SVF) cells and was then 
collected in the 50 ml tubes through a sterile mesh to remove tissue debris.  The SVF 
cells were then centrifuged at 800g for 5 minutes.   Cell pellet was re-suspended 
with the saline and filtered through the 100 m and 40 m cell strainers thereafter.  
SVF cells were then spun again and the pellet was re-suspended in the 160mM of 
NH4Cl for 10 minutes to break down remaining red blood cells.  The lysed cells in 
the supernatant were discarded after the centrifugation at 800 g for 5 minutes.  The 
SVF cell pellet was re-suspended in a small amount of EGM2 and the total number of 
cells was quantified.  ADSCs were then immediately isolated from the mixture of 
cells in the SVF by CD34 immunoselection.  
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6.2.2 Isolation of CD34+ cells and culture of adipose derived 
stem cells  
Cells that expressed CD34 were isolated from the populations of cells by using anti-
mouse IgG Microbeads (MACS Miltenyi Biotec).  ADSC CD34+ cells were labelled 
with monoclonal mouse IgG1 anti-human CD34 (Cell Signaling, UK) before being 
allowed to bind with the anti-mouse IgG Microbead in the magnetic column.  The 
heavy and light chain of IgG1 anti-CD34 binds to the Microbead and thus separates 
the bound cells from unbound non-CD34 labelled cells.  Since this method is based 
on the binding of the antibody on the cell surface and the Microbeads, a buffer 
containing Ca2+ and Mg2+ is not recommended.  Moreover, the isolation was 
performed quickly and the cells kept cold all the times.  
The Buffer was prepared by mixing 2mM EDTA and 0.5% BSA in PBS pH7.2 (Sigma-
Aldrich) and kept cold.  ADSCs were washed with PBS and isolated by centrifugation 
at 400g for 5 minutes at 4˚C.  The cell pellet was re-suspended in 100µl of the buffer 
and 1µl of the antibody against CD34 was added.  The antibody was left to bind on 
the cell membrane at 4˚C for 1 hour and the unbound antibodies were washed 
thereafter.  2ml of the buffer (for less than 107 cells) was added to the reaction and 
centrifuge at 300g for 5 minutes at 4˚C.  The supernatant was discarded and the cell 
pellet was re-suspended with 80µl of the buffer.  20µl of the Microbeads were added 
(for less than 107 cells) and mixed well.  The Microbeads and CD34 antibody were 
incubated at 4˚C for 15 minutes to allow binding between the antibody and 
Microbeads.  The non-bound Microbeads, which had no cells binding on them, were 
then washed off with 2ml of the buffer by centrifugation at 300 g for 10 minutes, at 
4˚C.  In a meantime, a magnetic column was placed in the magnetic field and rinsed 
with 500 µl of cold buffer.  After the isolation and removal of the “free-of-cells” 
Microbeads, the pellet was re-suspended in 500µl of the buffer.  The suspension was 
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then applied on the column.  The flow-through solution which contained CD34 
negative cells was removed and the column was washed with 500 µl of the cold 
buffer for 3 times.  After washing, 1ml of cold buffer was added to the column and it 
was removed from the magnetic field stand.  The ADSCs that expressed CD34 and 
were bound to the Microbeads in the column were washed away from the column 
by pushing the plunger into the column.  The “plunged” cells or CD34+ cells were 
collected in a 15ml tube and then centrifuged at 400g for 5 minutes.  The pellet 
containing the CD34+ cells was then re-suspended with EGM2 media and cultured in 
a culture flask coated with 1% of gelatine which was maintained in a CO2 incubator.   
    
6.2.3 Differentiation of adipose derived stem cells by VEGF and 
shear stresses  
ADSC CD34+ cells at were cultured with complete EGM2 until passage 4-5.  To start 
the EC differentiation, 2.0 x 104 cells were seeded on a 13 mm coverslip (Fisher 
Sciencetific, UK) in a 24 well plate.  The culturing of the cells was continued with 
complete EGM2 until reaching 80% confluence.  The media was then changed to low 
serum EGM2 to growth arrest overnight prior to commencing the differentiation 
protocol.  
Aortic and ventricular shear stresses were applied on the cells to attempt to 
differentiate them into ECs.  The flow patterns were generated by the Cone-and-
Plate machine, as described in the section 5.2.2.1.  The only difference in this 
experiment from ex vivo study was the plate.  Rather than using the bullets and lid to 
fix tissue, the cells on the coverslips were mounted on a plate which contained 9 
recessed wells which was then placed in the flow chamber.  The cells were then 
exposed to either AF or VF in 0.4% FBS with EGM 2 media supplemented with 
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50ng/ml of VEGF (Cell Signalling, UK) for 4 days for which used as the optimal flow 
incubation time by Bassaneze and colleagues (Bassaneze et al., 2010).  ADSCs that 
were maintained in a static environment with 50ng/ml of VEGF in low serum EGM2 
served as the control.  
 
6.2.4 Endothelial cell function: Acetylated LDL-uptake 
Differentiated ADSC CD34+ cells on the coverslips were removed from the Cone-
and-Plate machine and placed into 24-well plates.  All the washing and incubation 
was performed in the plate.  Both the static controls and differentiated cells were 
washed with PBS twice before being incubated with Alexa Fluor® 594 Acetylated 
LDL or AcLDL (Molecular ProbesTM, UK).  The AcLDL was prepared at 3 µg/ml in 
0.4% FBS with EGM2.  500 µl of the media containing AcLDL was added to every 
well and the incubation was then carried on in a 95% air/5% CO2 incubator at 37⁰ C 
for 4 hours with protection from exposure to light.  Following this incubation all 
samples were washed 3 times with PBS to remove the excessive AcLDL that had not 
been taken up by the cells.  They were then fixed with 4% PFA for 10 minutes.  The 
cell membrane was permeabilised by incubation with 0.5% Triton X in PBS for 3 
minutes to allow the staining of cell nucleui.  The nucleui was stained twice with 
DAPI for 5 minutes.  Finally the coverslips were the mounted on the slides with 
Permaflour (Beckman Coulter, UK).  The amount of LDL taken up by cells was 
photographed using a fluorescent microscope (Nikon, Japan) and the intensity of the 
fluorescence was analysed by Image J.  
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6.2.5 Immunocytochemistry of endothelial makers 
Endothelial and VIC markers expressed by the ADSC CD34+ cells after their 
differentiation was investigated using ICC. The staining protocol has been described 
in section 2.2.4 with the exception that human specific primary antibodies were 
employed for CD31 and NOS III rather than the antibodies used to investigate 
porcine tissue.  The mouse anti-human CD31 (Dako, Denmark) was prepared at 1:40 
dilution and the rabbit anti-human NOS III (Thermo Scientific, UK) was used at 1:50.  
 
6.2.6 Data Analysis 
The intensity of fluorescent staining was analysed by Image J.  The threshold of 
intensity was set for each staining and applied for every group of samples.  For 
every analysis, the area of fraction of the target protein staining (red or green 
colour) was normalised with the area fraction of nucleus (blue colour).  
Furthermore, mean values (of the area fraction) of each sample was calculated from 
2-5 optical fields and plotted on a graph using Excel programme.  The error bars 
represented SEM.   
The data from all sample groups was statistically analysed by Prism 5 using the 
Kruskal-Wallis test, which considers median variance as the criteria.  The pair-wise 
comparison was further assessed by Dunn’s Multiple Comparison Test.  P value less 
than 0.05, 0.01 and 0.001 are represented by *, ** and ***. 
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6.3  Results  
The effect of different shear stress patterns on the EC differentiation of human 
ADSCs was investigated by ICC.  The ADSCs were maintained in complete EGM2 
being exposed to AF and VF for 4 days.  During the 4 days of flow, ADSCs were 
supplemented with 50ng/ml of VEGF in EGM2 containing 0.4% FBS. ADSCs which 
were maintained under static conditions in EGM2 containing 0.4% FBS and 50ng/ml 
VEGF served as the control.   
The ability of cells to absorb AcLDL was investigated in ADSCs that were exposed to 
AF, VF or kept under static conditions.  Both AF and VF patterns led to increase 
uptake of AcLDL, as compared to the static control (Figure 6.1).  ADSCs under static 
conditions had nearly none of the staining of LDL (median value was at 0.2286).  In 
comparison, the AF and VF exposed cells increased the absorption and, thus, the 
staining of LDL to 5.675 and 5.031, respectively.  However there was no difference 
observed between cells exposed to AF or VF (p=0.0665, n=3). 
The expression of vWF, an EC marker, was also observed in ADSCs after they were 
exposed to the respective flow patterns.  As depicted in Figure 6.2, VF tended to 
increase the expression of vWF for all 3 ADSC samples; the median value of area 
fraction was 6.234.  However, there was no significant difference (p=0.0509) when 
compared to the static control or the AF treated samples.  Both static conditions and 
the AF did not induce the expression of vWF and had the area fraction of vWF 
staining lower than nucleus staining as demonstrated by the value < 1.  The median 
values of the control and AF samples were at 0.08409 and 0.3740, respectively.  
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a) 
 
b) 
 
Figure 6.1  Effect of shear stress patterns on AcLDL uptake.  a) Immunocytochemistry of 
differentiated ADSCs stained for AcLDL, in red.  Human ADSCs were cultured with 50 ng/ml of 
VEGF in (0.4% FBS) EGM2 during the maintenance under either static culture (left panel), aortic 
flow (middle panel) or ventricular flow (right panel) for 4 days.  b) Fluorescent quantitative 
analysis represented mean values of the area fraction and the error bars depicted the SEM.  The 
area fraction was calculated from 2-5 optical fields of each sample.  The mean values, n=3, among 
groups were statistically analysed by Kruskal-Wallis and pair-wise compared by Dunn’s Test.   
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a)  
 
b) 
 
Figure 6.2 Effect of shear stress patterns on the expression of vWF.   a) Immunocytochemistry of 
differentiated ADSCs stained for vWF, in red.  Human ADSCs were cultured with 50 ng/ml of VEGF 
in (0.4% FBS) EGM2 during the maintenance under either static culture (left panel), aortic flow 
(middle panel) or ventricular flow (right panel) for 4 days.  b) Fluorescent quantitative analysis 
represented mean values of the area fraction and the error bars depicted the SEM.  The area 
fraction was calculated from 2-5 optical fields of each sample.  The mean values, n=3, among groups 
were statistically analysed by Kruskal-Wallis and pair-wise compared by Dunn’s Test.   
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The expression of CD31 on the cell membrane was also observed in differentiated 
ADSCs.  The ICC of the cells from the control and flow-treated samples suggested a 
different base line expression of CD31 (Figure 6.3).  Whereas ADSCs from donor 1 
and 2 had low level of CD31 expression at the static control and increased 
expression of CD31 in response to flow, the cells isolated from the third donor 
expressed highest level of CD31 under static conditions that were maintained by AF 
but decreased by VF effect.   
Although the area fraction of CD31 expression by the AF effect the third donor 
remained the same as the static condition, CD31 staining revealed more uniformity 
around the cell membrane by the effect of AF.  There was no statistically significant 
difference among any culturing conditions (p=0.4911, n=3).  The median values of 
control, AF and VF groups were 0.08478, 9.089 and 5.742, respectively.  
The expression NOS III, an endothelial specific isoform of NOS, was also investigated 
in ADSCs that were exposed to different patterns of flow.  As shown in the Figure 
6.4, AF and VF induced shear stress led to the increased expression of NOS III by the 
cells exposed the flow for 4 days.  The median value of the amount of staining by the 
static control increased from 0.3110 to 4.347 after exposure to VF, and to 10.25 
following exposure of AF.  This increased expression by the effect of AF was 
significantly different from the control (p=0.0390).  Although there was a trend that 
the VF also induced the expression of NOS III in the ADSC cells to the higher level 
than that of the control, there was no statistical difference between these two 
groups.  
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a) 
 
b) 
 
Figure 6.3 Effect of shear stress patterns on the expression of CD31.  a) Immunocytochemistry of 
differentiated ADSCs stained for CD31, in red.  Human ADSCs were cultured with 50 ng/ml of VEGF 
in (0.4% FBS) EGM2 during the maintenance under either static culture (left panel), aortic flow 
(middle panel) or ventricular flow (right panel) for 4 days.  b) Fluorescent quantitative analysis 
represented mean values of the area fraction and the error bars depicted the SEM.  The area 
fraction was calculated from 2-5 optical fields of each sample.  The mean values, n=3, among groups 
were statistically analysed by Kruskal-Wallis and pair-wise compared by Dunn’s Test.   
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a) 
 
b)  
 
Figure 6.4 The effect of shear stress pattern on the expression of NOS III.  a) Immunocytochemistry 
of differentiated ADSCs stained for NOS III, in red.  Human ADSCs were cultured with 50 ng/ml of 
VEGF in (0.4% FBS) EGM2 during the maintenance under either static culture (left panel), aortic 
flow (middle panel) or ventricular flow (right panel) for 4 days.  b) Fluorescent quantitative 
analysis represented mean values of the area fraction and the error bars depicted the SEM.  The 
area fraction was calculated from 2-5 optical fields of each sample.  The mean values, n=3, among 
groups were statistically analysed by Kruskal-Wallis and pair-wise compared by Dunn’s Test.   
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The expression of SMαA was also investigated to assess the effect of shear stress on 
mesenchymal differentiation, as shown in the Figure 6.5.  The AF significantly 
induced the expression of SMA by ADSCs, as represented by the increasing median 
value of the staining to 6.526.  In comparison, the cells which were maintained in 
static conditions and those exposed to the VF show little or no expression of SMαA 
with median values at 0.04306 and 0.5834, respectively.  It was noted that the 
staining of SMαA in the AF samples did not appear as mature fibres. 
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a) 
 
b) 
 
Figure 6.5 The effect of shear stress patterns on the expression of SMαA.  a) Immunocytochemistry 
of differentiated ADSCs stained for SMαA, in red.  Human ADSCs were cultured with 50 ng/ml of 
VEGF in (0.4% FBS) EGM2 during the maintenance under either static culture (left panel), aortic 
flow (middle panel) or ventricular flow (right panel) for 4 days.  b) Fluorescent quantitative 
analysis represented mean values of the area fraction and the error bars depicted the SEM.  The 
area fraction was calculated from 2-5 optical fields of each sample.  The mean values, n=3, among 
groups were statistically analysed by Kruskal-Wallis and pair-wise compared by Dunn’s Test.   
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6.4  Discussion  
The effect of the shear stress patterns and VEGF on the differentiation of ADSCs into 
VECs is established in these studies.  Shear stresses increased the expression of 
endothelial cell markers and functional properties associated with ECs.  Moreover, 
the AF significantly enhances the expression of NOS III and SMαA by ADSCs, 
whereas the VF failed to stimulate the same effects.  
In these studies, the ADSCs were isolated by CD34 immunoselection before the 
culturing with EGM2 on a gelatin coated plate, for a number of reasons.  Firstly, 
ADSCs can be obtained from the SVF, of homogenised adipose tissue, which also 
contains other cells e.g. pre-adipocytes, macrophages, fibrobasts, pericytes, ECs and 
hematopoietic cells (Zimmerlin et al., 2010).  Although ADSCs share the expression 
of protein markers with mesenchymal stem cells and pericytes, a glycoprotein CD34 
is expressed only by (primary) ADSCs and absent in other mesenchymal and 
pericyte cells in the SVF (Mizuno et al., 2012; Lin et al., 2010).  The positive 
immunoselection of CD34+ cells maximises the number and purity of the stem cell 
population from the heterogeneous SVF cells (Gimble et al., 2007). 
Additionally, it has been demonstrated that CD34 is quickly lost in the cultured 
ADSCs by passage 3, although it is highly expressed in the primary ADSCs (Helder et 
al., 2007; Ning et al., 2006; Mitchell et al., 2006).  However, it has also been revealed 
that the loss of CD34 expression by cultured ADSCs does not affect the 
differentiation potential (Suga et al., 2009).  Thus the expression of CD34 by ADSCs 
at later passages was not pursued in these studies.  
After being selected for CD34+ cells, the ADSCs are differentiated into VECs by 
combined stimulators i.e. endothelial media, VEGF and shear stress.  It has been 
demonstrated that the culturing of ADSCs with EGM2 alone did not induce ADSCs to 
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express EC markers; however, those cells in the EGM2 were readily transformed 
into ECs when the VEGF or laminar shear stress was applied (Zhang et al., 2011).  In 
contrast, ADSCs in DMEM (Bassaneze et al., 2010) and endothelial cell growth 
supplement media (Fischer et al., 2009) had a restricted expression of EC markers 
after being exposed to shear stress alone.  Similarly, the static controls in this study, 
the ADSCs with VEGF in low-serum EGM2, do not take-up LDL nor express EC 
markers, with the exception of cells from one patient who had constitutive 
expression of CD31.  Moreover, those cells which were maintained at the same 
conditions as the controls respond to shear stresses by subsequently being able to 
taking-up LDL and expression of EC markers.  
The modified LDL (acetylated at the lysine residue of the apoprotein unit or AcLDL) 
can be taken-up by ECs and macrophages.  Thus, the positive staining of AcLDL in 
the cytoplasm of cells can be used to characterise ECs.  In these studies, there is a 
strong trend suggesting that both AF and VF induce the LDL up-take by ADSCs when 
compared to the static control, although this difference was not statistically 
significant, most likely due to the small number of experiments that were 
performed.  A similar effect of shear stress to stimulate the up-take LDL by ADSCs 
has been demonstrated previously (Fischer et al., 2009).   
In addition to the function of the LDL uptake, the effect of the differential flow 
patterns on the expression of EC markers is also investigated. 
It has been reported that porcine aVECs expressed higher levels of mRNA of vWF, 
CD31 and eNOS than vVECs (Simmons et al., 2005).  However, in this study, there is 
a prominent trend suggesting that the VF increase the expression of vWF by ADSCs, 
similar to the effect of shear stress reported on CD31-/CD45- ADSC (Zhang et al., 
2011).  Thus the sustained expression of vWF stimulated by AF, which is 
contradictory to the comparable cells (aVECs) reported by Simmons and colleagues, 
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suggests a complicated regulation on the production of vWF rather than a single 
effect from the flow pattern.   
There is no obvious effect of AF and VF on the production of CD31 by ADSCs.  While 
the ADSCs isolated from 2 patients respond to the shear stress in the similar 
manner, in that they increase the expression of CD31, there was a discrepancy with 
the data collected from the cells of the other donor.  The expression of CD31 by the 
ADSC of this patient indicates the biological variability that may exist with these 
cells, and hence the different potential of ADSCs to be derived into ECs.  Moreover, it 
is unlikely to be the expression by ECs that might contaminate in the ADSC 
population, as demonstrated by the fact that the ADSCs from this patient do not 
express other EC markers i.e. vWF and NOS III under static conditions.  In addition, 
in the mixture of SVF cells, percentages of CD31+, vWF+ and FLK-1+ cells 
maintained stability over passages (Mitchell et al., 2006).  Thus, if there is a 
presence of ECs in the ADSC culture, the positive staining of vWF and NOS III should 
be concomitant with the CD31.     
Endothelial NO plays important role in the regulation of the mechanical properties 
(El-Hamamsy et al., 2009) and the prevention of calcification (Richards et al., 2013) 
of the aortic valve.  The production of NOS III is thus considered as a functional 
marker of VEC-derived ADSCs.  In this study, the AF significantly increases the 
expression of NOS III by ADSCs.  This effect is comparable with the results 
demonstrating the higher mRNA expression of NOS III by VECs on the aortic side 
(Simmons et al., 2005).  Nonetheless, these observations are contradictory to the 
research carried out on the human valves,  which revealed the higher expression of 
NOS III on the ventricular side of the valve and its function to protect the 
calcification on that side (Richards et al., 2013).   
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There is a trend that the VF also increases the expression of NOS III by ADSCs; 
however it is not conclusive in this study, that the expression of NOS III by ADSCs is 
flow-pattern dependent.  In addition, it has been demonstrated that the expression 
of NOS III is complicatedly regulated by flow patterns (Ziegler et al., 1998b).  
Whereas laminar shear stress increased NOS III mRNA expression, oscillatory shear 
stress increased the activity of promoter of NOS III.  
The ADSCs also have the potential to derive into SMC lineage. It has been 
demonstrated that the ADSCs readily expressed SMαA when treated with TGF-β 
(Lee et al., 2006).  In these studies, ADSCs significantly increase the expression of 
SMαA when they are exposed to the AF, whereas the VF does not induce the same 
effect.  Interestingly, the expression of SMαA is co-expressed with NOS III.  This may 
suggest the potential to commit to EndoMT by EC-derived from ADSCs, similar to 
the ability of VECs that can transdifferentiate into mesenchymal cells and are 
considered as the source of VICs (Paruchuri et al., 2006; Paranya et al., 2001).  
Nonetheless, this raises the concern that the ADSCs that are differentiated by AF 
could participate in the pathological development of valve disease as evidenced by 
the expression of SMαA by VICs of calcified valves (Latif et al., 2014). 
Although these studies reveal the different expression of NOS III by the different 
flow patterns and this is similar to the differential expression by aVECs and vVECs 
(by Simmons and colleagues), the absolute marker for side-specific VECs has not 
been established yet.  Thus the differentiation of ADSCs into side-specific VECs 
remains unclear.  Moreover, the ability of EC-derived ADSCs to regulate the 
production of ECM by VICs requires further investigation.   
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6.4.1 Limitations of the study 
There are few technical issues in these studies.  The limited number of the Cone-
and-Plate flow chambers available did not allow the differentiation to be performed 
by exposing two shear stress patterns at a time.  Thus, the ADSCs at different 
cultures/passages were prepared.  Due to this limitation, the ADSCs were cultured 
under static conditions and used as the control separately for each differentiation.  
The isolation of ADSCs from the SVF (by selecting CD34+ cells) did not exclude the 
CD31+/CD34+ cells which are identified as capillary ECs.  The exclusion of capillary 
ECs could be done by another immunoselection of CD31 after CD34+ selection.  
However, it has been demonstrated that the human ADSCs at primary culture 
contained only 10% of CD31+ cells that also included CD31+/CD34- cells (Planat-
Benard et al., 2004).  Thus the exclusion of CD34+/CD31+ cells was not done in 
order to minimise the time of isolation and time that ADSCs were in the harsh 
condition (4⁰C without serum), during isolation.  It, in turn, increased the survival of 
CD34+ ADSCs to be further cultured.  
The quantification of LDL-uptake activity and the expression of EC markers by 
Image J is a semi-quantitative method.  The attempt to quantify the production of EC 
markers was performed by using Western Blots.  However, the blotting step was 
interfered by the grease which was used for mounting the coverslips in the flow 
chamber of the Cone-and-Plate machine.  The grease contamination in the protein 
solution prohibited the transfer of proteins on the membrane.  Further experiments 
are required to vary the speed and time of centrifugation to remove grease before 
Western Blot analysis is performed.   
The numbers of cell isolates could have been increased from more donors/patients.  
In addition, the experiments to evaluate the ECM regulation by EC-derived ADSCs in 
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a co-culture with VICs could have also been evaluated.  However those plans could 
not be accomplished due to the considerable of time was spent to develop the 
Western blot technique for samples exposed to the flow by Cone-and-Plate machine.  
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6.5  Conclusions and Future Directions 
The ADSCs have the potential to differentiate into VECs, as demonstrated by the 
expression of EC and mesenchymal markers, when stimulated by EGM2, VEGF and 
shear stress. However, a marker of side-specific VECs has not yet been established, 
making it is difficult to judge if the AF and VF stimulate differentiation into cells that 
resemble VECs from each side of the valve. The aortic shear stress significantly 
increases the expression of NOS III and SMαA by ADSCs, whereas the ventricular 
shear pattern does not statistically induce the same effect.   
Although the ability to uptake LDL and expression the EC markers by EC-derived 
ADSCs is demonstrated in these studies, their ability to regulate the production of 
ECM by VICs remains un-studied.   In order to evaluate if differential flow patterns 
can induce the differentiation of ADSCs into side-specific VEC, their effects on the 
ECM production by VICs need to be compared to the effects seen by aVECs and 
vVECs already presented in this thesis.  To address this question, the ADSCs will 
need to be seeded onto 3-D scaffolds containing VICs and continuously exposed to 
the different patterns of flow in a similar manner to the experiments in Chapter 5.  
Alternatively, the effects of condition media could be assessed or they could be co-
cultured with VICs as described in Chapters 3 and 4.  This information will be of use 
in choosing a cell type and conditioning protocol for the development of tissue 
engineered heart valves.  
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7 Chapter 7 Discussion  
The aims of this thesis were to demonstrate if there is a side-specific marker or 
functional response that differentiates between cells on each side of the valve.  From 
the functional perspective the thesis focused on the potential role that side-specific 
VECs play a role in the regulation of specific ECM proteins in the aortic valve.  
Moreover, it sets out to determine if the response of side-specific VECs to the 
patterns of shear stress generated on each side of the aortic valve, is also important 
for the ECM remodeling.   
This thesis established the method to isolate and culture VECs from the different 
aspects of valve individuals; allowing the investigation of communication and 
response between side-specific VECs and VICs practical. While there was no 
appreciable difference in phenotypic markers expressed by the cells, aVECs and 
vVECs show a differential effect on the content of collagen and GAGs produced by 
VICs.  The effect on collagen content is presumably mediated by stable factors that 
accumulate in vVEC conditioned media whereas GAGs content is affected by labile 
mediators differentially released by VECs under static condition.  When the effect of 
shear stress patterns was addressed, the AS shows a unique response to the AF such 
that this interaction influences the total amount of collagen and GAG in the valve 
tissue and it cannot be replicated by the VS exposed to the same pattern of flow.  In 
contrast to collagen and GAGs, elastin content is affected by the pattern of shear 
stress in a specific VEC-independent manner.  Taken together, these findings reveal 
the importance of cell sources and shear stress patterns on the regulation of the 
ECM components.  These observations are of value TEHV projects, in meeting the 
challenge of re-generating a heart valve that contains native valves ECM structure 
and biomechanical properties.  Thus, the differentiation of ADSCs into VECs that 
have side-specific characters to regulate the production of ECM was attempted by 
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applying different shear patterns.  Our data suggest that ADSCs are the potential 
source of VECs which can be induced to have EC functions and produce the EC 
functional markers.  However the effect of AF and VF on the differentiation of ADSCs 
and their ability to regulate the ECM contents needs further investigation.  
VECs contribute an important role to maintain valve integrity, in a similar way as 
vascular ECs elsewhere.  For instance, VECs regulate inflammatory reactions 
between blood and the valve (Muller et al., 2000), deliver nutrients to VICs 
underneath (Tompkins et al., 1989) and regulate phenotypes of the underlying VICs 
(Butcher and Nerem, 2006).  Moreover, they release the vasodilators and 
vasoconstrictor agents to adjust the contraction of the valve (Ku et al., 1990; 
Pompilio et al., 1998; Peltonen et al., 2009) as well as to regulate valve mechanical 
properties (El-Hamamsy et al., 2009).  In addition to the regulation of valvular 
homeostasis, VECs are also thought to be VIC progenitor cells and replenish VICs via 
the activation of EndoMT (Wylie-Sears et al., 2011; Paruchuri et al., 2006; Paranya et 
al., 2001).   
Although VECs share some function with vascular ECs, the studies at genetic and 
molecular level reveals different transcription profiles (Farivar et al., 2003) and the 
unique signalling pathways (Butcher et al., 2004) between VECs and the nearby ECs 
from the aorta.  Additionally, there are an increasing number of studies 
demonstrating the phenotypic heterogeneities of VECs from the aortic and 
ventricular side of the aortic valve.  These include a differential gene transcription 
profile (Simmons et al., 2005), differential production of NOS III and Cx43 proteins 
(Richards et al., 2013; Inai et al., 2004)  and  the differential expression of miRNA-70 
in a flow-pattern independent manner (Holliday et al., 2011).  More importantly, AS 
and VS differentially respond to the same patterns of shear stress, in terms of 
production of inflammatory molecules (Sucosky et al., 2009) suggesting the unique 
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inherited properties of aVECs and vVECs which are independent of the flow 
patterns. 
The protocol to isolate and maintain VECs and VICs from the same valve was 
validated in this study, in the attempt to investigate and compare the intrinsic 
phenotypes of side-specific VECs without shear stress effect.  aVECs and vVECS are 
isolated by the method which is adapted from collagenase and single colony 
expansion (Butcher et al., 2004).  Being isolated by collagenase in a separate 
isolation chamber and expanded as a cluster, mimics the physiological environment 
of ECs (as opposed to trying to grow populations of cells from a single VEC).  VECs 
were cultured in conditions that reduce the chance of contamination of VECs from 
another side of the valve, but increases VEC growth; thus, in turn, increasing the 
efficiency of VEC isolation.  Moreover, aVECs and vVECs maintain EC phenotypes 
over passages in the similar manner as those found in situ in the current study. 
Besides the vasodilators and constrictors that have been investigated, this thesis 
reveals further function of aVECs and vVECs to release and modulate the cytokines 
which are involved in inflammatory responses and remodeling of ECM components.  
Those stable molecules which are increased in the media cultured with aVECs and 
vVECs sides, at 48 hours under the resting condition, are IL-1β, IL-8 and TGF-β.  In 
addition, IFN-γ and TNF-α which are present in the media appear to be metabolised 
by culturing with VECs.   
It has been reported that IL-1β and TGF-β increase the production of collagen.  The 
amount of collagen that was secreted into the media was increased in the peritoneal 
mesothelial cells treated with IL-1β (Yang et al., 1999).  The treatment with IL-1β 
increases TGF-β mRNA expression by the mesothelial cells (Yang et al., 1999).  
Endothelial progenitor cells that are treated with TGF-β augment the production of 
collagen type I and III (Sales et al., 2006).  The production of collagen and MMP-2 is 
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increased by stretched vascular SMC in the TGF-β dependent manner (O'Callaghan 
and Williams, 2000).  Moreover, TGF-β is postulated to reduce the synthesis of 
proteases involving in the degradation of ECM, thus increasing in the effect on 
matrix protein synthesis (Roberts et al., 1992). 
However, IL-1β and TGF-β have also been shown to reduce the production of GAGs.  
For example, the synthesis and expression of sulfate-GAGs are reduced by IL-1β 
treated fibroblasts (Qwarnstrom et al., 1993; Qwarnstrom et al., 1989).  The release 
of GAGs from cartilage explants into the media was also reduced by the treatment 
with either IL-1β or TGF-β (Zanni et al., 1995). 
Interestingly, the increase in the amount of GAGs was found only when VICs were 
co-cultured with vVECs.  This effect could be a result of a short-life mediator which 
might be produced and degraded during the 48 hours of incubation.  In the CM, it is 
likely that there is only the effect of molecules which are stable after 48 hours e.g. 
IL-1β and TGF-β and those molecules can attenuate the effect of GAG production 
when they are left to incubate with VICs. This can explain why the increasing 
amount of GAGs was not found by VICs cultured with vVEC-CM.  Additionally, the 
modulation of GAGs was also not observed by aVECs which suggests the differential 
effect of aVECs and vVECs on the interaction with VICs at resting condition.  
In contrast to collagen and GAGs, the amount of elastin was not affected by cultured 
VECs so that it leads to the hypothesis that elastin may be modulated by shear 
stress.  
 It has been proposed that ECs transmit shear stress into biological response 
through various mechanotransducers; for example, shear-sensitive ion channels 
(K+/Cl- channels), integrin binding proteins and glycocalyx (a thin layer of PGs 
around cell membrane) (Tarbell et al., 2005).  Beyond being able to response to 
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shear stress, ECs can distinguish different types of flow and respond to them 
differentially (Barakat and Lieu, 2003). For instance, ECs from the aorta 
differentially express TGF-β and NOS III mRNA in response to the different flow 
patterns of laminar and oscillatory shear stress (Lum et al., 2000; Ziegler et al., 
1998a).  Umbilical vain ECs increased the production of antioxidant (Cu/Zn 
superoxide dismutase) and anti-inflammatory factors following the exposure to 
laminar waveform whereas pro-oxidant (NADH oxidase) was increased by the effect 
of oscillatory waveform (De Keulenaer et al., 1998; Weinberg et al., 2010).  
Furthermore, ECs have been shown to discriminate between steady laminar from 
oscillatory shear stress through the Na-K-Cl co-transporter protein (Suvatne et al., 
2001).  Whereas the laminar flow exposed ECs increased both amount and activity 
of the co-transporter, oscillatory flow did not have an effect on the co-transporter 
level.    
VECs from the opposite sides of the aortic valve have been demonstrated to have a 
differential response to different flow patterns.  Whereas AS that was exposed to VF 
increased in the production of inflammatory molecules (VCAM-1, ICAM-1, TGF-β1 
and BMP-4), VS did not respond to the VF in the same manner (Sucosky et al., 2009).  
Moreover, VS did not induce the production of inflammatory factors by the AF which 
is believed a cause inflammation and calcification on the fibrosa of the valve.  Taken 
all together, this information suggests that VECs are not only able to discriminate 
the flow patterns but aVECs and vVECs also show a unique response to the different 
flow types. 
This thesis further aimed to investigate the effect of different flow patterns on the 
response of VECs, from the different aspect of the valve, in terms of the regulation of 
ECM remodelling.  It has been demonstrated that mechanical force is important to 
maintain the amount of GAGs and elastin as compared to the effect of static 
condition.  Particularly, the laminar waveform plays a crucial role on the modulation 
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of elastin in the valve in side-independent manner.  This can explain the absence of 
the effect of VEC-CM and VEC co-culture on the elastin content when VECs are 
maintained under static condition.  Furthermore, the unique response of AS to the 
AF to increase the amount of collagen and GAGs in the valve cannot be replicated 
when the VS that was exposed to the same flow.  In contrast, vVECs (instead of 
aVECs) under static culture were able to affect the content of collagen and GAGs, 
produced by VICs, as previously shown by the CM and co-culture experiments.  This 
may be due to a differentially expression of shear-sensitive channels e.g. K+/Cl- ion 
channels or a  differential sensitivity to the flow between aVECs and vVECs   Thus 
the regulation function of VECs under static culture is distinct from those exposed 
flow patterns.  
In addition to the shear stress experienced by VECs on the surface, the valves are 
subject to other mechanical forces every cardiac cycle.  Those are cyclic stretch and 
pressure and have been demonstrated to regulate the ECM in the valve 
(Balachandran et al., 2006; Konduri et al., 2005; Merryman et al., 2006; Xing et al., 
2004).  This study additionally highlights the crucial role of flow patterns and their 
responses by side-specific VECs on the modulation of ECM components.  It thus 
provides the fundamental implication to the regeneration of a functional heart 
valves in a laboratory; leading to the production of a living valve that possesses 
biomechanic properties and capability to adapt to the hemodynamic environment. 
Up to date, surgical replacement, either mechanical or biological prostheses is 
considered to be the only treatment for aortic valve disease.  The ability of the valve 
substitutes to grow in paediatric patients cannot be achieved by mechanical or 
bioprosthetic valves since neither contains living cells.  Moreover, the adaptive 
remodelling of mature heart valves during pregnancy implies the crucial 
requirement of valve substitutes to be able to continuously adapt to the changing 
haemodynamic environment (Wells et al., 2012).  The significant ability of a living 
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valve is further demonstrated by Ross operation in which the pulmonary valve is 
grafted to the aortic position.  The replacement with the viable valve allows the 
valvular adaptation to occur at both the cellular and tissue level (Ikhumetse et al., 
2006; Rabkin-Aikawa et al., 2004a) and can improve the survival rate of the 
recipients (El-Hamamsy et al., 2010).  All these data imply the important properties 
of the living valve substitutes for TEHV. 
The original purpose of the last chapter in this thesis was to generate EC that would 
act as side-specific VECs and be able to function and respond to the heamodynamic 
environment by regulating ECM components.  However, due to the time limitations, 
ADSCs are only derived into VECs by shear stresses generated on the aortic valve in 
vivo i.e. AF and VF.   
ADSCs are differentiated into VECs by both AF and VF.  After shear stress exposure, 
they increased the LDL uptake activity and the production of EC markers such as 
vWF and CD31. Furthermore, they also responded to the different flow patterns 
differentially.  Those responses are the production of an EC functional marker, NOS 
III and the myofibroblast SMαA, which was increased after being exposed to the AF.  
Although the co-expression of NOS III and SMαA by AF-differentiated ADSCs 
suggests the ability to commit EndoMT and act as a potential source of VICs, similar 
to the previous finding (Colazzo et al., 2011), this raises the concern of disease 
development by SMαA expression cells (Aikawa et al., 2006; Latif et al., 2014; 
Rabkin et al., 2001).  Overall, this data suggest the potential of ADSCs to be used for 
TEHV.  Moreover, the function of VEC-derived ADSCs that are differentiated by 
different types of flow need to be further investigated for their ability to modulate 
the ECM components through the response of VICs.  
It is noted that although there is an increasing research on the heterogeneous 
phenotypes of side-specific VECs, the markers to identify their distinction have not 
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been established.  Thus, the identification of which VEC phenotypes differentiated 
ADSCs correspond to is not clear possible.   
It is likely that side-specific VECs exert a different function to modulate the ECM 
components, as demonstrated in this thesis, rather than a different expression of a 
cell surface.  In addition, the unique physiological function between aVECs and 
vVECs has been revealed, in a flow pattern-independent manner.  
Nearly to the end of this thesis, I have contributed a project to demonstrate 
differences in the mechanical properties of VECs on the AS and VS of valves.  This 
effect was related to differences in actin expression by aVEC and vVECs.   In situ 
analysis demonstrated that actin expression was significantly higher in vVECs, as 
compared to aVECs.  This characteristic remained when VECs were cultured for 
several passages and exposed to the reverse pattern of their respective flow.  The 
stiffness of vVECs in flow-independent manner was further confirmed by ex vivo 
analysis of the valves that were exposed a surface to both physiological and reverse 
patterns of flow.  The results also showed that the stiffness of vVECs was remained 
even if they are exposed to the other side pattern of flow (Chester un-published 
observations).  The possibility exists that differences in cell mechanics may be a 
differential marker that can distinguish between aVECs and vVEC.  However, the 
relevance of this difference to cell function is currently under investigation.  
In summary, this thesis reveals the function of aVECs and vVECs as well as their 
unique response to the shear stress to modulate the ECM components produced by 
VICs.  Moreover this finding is important for the development of TEHV.   
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